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Abstract
Ischemic heart disease and stroke are the leading causes of death in the industrialized
countries. The driving mechanism behind these diseases is the atherosclerotic pro-
cess leading to narrowing of the arteries and eventually a reduction of blood supply
to the target organs. Lipoproteins known as carriers of cholesterol play an essential
role in that process. However, despite intensive research over more than 100 years,
the molecular level structure and function of lipoproteins are not fully understood.
This largely stems from the fact that due to the small size and the dynamic nature
of lipoproteins, experimental techniques are not able to gauge lipoprotein structure
and dynamics in sufficient detail. Meanwhile, molecular dynamics (MD) simulation
has proved to be a powerful and simple method to explore the properties of various
biological systems and to overcome many limitations of experimental techniques. In
this thesis, the MD method was used to study lipoproteins at the molecular level.
To this end, coarse-grained molecular models for high- and low-density lipoprotein
(HDL and LDL, respectively) particles were constructed to study their structure and
dynamics. Further, atomic-scale models were used to study the interaction between
HDL and CETP, a lipid transfer protein. Finally, atomic simulations were also em-
ployed in a lipoprotein-like environment to assess the validity of using BODIPY, a
common molecular probe, to explore lipoprotein properties.
The first key result of this thesis is the detailed structural model found for both
HDL and LDL, showing that the previously proposed 2- and 3-layer models are inad-
equate for describing lipoprotein structure to a sufficient degree. It was found that
the structural and dynamic properties of lipids hosted by lipoproteins depend signif-
icantly on their location and distance from the center of the particle. Second, this
thesis work revealed the mechanism and the residues involved in anchoring CETP
to the surface of lipoprotein particles. Also, the critical role of helix X as a door
to the hydrophobic tunnel carrying the cargo lipids was clarified. Third, based on
BODIPY-simulations reported in this thesis one can conclude that BODIPY-labeled
cholesteryl oleate is not a suitable probe for experimental cholesteryl oleate tracking
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studies in lipoprotein environments. It appears that a successful probe in a lipoprotein
environment should have no significant affinity for the hydrophilic surface region.
The findings give a solid grounds for further studies to explore the key initial
steps associated with atherosclerosis and also the molecular-level events in the lipid
exchange processes. For future purposes, this work demonstrates that the used
simulation methods are particularly useful for studies of, e.g., the coupling between
the lipid composition of lipoprotein particles and their structure and function.
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1 | Introduction
Cholesterol was found more than 100 years ago, and the research in this field has
been very active ever since [1]. Cholesterol plays many roles in biological processes,
for instance as an important structural component of cell membranes, as a building
block of different hormones, and as a key player in cardiovascular diseases caused by
atherosclerosis [2]. Meanwhile, lipoproteins are macromolecular complexes consisting
of lipids and carrier proteins transporting cholesterol to every part of the body via the
bloodstream [2]. Lipoproteins are very heterogeneous, differing in size, density, and
molecular composition. There are different classes of lipoproteins with different roles
in the cholesterol metabolism. For example, low-density lipoprotein’s (LDL) main
task is to carry cholesterol to the periphery, while high-density lipoprotein (HDL)
transports cholesterol to the opposite direction [2].
In certain conditions, LDL and very low-density lipoprotein (VLDL) start to accu-
mulate inside the arteries [3]. Under normal circumstances, the endothelium lining,
i.e. the interior surface of blood vessels, maintains vascular tone, hemostasis, and
permeability [4]. However, a range of different factors can cause endothelial dysfunc-
tion, where endothelial barrier integrity is compromised, initiating the accumulation
process [4, 5]. This is the initial phase of the process called atherosclerosis, which
leads to lesion development, narrowing the blood vessel and limiting the blood flow
[6]. The endpoint of this atherosclerotic process is plaque rupture resulting in a
rapid stop in blood flow, i.e. a heart infarct or stroke depending on the location of
the plaque. Atherosclerosis is a key mechanism behind a considerable fraction of
cardiovascular diseases [7]. Given this, understanding the causes of atherosclerosis
is essential, and indeed cardiovascular diseases are the primary cause of death in the
industrialized countries [8, 9].
Pushing further in lipoprotein research is essential for understanding the biophys-
ical and pathophysiological processes related to cholesterol, lipoproteins, and the
development of atherosclerosis. This information can be used to develop methods
to prevent or hinder atherosclerotic processes. Lipoproteins, as well as many other
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biological systems, are small in size, complex in structure, and highly dynamic by na-
ture. These are challenges for experimental research. To overcome these challenges,
computer simulations, e.g. molecular dynamics (MD) simulation, can be used to
study the systems on a molecular and even atomic level. MD simulation has been
proven to be a robust method to explore a variety of different biological systems.
Despite extensive studies, the structures and dynamics of HDL and LDL are not
well understood. The objective of this thesis is to obtain more detailed insights
into the lipoprotein particles. The primary focus is on the molecular structures,
dynamics, and interactions between the lipid and the protein part of lipoproteins.
The secondary objective is to study the interaction between HDL and one of the
lipid transfer proteins. Finally, the last goal is to assess the validity of a molecular
probe often used in a lipoprotein-like environment.
The structures and dynamics of both HDL and LDL were studied using a coarse-
grained model over time and length scales not accessible by atomistic simulation
models [10–12]. The first detailed models for HDL and LDL were clarified. It was
found out that the structural and dynamic properties of lipids inside the lipoproteins
depend significantly on the location and the distance from the center of the parti-
cle, and that the lipid and the protein part interact strongly instead of being largely
independent of one another. Next, the initial steps in the lipid exchange mecha-
nism of cholesterol ester transfer protein (CETP) were studied [13], and the results
provided information as to how CETP anchors to the lipoprotein particle through
charged residues. The new knowledge gained in this work helps to understand the
initial steps of the CETP-mediated lipid exchange process. Finally, the feasibility of
BODIPY-labeled cholesteryl oleate in a lipoprotein-like environment was examined,
and the result revealed that the BODIPY-labeled cholesteryl oleate is quite unsuit-
able for studies in a lipoprotein-like environment [14]. The accumulated information
is interesting and relevant as such, but more importantly it provides a solid platform
for further studies.
The thesis is structured as follows. The necessary biological background infor-
mation related to lipoproteins and the current knowledge about their structure and
function is covered in Chapter 2. The used research methods, including the molec-
ular dynamics method, the concept of coarse-graining, and analysis methods are
described in Chapter 3. Chapter 4 gives an overview of the studied systems. In
Chapter 5 the primary findings of this thesis are introduced and discussed. Chap-
ter 5.1, based on Paper I, focuses on HDL and its structure and dynamics through
coarse-grained MD simulations. In the same fashion, the properties of LDL studied
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in Paper II are covered in Chapter 5.2. Chapter 5.3, based on Paper III, gives in-
sight into the function of CETP anchored on the surface of an HDL lipid droplet.
The feasibility of the BODIPY molecular probe in a lipoprotein environment to track
cholesteryl oleate molecules is discussed in Chapter 5.4, based on Paper IV. Finally,
concluding remarks are given in Chapter 6.

2 | History and Background
The early history of cholesterol dates back to the 18th century when Poulletier
de la Salle discovered the molecule we know as cholesterol in gallstones in 1769
[1]. Chevreul introduced the name ’cholesterine’, later changed to ’cholesterol’, in
1816. Some twenty years later cholesterol was found in human blood, brain, and
liver. Gradually it was recognized as a normal component of all animal cells and
also as a component of specific pathological collections, i.e. atheromatous arteries
and cholesteatomas [1]. The structure of cholesterol was determined by Heinrich
O. Wieland and Adolf Windaus in the 1930s, who were awarded the Nobel Prize in
chemistry in 1927 and 1928, respectively. In 1964 Konrad Bloch was awarded the
Nobel Prize for resolving the steps of cholesterol synthesis.
Cholesterol serves as a constituent of cellular membranes and a precursor for bile
acids, sex hormones, and cortisol. Further, already in 1901 is was observed that
lipids in the blood were bound to proteins, but still, the discovery of lipoproteins was
delayed for many years [15]. In 1924 chylomicrons were identified by Cage and Fish
[16]. Finally, HDL was discovered in 1924, and later LDL and VLDL in the 1940s
[16].
The structure and function of cholesterol and lipoproteins and their role in cardio-
vascular diseases have been under extensive studies for over 100 years, and multiple
Nobel prizes have indeed been awarded to this field. However, the research is still
active, and the structure and function of lipoproteins are not fully understood, and
the role of the lipoproteins in cardiovascular diseases is debated.
In this chapter the biological roles of cholesterol and lipoproteins are discussed,
after which their role in cardiovascular morbidity is explored in more detail. Finally,
the current knowledge of the molecular level structure and function of lipoproteins is
reviewed together with the limitations of experimental methods in lipoprotein research
to justify the use of computer simulations in this work.
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2.1 Biological Roles of Cholesterol
Cholesterol plays essential roles in different biological processes. Next, a short
overview of these functions is discussed to give an idea about the importance of
cholesterol in human body.
Structural Component
Cellular membranes are composed of a lipid bilayer hosting proteins that interact
with lipids [17]. Cellular membranes are characterized by an impressive complexity
to perform all the functions required by cells. Cholesterol is an essential component
of cellular membranes. Eukaryotic cell membranes contain a significant amount of
cholesterol, as much as up to one cholesterol for each phospholipid [17].
The cellular membrane can segregate its constituents laterally to perform and co-
ordinate its functions. This property of subcompartmentalization is described by the
lipid raft concept [18]. Lipid rafts are considered as functional, fluctuating nanoscale
structures composed of sphingolipids, cholesterol, and proteins. According to the
current view, cholesterol is a fundamental component of rafts that form a platform
for membrane signaling and trafficking [18].
The axons of some nerve cells are surrounded by a myelin sheath [19]. The
purpose of the myelin sheath is to form an electrically insulating layer that increases
the impulse conduction velocity that is essential for the proper functioning of the
nervous system [19]. Cholesterol is one of the components forming the myelin sheath,
and it has been shown that it is an indispensable component [20].
Hormones
Steroid hormones, including cortisol, the steroid sex hormones, and vitamin D utilize
cholesterol as a necessary building block [2]. Cortisol is produced in the cortex of
the adrenal glands and affects many biological functions, such as regulating the
metabolism of sugar, fat, and protein; it also suppresses the immune system and
reduces the formation of bone and collagen synthesis, and many other processes [2,
17]. The steroid sex hormones define the secondary sex characteristics distinguishing
males from females, and the testes and the ovaries are responsible for their production
[2, 17]. Vitamin D is synthesized in the skin in response to sunlight, and the activation
happens in the liver and the kidneys [2, 17]. Vitamin D has an essential role in the
bone synthesis as well as in many other health benefits that however are still under
further research [2, 21].
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Biosynthesis
Most of the cholesterol is produced in the liver, but since all cells can synthesize
cholesterol, it is not indispensable in the diet [2]. The structure of cholesterol sug-
gests a complex biosynthetic pathway, but the building blocks are the same as for
long-chain fatty acids, i.e. acetyl-CoA [2]. The actual synthesis requires several
complex reactions that are not of major interest here, but it is interesting that the
intermediates in the synthesis process serve as precursors for many important bi-
ological molecules, such as many vitamins. After synthesis cholesterol is exported
in three forms: biliary cholesterol, bile acids, and cholesteryl esters. Bile acids and
biliary cholesterol are formed in the liver and excreted into the gut aiding in lipid
digestion and serving as a means to eliminate excess cholesterol from the body [2].
Cholesteryl ester molecules are transported in blood inside lipoproteins to the tissues
or cells in which they are stored or consumed. The basis of the transportation system
is covered in the next section, and the structures and the dynamics of lipoproteins
are discussed in more detail in Section 2.4.
2.2 Lipoproteins - the Cholesterol Carriers
Lipids are virtually insoluble in water, and thus a unique system is required for the
transportation of these molecules in the blood that is virtually a water-like environ-
ment. Many lipids are carried by lipoproteins that are macromolecular complexes
consisting of carrier proteins, called apolipoproteins, and a lipid part, consisting of a
mixture of phospholipids, cholesterol, cholesteryl esters, and triacylglycerols [2].
Lipoproteins are very heterogeneous and classified based on their density, size,
and molecular composition (Table 2.1). The different classes have different roles in
the lipoprotein metabolism [2].
Chylomicrons
Chylomicrons are the largest and the least dense of the lipoproteins, functioning in
the transportation of dietary fats from the intestine to other tissues [22]. Epithelial
cells that line the small intestine synthesize chylomicrons that enter the bloodstream
through the lymphatic system. The apolipoproteins associated with chylomicrons
are apoB-48, apoE, and apoC-II [2, 22]. From these apoC-II activates lipoprotein
lipase (LPL) in the capillaries of adipose, heart, and muscle tissues, releasing free
fatty acids to these target tissues, where fatty acids are either stored or utilized
[22]. After almost depleting triacylglycerols, the remnants containing cholesterol are
CHAPTER 2. HISTORY AND BACKGROUND 8
Lipoprotein Density
(g/ml)
Size
(nm)
Apolipoproteins Function
Chylomicrons <1.006 50-200 apoB-48, apoE,
apoC-II
Transport of dietary fatty
acids from the intestine
to other tissues
VLDL 0.95-1.006 28-70 apoB-100,
apoC-I, apoC-II,
apoC-III, apoE
Transport of
triacylglycerols from liver
to other tissues
LDL 1.006-1.063 20-25 apoB-100 Carries cholesterol to
extrahepatic tissues
HDL 1.063-1.210 8-11 apoA-I, apoA-II,
apoC-II,
apoC-III, apoD,
apoE
Reverse cholesterol
transport
Table 2.1: Major classes of human lipoproteins: Density, size, composition, and
function. Data adapted from [2].
conveyed to the liver where their uptake is mediated by endocytosis, and cholesterol
content is released, and the rest of chylomicrons are degraded [22].
Very Low-Density Lipoproteins
The excess fatty acid that is not used immediately is converted to triacylglycerols
in the liver and combined with specific apolipoproteins to form a very low-density
lipoprotein (VLDL) [22]. Also, surplus carbohydrate can be converted to triacylglyc-
erols in the liver and exported in VLDLs. Also, some cholesterol and cholesteryl esters
and apolipoproteins apoB-100, apoC-I, apoC-II, apoC-III, and apoE are included in
VLDLs [2, 22]. The blood carries these lipoproteins from the liver to the muscle and
adipose tissues, where apoC-II causes the activation of lipoprotein lipase, and fatty
acids are released into the target tissues [22]. Muscle cells use the fatty acids as fuel
while adipocytes, i.e. fat cells, reconvert them to triacylglycerols for storage [22].
Most VLDLs depleted of triacylglycerols are removed from the blood circulation by
the apoE dependant uptake in the liver [22].
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Low-Density Lipoproteins
Further decrease in the triacylglyceride content of VLDL and exchange of apolipopro-
teins between other lipoproteins leads to the formation of low-density lipoprotein
(LDL) [22]. The cholesterol and cholesteryl ester content in LDL is considerable.
The main apolipoprotein is apoB-100 [22]. The main function of LDL is to carry
cholesterol and cholesteryl esters to extrahepatic tissues. LDL receptors on the sur-
face of the cells, taking up cholesterol, recognize apoB-100, and the binding of LDL
to the LDL receptor initiates endocytosis [22]. LDL is contained inside an endosome
that fuses with a lysosome which contains enzymes that hydrolyze the cholesteryl es-
ters. Cholesterol and fatty acids are released inside the cell, and apoB-100 is broken
down into amino acids. The LDL receptor escapes the degradation and is recycled
to the cell surface. Experimental studies suggest that the liver removes over 70%
of circulating LDL, and the rest is taken up by other tissues [22]. ApoB-100 is also
found on the surface of VLDL, but the receptor-binding domain is not exposed on
VLDL [23]. The cell can then use the cholesterol immediately or re-esterify and store
it in cytosolic lipid droplets. The uptake of cholesterol inhibits cholesterol synthesis
in the cell and thus prevents accumulation of excess intracellular cholesterol [22].
High-Density Lipoproteins
All of the previously described lipoproteins carry their load to the periphery, but
the fourth primary lipoprotein type, high-density lipoprotein (HDL), works oppositely
[22]. HDL is synthesized in the liver and initially contains just a little of cholesterol
and apolipoproteins apoA-I, apoC-I, apoC-II, as well as other apolipoproteins, see
Table 2.1. After synthesis, HDL is secreted into the blood where HDL is subject to
a continuous and extensive remodeling by a range of different factors.
On the surface of HDL resides the enzyme lecithin-cholesterol acyltransferase
(LCAT) that aids in the formation of cholesteryl esters from lecithin (phosphatidyl-
choline) and cholesterol. LCAT takes phosphatidylcholine and cholesterol from chy-
lomicrons and VLDL remnants and stores the resultant cholesteryl esters in HDL,
which gradually transforms the HDL from a disc-like to a spherical particle where
cholesteryl ester is stored in the core [2, 22]. Phospholipid transfer protein (PLTP)
is another glycoprotein contributing to the transfer of phospholipids between HDL
and other lipoproteins [22]. PLTP also transfers unesterified cholesterol between
lipoproteins [22]. Both LCAT and PLTP increase the size of HDL [2, 22].
Cholesteryl ester transfer protein (CETP) is a hydrophobic glycoprotein in plasma,
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facilitating the redistribution of cholesteryl esters and triglycerides between different
lipoproteins. The net effect is the transportation of cholesteryl esters from HDL to
VLDL and LDL, while triglycerides are transferred in the reverse direction [22]. Also,
hepatic lipase (HL) on the luminal surface of endothelial cells in the liver is involved
in the HDL metabolism by selective uptake of HDL cholesteryl esters. The activity
of both CETP and HL reduces the size of HDL [22].
Experimental studies are suggesting that the conversion of small HDL particles
to larger ones occurs in proximity to the cells and not while HDL circulates in the
blood [24]. Picking up cholesterol from extrahepatic tissues back to the liver is
called reverse cholesterol transport, which takes place by two alternative pathways
[25]. HDL interacts with the specific receptors on the surface of cholesterol-rich cells
and that in turn triggers passive movement of cholesterol from the surface of a cell
into HDL. The second pathway involves endocytosis of HDL by an active transporter
protein, after which HDL is resecreted with a load of cholesterol. HDL then returns
to the liver where the cholesteryl esters are unloaded. Lipid-free or lipid-poor Apo
A-I is removed partly by the kidneys, and the remainder is catabolized by the liver
[25].
2.3 Role of Lipoproteins in Atherosclerosis and Cardiovascular
Morbidity
Cardiovascular diseases, e.g. heart attack, stroke, and peripheral vascular diseases,
are the primary cause of deaths in the industrial world [8, 9]. Atherosclerosis, i.e.,
accumulation of lipids and plaque formation on arterial walls, is the underlying cause
of these diseases [7]. The goal of this section is to focus on the role of lipids and
lipoproteins in the pathogenesis of atherosclerosis. The cellular and molecular level
of the process is covered in more detail, since the work conducted in this thesis deals
with the molecular level structure and function.
2.3.1 Short History of Atherosclerosis
Atherosclerosis is a disease mankind has been suffering for thousands of years, demon-
strated by the findings in the aorta, coronary and peripheral arteries of ancient Egyp-
tian mummies [26–28]. The findings show that the lesions found in the ancient
mummies are similar to those of lesions in patients who have atherosclerosis today.
At the beginning of the 19th century, medical research started showing interest
in vascular alterations in the search for the reason of angina pectoris, i.e. precordial
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Figure 2.1: Atherosclerotic process. A) Normal artery. B) Endothelial dysfunction.
The permeability of the endothelium increases and macrophages (blues cells) and
low-density lipoproteins (yellow spheres) migrate to the tunica intima under the en-
dothelium. C) Fatty streak formation. Macrophages uptake LDL and transform into
foam cells. Also smooth muscle cells migrate and transform into foam cells. D)
Stable plaque formation. Foam cells die and release lipid debris from the core of the
plaque. Smooth muscle cells form a fibrous cap to cover the plaque to prevent ex-
posure to the artery lumen. E) Unstable plaque formation. If the plaque is exposed,
platelets (bright blue) start to cover the exposure and the release of procoagulation
factors leads to formation of thrombus.
pain. The term arteriosclerosis (later became atherosclerosis) was introduced in 1829
by J. Lobstein [29]. Virchow discovered in the 19th century that the lesions in the
arteries contain a yellow fatty substance, and later Windaus identified that the lesions
consisted of calcified connective tissue and cholesterol [30]. Anitschkow and Chaltow
managed to induce atherosclerosis in rabbits by feeding them with a cholesterol-rich
diet [31]. These findings suggested that lipids and lipoproteins have a significant role
in the pathogenesis of atherosclerosis. Virchow was first to recognize atherosclerosis
as an inflammatory disease, and this recognition has led to massive progress in the
understanding of the pathogenesis of atherosclerosis. Next, a description of the
current understanding of the molecular level events of atherosclerosis is discussed.
2.3.2 Initiation of Atherosclerotic Lesions
The endothelium lining, i.e. a thin layer of squamous cells lining the interior sur-
face of blood vessels, plays a crucial role in the initiation of atherosclerotic lesions
[4, 5]. The normal function of the endothelium lining is to maintain vascular tone,
hemostasis, and inflammation [4]. Laminar flow and the resultant laminar shear stress
activate signaling pathways that maintain the normal function of the endothelium.
Atherosclerotic lesions likely occur at arterial curves and branches, where the laminar
blood flow is disturbed, and the endothelium is subjected to a low shear stress [25].
The mechanical stimuli in addition to traditional cardiovascular risk factors includ-
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ing smoking, aging, hypercholesterolemia, hypertension, hyperglycemia, and family
history are associated with alteration in endothelial function, resulting in endothelial
dysfunction [4].
Endothelial dysfunction is a systemic pathological state of the endothelium in
which an imbalance between vasodilatation and vasoconstriction is present due to the
substances produced by the endothelium. In endothelial dysfunction, the endothe-
lial barrier integrity is compromised leading to increased accumulation and retention
of subendothelial atherogenic LDL and remnant of VLDL [25]. Also, the produc-
tion of reactive oxygen compounds is increased, causing oxidative modifications of
apoB-containing lipoproteins [25]. The increased expression of monocyte adherence
proteins, proinflammatory receptors, and different cytokines lead to monocyte re-
cruitment and migration of monocytes into the subendothelial space [25].
Monocytes are converted into macrophages that start to take up apoB-containing
lipoproteins, degrading and storing resultant cholesterol in cytoplasmic lipid droplets
as cholesteryl ester through a regulated pathway [25]. Lipoproteins modified by
oxidation or glycosylation are taken up by macrophages through a non-regulated
receptor pathway including CD36, scavenger receptor A, and lectin-like receptor
family [25]. Aggregation of apoB-containing lipoproteins enhances the uptake via
phagocytosis contributing to the influx of cholesterol into macrophages and forming
of the so-called foam cells [25]. ApoB containing lipoproteins that also contain apoE
(apoE remnants, VLDL) can cause cholesterol accumulation via interaction of apoE
with apoE receptors, which are not regulated by cellular cholesterol [25]. This phase
of the pathogenesis is usually called fatty streak formation.
2.3.3 Progression of Lesions and Rupture
Fatty streaks do not cause any symptoms and can undergo even regression [25, 32].
However, once the process progresses the regression is less likely to occur because
of the more irreversible changes that take place [25]. Macrophages infiltrated to the
subendothelial space produce cytokines and growth factors that promote smooth
muscle cells (SMC) infiltration. These SMCs originate from the SMCs already
present in the intima and also from tunica media. Accumulated SMCs produce a
complex extracellular matrix composed of collagen, proteoglycans, and elastin to
form a fibrous cap covering the foam cells [32]. The role of the fibrous cap is to pre-
vent occlusion and exposure of prothrombotic factors that might lead to thrombus
formation causing heart infarct or stroke.
Some SMCs can take up cholesteryl oleate and transform into foam cells [25].
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Compared to macrophages SMCs are more inefficient in processing and transporting
cholesterol, resulting in impaired cholesterol eﬄux. Also, the ability of macrophages
to process cholesterol is reduced in more advanced lesions. Due to the accumulation
of cells, the volume of the lesion grows. However, there is vascular remodeling of
the lesion to reduce the protrusion into the lumen [33].
Within a lesion, changes in different signaling pathways accelerate macrophage
death, and decreased phagocytosis of dead macrophages lead to the necrotic death
of macrophages [25]. Necrotic death causes a release of intracellular oxidative and
inflammatory components that in turn contribute to a vicious circle of forming a
necrotic core of the lesion. Components of the necrotic core lead to increased SMC
death, accelerated degradation of extracellular matrix, and decreased extracellular
matrix production [25]. This, in turn, causes thinning of the fibrous cap, which
makes the cap prone to rupture that might expose prothrombotic components and
procoagulation factors, leading to the formation of thrombus and clinical ischemic
cardiovascular events [25].
2.3.4 Role of HDL
Reverse Cholesterol Transport
HDL in both forms, lipid-poor apoA-I, and mature HDL, contribute to removing
cholesterol from macrophages, and thus preventing the formation of foam cells [25].
The eﬄux of cholesterol from macrophages to HDL reduces inflammation, being the
first step in reverse cholesterol transport [25]. HDL collects cholesterol via different
transporter proteins on the surface of the macrophages and also via passive diffusion.
The more lipid-poor HDL is, the more it stimulates HDL eﬄux, and it loses the ability
to bind different transporters as it grows and transforms into spherical mature HDL,
at the same time promoting free cholesterol eﬄux from the plasma membrane [25].
HDL then transports cholesterol to peripheral tissues and back to the liver. HDL
also interacts with other plasma lipoproteins, as discussed in Section 2.2. See Figure
2.2 for illustration of reverse cholesterol transport.
Other Functions of HDL
Reverse cholesterol transport has historically been assumed to be the reason for
HDL’s anti-atherogenic properties given that HDL removes excess cholesterol from
the atherogenic lesions and other peripheral tissues. However, other alternative HDL
functions probably contribute to protective cardiovascular properties, perhaps even
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Figure 2.2: Reverse cholesterol transport. Nascent HDL is secreted from the liver
and the small intestine. After secretion HDL picks up cholesterol from macrophages
and peripheral cells, where it also interacts with other lipoprotein particles. As a
result, a mature HDL particle is formed carrying cholesterol back to the liver. IDL
stands for intermediate density lipoprotein. (the "Liver" symbol is by Laymik, the
"Intestine" symbol is by Nook Fulloption, and the "Fried Egg" symbol by Curve
represents a macrophage. All symbols are from thenounproject.com.)
more than reverse cholesterol transport.
HDL’s apoA-I has been found to decrease expression of adhesion molecules in
the endothelial cell through multiple mechanisms [25]. HDL has effects also on
monocytes and macrophages, in which it inhibits monocyte adhesion and migration
and activation of macrophages. Through removal of excess cholesterol and induction
of signaling pathways, HDL can promote migration of macrophages from the lesions
[34]. In addition to HDL’s effect on macrophages and monocytes, also neutrophile
activation is suppressed. All these contribute to HDL’s anti-inflammatory properties
and thus limit atherosclerosis [25].
HDL also has anti-thrombotic properties that inhibit thrombus formation, which
forms after a plaque is ruptured, and thus contributes to HDL’s anti-atherogenic
properties [35]. For normal function of platelets, the removal of surplus cholesterol
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from the platelet plasma membrane by HDL is required [25]. HDL also affects sig-
naling pathways that reduce platelet activation [36]. Further, inhibition of thrombus
promoting coagulation factors by HDL has been observed [37].
Oxidized LDL deposited in the subendothelial space is a major factor inducing
monocyte migration and activation. Oxidized LDL is more pro-inflammatory and
thus more atherogenic than normal unmodified LDL [25]. HDL can reduce and
prevent oxidation of LDL [38, 39]. HDL can uptake oxidized lipids and other oxidizing
factors from cells, preventing LDL oxidation, and HDL is also capable of removing
lipid peroxides, i.e., oxidized lipids, directly from LDL [39]. On the surface of HDL,
there are also other proteins in addition to apoA-I, and these HDL-associated proteins
seem to have anti-oxidative functions [25].
As described earlier, the loss of endothelial barrier function is the initial step
in the process of lesion development. In addition to affecting adhesion properties
of endothelial lining, HDL also affects the barrier integrity. HDL improves vascular
integrity by inducing vasodilatation, tightening of cell-to-cell junctions [40]. HDL has
also been found to have anti-apoptosis properties [25]. Apoptosis of macrophages
and endothelial cells contributes to the development of the necrotic core of a plaque.
2.4 Current Knowledge of the Lipoprotein Structure and Function
The current knowledge and understanding of the molecular composition of different
lipoprotein particles are quite extensive. Meanwhile, the structures of lipoproteins are
rather poorly understood. This is primarily due to experimental difficulties to deal
with dynamic nano-sized particles. The limitations are discussed in Section 2.5, while
this section covers the current state of the knowledge about lipoprotein structure
and function. First, the molecular composition is briefly covered, and secondly, the
molecular structure is discussed in more detail.
2.4.1 Molecular Composition
The lipoproteins are macromolecular complexes composed of proteins and lipids, as
discussed in Section 2.2, and the lipoproteins can be classified into different sub-
classes based on their size, density, protein content, and function. The following
discussion covers only the lipoproteins studied in this thesis, namely HDL and LDL.
The molecular composition expressed in weight percent are shown in Table 2.2.
The lipid part of LDL consists on average of about 3000 lipids: 1600 cholesteryl
esters, 700 phospholipids, 600 unesterified cholesterol molecules, and 170 triacylglyc-
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Composition (wt %)
Lipoprotein Protein Phospholipids Cholesterol CE TG
HDL 55 24 2 15 4
LDL 23 20 8 37 10
Table 2.2: Molecular composition of high density lipoprotein (HDL) and low density
lipoprotein (LDL) expressed in weigh percent. CE stands for cholesteryl ester, TG
triacylglycerol. Data adapted from [2].
erides [41, 42]. The main phospholipid components are phosphatidylcholine (POPC,
about 450 molecules), sphingomyelin (about 185 molecules), and lysophosphatidyl-
choline (about 80 molecules). In addition to these phospholipids, smaller amounts
of other molecules are usually present in LDL [43–46].
On the surface of LDL lies a single copy of the apoB-100 apolipoprotein that
wraps around the lipid part of the lipoprotein. ApoB-100 is one the largest monomeric
proteins known and consists of 4536 amino acids [41].
HDL is a very heterogenous subclass of lipoproteins. Its molecular composition
varies markedly according to the stage in the HDL life cycle. The most abundant
protein in HDL is apoA-I, though also some other proteins are found, see Table 2.1.
The lipid-poor, disc-like HDL particles contain two copies of apoA-I in a double belt
conformation on its surface [47–52]. A recent study proposed that spherical HDL
contains three apoA-I molecules in a cage-like formation and even five copies on a
single particle seem possible [53].
Compared to LDL the lipid composition of HDL is considerably different and
varies greatly depending on the size of HDL. In the HDL studied in this work, there
is relatively speaking twice as many phospholipids in HDL than in LDL. The same also
applies to triacylglycerides. At the same time, the number of unesterified cholesterol
and cholesteryl esters is half of the amount compared to LDL.
2.4.2 Molecular Structure
High-Density Lipoprotein
Like all lipoproteins, also HDL constitutes a heterogeneous class of lipoproteins, and
different subclasses can be isolated by particle size, density, shape, and apolipoprotein
content [54–57]. During assembly and early remodeling, HDL is in discoidal form
(dHDL). However, it is converted to spheroidal HDL (sHDL) during maturation.
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Figure 2.3: Example of a protein-free lipid droplet (left), its molecular distribution
shown through a slice across the particle (middle), and HDL including two apoA-I
proteins (right). Dark gray stands for POPC headgroup and dark brown for PPC
headgroups, light gray for POPC hydrocarbon chains, light brown for PPC chains,
light orange for CHOL OH-groups, bright yellow for cholesterol body, dark orange for
CE ester bond, orange for CE ester body and chain, dark green for TG ester bonds,
and bright green for TG chain. In HDL, proline residues in apoA-I sequences are in
green. Reproduced from [10].
dHDL contains a core of apolar cholesteryl esters and triglycerides as a disordered
lipid melt. On the surface are located amphipathic phospholipids and the proteins.
Figure 2.3 illustrates the structure of spheroidal HDL.
A number of experimental studies have focused on the structure and dynamics
of apoA-I in a lipid-free form [58], in lipid-bound dHDL [59, 60], and also in sHDL
[53, 55]. Earlier computational attempts have focused on dHDL composed of phos-
pholipids and two apoA-I [61–64]. Catte et al. performed the first computational
approach towards understanding the structure of sHDL [65]. Shih et al. modeled the
maturation process from dHDL to sHDL [66]. Regardless of the previous studies,
the role of lipids is still only vaguely understood. Lipid organization and interplay
with apoA-I are still yet to be grasped. Considering findings that lipids are essential
components of protein structure, e.g. proteins embedded in cellular membranes are
in constant interplay with lipids [67], it is clear that one cannot overemphasize the
importance of clarifying the role of lipids in HDL properties. In Paper I [10], sHDL
with a realistic lipid composition together with two apoA-I was simulated and pro-
vided the first detailed structural model for HDL and its dynamics with and without
apoA-I.
Circulating sHDL contains 2-4 apoA-I molecules, which represent about 70-80%
of HDL protein content by weight, apoA-II about 20%, the rest is due to other
proteins in rather minimal quantities associated with sHDL [55]. Apo-I and apoA-II
interact with lipids just like some other proteins associated with HDL, but certain
CHAPTER 2. HISTORY AND BACKGROUND 18
HDL associated proteins also interact through protein-protein interactions with apoA-
I [55].
Studies applying immunoaffinity chromatography methods have isolated two sub-
sets of sHDL. One subset contains both apoA-I and apoA-II, and the other contains
only apoA-I [55]. A recent study combining immunoaffinity chromatography with vol-
umetric analysis discovered that sHDL contains 3-4 apoA-I molecules usually, while
a small HDL particle contains two copies of apoA-I [55]. In the case of two apoA-I
molecules, the double-belt organization is observed, while in the case of three copies
a modification of the double-belt model called the trefoil model was found to result
in a cage-like structure [53].
Low-Density Lipoprotein
The current understanding of the structure of LDL describes LDL as a spherical
particle consisting of an apolar core and an amphipathic surface [2, 17, 41]. The
core is comprised mostly of cholesteryl esters, a small amount of triacylglyceride, and
also some free, i.e. unesterified cholesterol. The surface is formed by a phospholipid
monolayer incorporating free cholesterol and a single copy of apoB-100 apolipo-
protein. An average diameter of an LDL particle is 22 nm. However, LDL particles
are very heterogeneous, and their size varies from 18 to 25 nm [68].
The core of LDL has been shown to have a phase transition at almost physiological
temperatures [69]. Below the transition temperature, the core-located lipids are
arranged in an ordered liquid-crystalline phase. Above the transition temperature,
however, the neutral core lipids are organized in a fluid, randomly distributed state
[70]. The importance of this phase transition is unknown.
The surface layer surrounding the apolar core has been shown to separate into
local molecular environments rich in phosphatidylcholine and/or sphingomyelin and
cholesterol [43]. These microenvironments are most likely highly dynamic and in
relation to the dynamics and the structure of apoB-100. It has been estimated that
about 20% of the polar headgroups are immobile and probably interacting closely
with apoB-100 [71]. Cholesterol modulates surface layer fluidity, which influences
the availability of molecules in chemical reactions directly. A correlation between
fluidity, enzyme activity, oxidisability, and LDL metabolism has been seen in different
studies [68]. According to Hevonoja et al. [41], the two-layer model for the LDL lipid
droplet is not sufficient, and a more advanced model is needed. They have proposed
a new three-layer model to explain the details of the LDL structure. This model
includes an interfacial layer between the core and the surface and contains molecules
CHAPTER 2. HISTORY AND BACKGROUND 19
of interpenetrating core and surface lipids.
The protein component of LDL, apoB-100, is one of the largest monomeric pro-
teins known with its 4536 amino acid residues. ApoB-100 is moderately hydrophobic
and thus insoluble in water, remaining bound to LDL during circulation in the blood-
stream [72]. Results from experimental studies suggest that apoB-100 consists of
globular domains connected by flexible chains that surround the LDL particle in a
belt-like configuration [68]. Experimental studies have been able to identify a varying
number of domains [73, 74], but the knowledge of the detailed configuration has
remained a mystery. The locations of different domains have been studied using
electron microscopy methods [75]. Computational modeling based on the secondary
structure analysis has yielded a model consisting of five separate domains with amphi-
pathic α-helixes and β-sheets representing the major secondary units, and this model
currently serves as a basis for further research [76, 77]. The first 1000 residues have
been found to be similar to lipovitellin, and using this information a homology model
for the first 1000 residues has been constructed [78]. The most recent effort using
sequence homology modeling and fold recognition has lead to a theoretical model
consisting of eight connected domains [79], however, the validity of the model has
not yet been confirmed experimentally.
Somewhat surprisingly, LDL has been studied only a little using molecular dy-
namics (MD) simulations. The structure of the LDL core has been studied earlier,
but these studies completely ignored the surface layer and other lipids present in
the core [80]. According to these results, cholesteryl ester molecules close to each
other seem to have some orientational ordering, which gradually vanishes at longer
distances. The hydrocarbon chains were found to be highly mobile, but the diffusion
of the molecules was found to be slow and of the order of 2 × 10−9 cm2/s. The
slow diffusion supports the assumption that cholesteryl ester tails are strongly en-
tangled above the phase transition temperature [70, 81]. Also, properties of a pure
triglyceride melt have been studied using MD simulations [82]. In Paper II [11], we
conducted the first MD simulations using a molecular-scale model for LDL structure
and dynamics based on near-atomistic models.
2.5 Limitations of Experimental Methods In Lipoprotein Research
In science experiments play a central role. The abundance of experimental results
has laid down the basis for the understanding of the chemical machinery of life.
Despite great advances in experimental methods, in some cases, experiments can
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be impossible, dangerous, expensive, or blind. In the case of biological systems,
experimental methods often face the challenge of dealing with short time and length
scales, and many events are therefore invisible to experiments, i.e., they take place
over time and length scales that are inaccessible to experiments.
Lipoproteins, as many biologically relevant systems, are not static objects but
highly dynamic. Conformational changes of proteins and lipids play a key role in
their functionality. Thus knowing the molecular structure and dynamical behavior is
essential for understanding how they function. High-resolution structural information
can often be obtained by X-ray crystallography or nuclear magnetic resonance (NMR)
spectroscopy. The results are however like snapshots, as they describe the transient
structure of the target at a specific time, thus usually these methods are unable to
provide sufficiently detailed information about the dynamics, especially on a single-
molecule level.
Progress in experimental techniques, e.g. pump-probe spectroscopy, neutron
scattering, cryo-electron microscopy, and advanced NMR experiments, provide in-
formation about the dynamics. However, it is not straightforward to translate the
results into a detailed atomic picture because the results represent data averaged over
quite long periods of time, and therefore, interpretation requires additional tools, such
as molecular simulations.
In the MD method, each particle in the system is followed: its position and veloc-
ity in space relative to all other particles are known at all times. MD methods make
it possible to observe atomic motion over broad time scales spanning from femtosec-
onds to milliseconds. Spatiotemporal domains challenging to probe by experimental
techniques are therefore accessible to MD simulations.
3 | Methods
3.1 Classical Molecular Dynamics
The molecular dynamics (MD) method can be divided into two main categories [83].
In classical MD, atoms, and molecules are modeled as classical objects, such as
the ball-and-stick models. Balls describe the atoms, and elastic pegs describe the
bonds. The dynamics of the system is defined by the laws of classical mechanics.
Meanwhile, the quantum mechanical approach takes the quantum nature of the
chemical bond into account when describing the behavior of the system. The electron
density functions for the valence electrons are computed using quantum mechanical
equations, however, the dynamics of atoms is often managed using classical equations
of motion [83].
There is a reason to stress that here we used the concept of ”quantum mechanical
approach” in a quite loose sense. There are rigorous theoretical descriptions to deal
with quantum mechanical degrees of freedom, without any classical component.
Such first-principles (ab initio) techniques are the method of choice to consider,
e.g., reactions or protons. Yet, due to their computational complexity, fully quantum
mechanical techniques are often not used in cases when the impressive accuracy
given by quantum mechanics is not needed. For discussion on these methods, see
for example [83–85].
Quantum MD simulations are indeed superior to classical MD when the accuracy
is considered. However, as mentioned above, they require enormous computational
capacity compared to the classical approach. In many cases, classical MD can provide
as accurate answers as quantum MD in a fraction of the computer time [86]. In
this work, classical MD is used because the time and length scales of the studied
lipoprotein systems are out of scope of quantum MD methods. In the remainder of
this work, the classical MD will simply be referred to as MD. The following sections
give an overview of the MD method. The overview is based mostly on the GROMACS
manual [87] and the book by Tamar Schlick [83], which give a solid description of
21
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MD.
3.1.1 Force Field
The term "force field" is used to refer to the collection of mathematical equations
describing the chemical interactions, parameters used in these equations, and also
the algorithms used [88]. The force field describes the potential energy of the system
as a function of the coordinates of its particles. The forces acting on each particle
can be derived from the potential energies.
The potential V (~r1, ~r2, ..., ~rN) represents the potential energy of N interacting
atoms as a function of their position ~ri = (xi , yi , z i). The force ~Fi acting on a given
particle i can be calculated from the potential function in terms of
~Fi = −dV
d~ri
. (3.1)
The interactions between particles are divided into bonded and non-bonded inter-
actions. Bonded interactions describe the interactions between particles connected
by chemical bonds. In addition to bonded and non-bonded interactions, different
types of restraints can be imposed on the motion of the system. This is done by
adding special potentials to achieve the wanted effects. The reason for adding these
restraints is to include knowledge from experimental results, and to avoid unwanted
deviations that might even crash the simulation.
Bonded Interactions
Covalent bonds between atoms are modeled by introducing a bonded potential be-
tween two atoms involved in the covalent bond in question. This potential allows
small-scale deviations around the reference bond length value. The reference values
for different bonds can be obtained either from X-ray crystal structures or quantum
mechanical calculations. Values are presented in many textbooks, e.g. CRC Press
Handbook of Chemistry and Physics [89]. The most straightforward formulation for
bond length vibration is the harmonic potential given as:
Vb(ri j) =
1
2
kbij(ri j − bi j)2, (3.2)
where bi j is the reference bond length, ki j is the force constant, and ri j is the distance
between the particles i and j in question. The harmonic potential is suitable for
modeling only small deviations from the reference values. To model deformations that
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exceed these small fluctuations, a more advanced and computationally demanding
formulation can be used, e.g. Morse potential [90].
The hybridization of the orbitals around the atom determine the bond angles
of each atom. As for the bond stretching, the harmonic potential is also used for
modeling the bond angle vibration, see Equation 3.3.:
Va(θi jk) =
1
2
kaijk(θi jk − θ0i jk)2, (3.3)
where i , j , and k are used for a sequence of bonded particles. Particle j is in the
middle and i and k in the ends. kaijk is the force constant, θi jk is the bond angle, and
θ0i jk the reference angle. The force constants for angle bending are obtained from
vibrational frequency measurements [83].
The previously presented potentials (stretching and bending) do not prevent in-
ternal rotations. To prevent this, a torsional dihedral angle potential is included. The
general function for the torsion potential τ can be written as
Vt(τ) =
∑
n
Vn
2
[1 + cos(nτ − τ0)], (3.4)
where τ is the torsional angle, defined as the angle between the planes of atoms
(i , j, k) and (j, k, l), whereas τ0 is the reference angle, n is an integer denoting the
periodicity of the rotational barrier, and Vn is the associated barrier height. The
value used for n depends on the atoms sequence and the force field parametrization
(typical values of n are 1, 2, and 3). Experimental data from spectroscopic studies
can be used to estimate the values for n and Vn [83].
To keep the planar groups (e.g., aromatic ring structures) planar and to prevent
molecules from flipping over to their mirror-image enantiomer, improper dihedral po-
tentials are introduced. The most straightforward potential for the improper dihedral
is the harmonic potential:
Vid(ξi jkl) =
1
2
kξ(ξi jkl − ξ0)2, (3.5)
where the improper dihedral angle ξ is defined as the angle between the planes of
atoms (i , j, k) and (j, k, l), kξ is the force constant for the potential, and ξ0 is the
reference angle.
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Non-Bonded Interactions
Non-bonded interactions typically contain three different terms: a repulsion term,
a dispersion term, and a Coulombic term. The repulsion and dispersion terms are
combined in terms of the van der Waals force using the Lennard-Jones (LJ) potential,
while charged particles interact via the Coulombic potential:
VLJ(ri j) =
(
C
(12)
i j
r 12i j
)
−
(
C
(6)
i j
r 6i j
)
, (3.6)
VC(ri j) =
qiqj
4pi0ri j
, (3.7)
where qi and qj are the charges of atoms i and j , ri j is the distance between atoms,
and C(12)i j and C
(6)
i j are parameters depending on the pair of atom types.
Since the LJ potential decays rapidly, it is possible to cut off the interaction
beyond a distance between the atoms that is greater than the preset cut-off value
(typically 2 nm). This decreases the computational load by reducing the number
of pairs for the LJ potential calculation without causing significant errors in results
[87].
Contrary to the LJ potential, Coulombic potential’s decay rate is slow, and ignor-
ing it after some cut-off distance would produce undesired artifacts [91]. A method
to overcome the problems arising from cutting off the Coulombic interactions after
some specific distance is the reaction field method [92]. It also features a cut-off, but
instead of just ignoring everything beyond the cut-off, a correction is introduced by
assuming a uniform dielectric constant. Another popular method is the Ewald or the
Particle Mesh Ewald (PME) method [93]. By utilizing periodic boundary conditions
(see section 3.1.4) and Fourier transformations, some of the calculations can be
efficiently done in reciprocal space and transferred back into real space. PME is con-
sidered more reliable, but RF scales up better and makes simulations of multimillion
atoms more feasible [91, 94].
3.1.2 Atoms in Motion
From the force field, the force acting on each atom in the system can be derived,
and the resulting movement of each atom can be solved by Newton’s equations of
motion:
d2~ri
dt2
=
~Fi
mi
, (3.8)
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where mi is the mass, ~ri is the position of the atom i , and ~Fi is the total force
calculated from the potential.
The equations of motion are numerically integrated over a discrete time step ∆t.
A trajectory describes the positions and velocities of each atom at each time step.
There are several different algorithms to do the job, from which the most commonly
used one, the leap-frog algorithm, is also used in this work [95]. The algorithm can
be written as
~v
(
t +
∆t
2
)
= ~v
(
t − ∆t
2
)
+
~F (t)
m
∆t, (3.9)
~r(t + ∆t) = ~r(t) + ~v
(
t +
∆t
2
)
∆t, (3.10)
where ∆t is the length of a time step, ~r is the position, and ~v the velocity.
3.1.3 Temperature and Pressure
Direct use of MD leads to an ensemble, where the particle number, volume, and
energy are constant. The simulations included in this work were conducted in the
NpT ensemble, where particle number (N), pressure (p), and temperature (T ) were
kept constant. To achieve this, special algorithms for a thermostat, and a barostat
were used.
In the early parts of the simulations included in this work, the Berendsen temper-
ature coupling [96] was used to equilibrate the systems. In this approach, the idea
is to mimic weak coupling to an external reservoir. The Berendsen algorithm slowly
corrects the deviation of the system temperature from the reference temperature T0:
dT
dt
=
T0 − T
τ
, (3.11)
meaning that the temperature deviation decays exponentially with a time constant
τ . The advantage of the Berendsen method is that the strength of the coupling can
be easily adjusted. By using the Berendsen method fluctuations of kinetic energy
are suppressed, however, the fluctuations of energy and temperature are not cor-
rectly captured. Because of that, this method does not generate a proper canonical
ensemble.
To overcome this significant limitation of the Berendsen method, a different ap-
proach by Nosé and Hoover [97, 98] was also exploited. The Nosé-Hoover thermostat
produces the correct canonical ensemble. A thermal reservoir and a friction term are
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introduced into the equations of motions:
d2~ri
dt2
=
~Fi
mi
− ξd~ri
dt
, (3.12)
where the heat reservoir parameter ξ follows the equation
dξ
dt
=
T − T0
Q
. (3.13)
The reference temperature is T0, the instantaneous temperature T , and Q is the
parameter defining the strength of the coupling.
Similar to temperature coupling, there are different methods for controlling the
pressure. The Berendsen method [96] for pressure coupling functions basically the
same way as in the temperature coupling. It scales the atom coordinates and the
simulation box vectors leading to exponential relaxation towards the reference pres-
sure. As with the temperature coupling, the Berendsen method does not yield a
correct NpT ensemble. It is mainly used in equilibrating the system. After equilibra-
tion, a more sophisticated and complex method by Parrinello and Rahman is often
used [99, 100]. This method introduces changes in the equations of motions similar
to the Nosé-Hoover method for thermal coupling. The Parrinello-Rahman method
produces the true NpT ensemble. For more details of this method, see [87, 99].
3.1.4 Simulation Boundaries
There are several ways to treat the boundaries of the simulated system in MD simu-
lations. The most common method is to use periodic boundary conditions (PBCs).
In PBCs, the particles to be simulated are put in a space-filling box, which is sur-
rounded by translated copies of itself. With PBCs a particle crossing one side of
the simulation box re-enters the box immediately from the opposite side of the box.
The particles in the box always interact with their nearest neighbors and it does not
matter if the neighbor is in the original box or one of its copies.
3.1.5 Limitations of Molecular Dynamics Method
MD is a method that makes a study of biological phenomena on the molecular level
possible. However, the phenomena on the molecular level are very complex, and some
simplifications and assumptions have to be made to make the simulations feasible.
This leads to several limitations, and it is important to be aware of those when
considering the results.
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Quantum Effects
Many biological phenomena involve quantum effects, e.g. chemical bonds, and tun-
neling of protons and electrons. Classical MD cannot model those kinds of events.
There are ab initio simulation methods based on full quantum mechanical treatments
of the Schrödinger equation for a given many-body system, but these methods are
limited to very small systems and short time scales.
Reliability of the Force Field
The force field defines all interactions between particles, and thus the results will
be realistic only if the potential energy functions mimic accurately enough the real
forces acting on the real atoms. Furthermore, the form of the potential functions
should be computationally efficient. In addition to these properties, the force field
should be applicable to many different systems in different conditions. Currently,
there are many different force fields available, some suitable for simulating proteins,
while others being appropriate for lipid simulations. There is a need to develop force
fields that could cover a wide range of chemical and biological systems [87].
A general approach is to combine experimental data for structural parameters
and ab initio calculations for defining partial charges. Experimental methods have
limits, however. Sometimes there are limited or no experimental data available. Then
one has to use what is available and for example, combine a force field for a large
molecule from smaller pieces of knowledge, and sometimes make educated guesses
about the molecular structure [11].
Limits in Time and Size
The most severe limitation of MD is the time limitation. Time scales for many
relevant biological processes extend over many orders of magnitude. For example,
the nitric oxide binding to myoglobin takes tens of picoseconds, while protein folding
may take minutes [101]. To access the large time scales, enormous computational
power is required. The current state-of-the-art atomic MD simulations can handle
the millisecond time scale [102, 103]. Computational capacity of supercomputers
is improving all the time, and also novel methods are developed to overcome or at
least push back the limitations related to time and size. One of these methods,
coarse-graining, is discussed in the next section 3.2.
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3.2 Coarse-Graining Method
Conventional atomic scale MD simulations provide valuable and detailed informa-
tion about the properties of the local structure and dynamics. However, the length
and time scales related to phenomena seen in large systems or phenomena taking
place in the micro- or millisecond range are out of reach from the conventional
atomistic methods because of the enormous computational load. To decrease the
computational requirements and thus make longer and larger simulations feasible, it
is possible to eliminate some of the details. This process is called coarse-graining.
Coarse-grained (CG) models do not attempt to describe the shortest atomic length
scales, but instead, they focus on features that are relevant on larger scales, de-
scribing large-scale behavior such as viscosity or order. To achieve this aim, CG
models simplify molecular description by modeling the behavior of a group of atoms
using only a single particle or an interaction site. The reduction in computational
requirements is achieved through a reduction of the number of degrees of freedom
and by simplifying the description of interatomic interactions. Meanwhile, when one
simplifies the description of a molecular system, it also has a price that one has to
pay. The main disadvantages are obvious, the loss of some details and the question
regarding the validity of the coarse-grained model. The loss of details has to be ac-
cepted, since it is an inherent feature of this simplification process. Confirming the
validity of the coarse-grained model is a more tedious process, but with systematic
and careful validation processes using solid experimental and theoretical/simulation
data, this challenge can be overcome in a successful manner.
Different ways to employ coarse-graining are briefly introduced in the following
section, and the method applied in this work is discussed in more detail in Section
3.2.3. Also, the limitations of coarse-graining are discussed in Section 3.2.2.
3.2.1 Different Approaches to Coarse-Graining
Since the number of non-bonded interactions, and thus the computational load,
scales with the square of the number of interaction sites, there are obvious advantages
if the number of interacting sites is trimmed. The simplest solution is to group some
atoms into a new interaction site, e.g. a methyl group would be represented by a
single site. In the united-atom approach, nonpolar hydrogen atoms are fused into the
adjacent carbon atom [104–106]. In the case of membrane systems, this approach
gives up to 60% reduction in particle number, providing a substantial reduction in
the computational load.
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The previously described method can be taken further by grouping more atoms
into a single interaction site. The Martini force field maps on average four heavy
atoms and their associated hydrogen atoms into a single interaction center [12, 107,
108], whereas the model by Shelley et al. uses a three-to-one mapping [109]. From
these approaches, the Martini model has become more popular and has successfully
been used in many studies ranging from lipid membranes and lipoproteins to mem-
brane fusion and nanoparticles and many more, see [110] and references therein.
The particle types and interaction parameters of the Martini force field are calibrated
against thermodynamic data of oil/water partitioning [12]. The Martini force field
is discussed in more detail in Section 3.2.3. Another commonly used approach to
derive interaction parameters is force matching. In this method, a trajectory from
atomistic MD simulation is used to match the force acting on a coarse-grained par-
ticle (describing multiple atoms) with the forces acting on the corresponding group
of atoms in an atomistic system [111].
Developing even coarser descriptions usually means ignoring of electrostatic in-
teractions and reducing the interaction action site types. Smit et al [112] and Goetz
and Lipowski [113] have modeled amphiphiles using only oil- and water-like particles
connected via harmonic springs. Despite their simplicity, these models can reproduce
many structural, thermodynamic, and mechanical properties of bilayers and vesicles.
A further step in coarse-graining is to eliminate the solvent while taking its effect
into account implicitly. The number of solvent particles increases much faster than
the number of amphiphiles, and often the role of the solvent is just to stabilize the
amphiphiles. Therefore, the removal of the solvent would result in a huge computa-
tional speed-up. Several methods utilizing this approach and even coarser ones have
been developed, see [114] and references therein.
All the previous methods are so-called off-lattice models where the interaction
sites are allowed to move freely in space. The next step in coarse-graining is to
limit the movement of interaction sites by introducing a lattice. Models taking this
approach are called on-lattice. Many on-lattice models are based on the idea of
Larson’s on-lattice model [115–117], where a simple cubic lattice of interaction sites
was used. Each interaction site interacts with all 26 interaction sites within one lattice
spacing. Interaction sites are either oil-like or water-like, and amphiphiles are formed
by connecting water and oil sites together. Interaction strengths are equal between
similar sites, but interactions between different types of sites are not favored. The
model is characterized by only one parameter, the difference in interaction strength.
Monte Carlo simulations using a model similar to Larson’s have successfully produced
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phase behavior and given insight into the nature of micelles [115].
As shown by this short introduction of different coarse-graining concepts, there
is a wide range of alternatives when choosing a suitable research method for the
task. One has to know what kind of properties one wants to study and what are
the advantages and disadvantages of different methods. The Martini force field was
used in Papers [I]-[III]. The method is discussed in more detail in Section 3.2.3.
3.2.2 Limitations of Coarse-Graining
Each different approach to coarse-graining has distinct limitations. The limitation
affecting all approaches is the loss of information. Some information is always lost
when coarse-graining is carried out, and this applies to all research methods, both
experimental and computational. The more important question is how much the loss
of information affects the results.
There is no general answer for the effect of the loss of information covering all
different coarse-graining approaches. The only reasonable way is to test the used
method with different systems under varying conditions to understand how and why
the excluded interactions or particles affect the results. Coarse graining can provide
unique insights, but without testing the results cannot be trusted.
Coarse graining methods thus cannot be used as a standalone tool from start
to finish, but they have to be used in conjunction with other techniques to get a
more solid understanding of the system studied. In particular, validation against
solid experimental data is essential.
3.2.3 The Martini Coarse-Grained Force Field
The first version of the force field for lipids developed by Marrink et al. was published
in 2004 [12]. The name ’Martini’ was adapted in 2007 when the version 2.0 for lipids
was released [107]. The parameters for peptides and proteins were released in the
version 2.1 in 2008 [108]. The most recent version with parameter refinements was
published in 2013 [118].
The Martini force field does not focus on reproducing accurate results for a
specific system under specific conditions. Instead, it aims to describe a broad range
of applications without the need to reparameterize the model each time. Interactions
and other simulation parameters were adjusted using a reference oil/water system
to reproduce the experimental densities of pure water, and oil, the mutual solubility
of oil and water, and the relative diffusion rates [12].
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The Martini model is based on a four-to-one mapping, i.e., on average four heavy
atoms and adjacent hydrogens are grouped into a single interaction center. Some
situations, e.g. ring-like fragments or molecules, require finer description and thus
even a two-to-one mapping is used. The mapping ratio was chosen as an optimum
between computational efficiency and chemical representability. The Martini model
has four main types of particles: polar, non-polar, apolar, and charged. Each category
has subtypes based on the hydrogen-bonding capacity and the degree of polarity.
Altogether there is a total of 18 particle types.
Non-bonded interactions are described by a Lennard-Jones potential, see Equa-
tion 3.6. Different interaction strengths for a given particle pair is assigned based
on the types of the particles. The values for different types of pairs can be found in
the reference [107]. The electric interaction between charged groups is described by
Coulombic potential, see Equation 3.7. A relative dielectric constant is introduced
to account for the reduced number of partial charges and dipoles present in atom-
istic force fields. Both the LJ and Coulombic interactions are cut off at a distance
rcut = 1.2 nm. The LJ potential is shifted from rshif t = 0.9 nm to rcut , whereas
the Coulombic potential is shifted from rshif t = 0.0 nm to rcut . The shifting of the
electrostatic interactions mimics the effect of distance-dependent screening. The
interaction strengths are based on experimental thermodynamic data. The Martini
model gives correct trends in free energies of hydration and solvation, but the actual
values are systematically too high [107]. Because of that, the use of the Martini
model should be restricted to a condensed phase. As mentioned earlier, the Martini
model has been parameterized on the basis of solvation free energies, describing the
partitioning of molecules to different environments. Thus, the Martini model can-
not describe short-scale interactions such as hydrogen bonding in a reliable fashion.
Bonded interactions are described by a standard potential shown in Section 3.1.1.
The parametrization of the bonded interactions is based on the atomistic geometry
or by a comparison with atomistic simulations.
The Martini model currently contains parameters for different lipids, sterols, pep-
tides and proteins, sugars, polymers, nanoparticles, and dendrimers built from the
different CG particle types connected together. The model has been well validated,
and compared with atomistic simulations as well as experimental data [110]. The
parametrization of conformational changes of protein secondary structure is not ad-
equate, thus the secondary structures of proteins simulated in this thesis are fixed
[108].
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3.3 Analysis Methods
3.3.1 Radial Density Distribution
To characterize the structure of lipoprotein droplets, radial density distributions were
coupled using number densities of particles. The distance from the center of mass
of the lipids to each particle was calculated at each time step, and a histogram was
created. The number of particles in each bin was normalized by the volume of the
bin.
3.3.2 Order Parameter Describes Orientational Ordering
The intermolecular ordering induced by cholesterol and cholesteryl oleate ring struc-
tures between cholesterol and cholesteryl oleate molecules is studied using an order
parameter SRR, defined as
SRR =
1
2
〈3 cos2 θ − 1〉, (3.14)
where θ is the angle between the directors of two cholesterol (or cholesteryl oleate)
molecules. The director of the cholesterol (or cholesteryl oleate) ring structure is
defined as a vector from the particle where the short acyl chain is connected to the
ring and pointing to the carbon connected to the hydroxyl oxygen. Also, the distance
between the centers of the directors was measured and divided into bins, and within
each bin, the average order parameter was computed to give a plot of the order
parameter as a function of the distance between the directors.
A similar order parameter is used to measure ordering relative to the local normal
of the particle. The local normal is the vector pointing from the center of mass of
a lipid to the center of the director. The distance from the center of mass of the
droplet was measured, and the average order parameter was plotted as a function of
radial distance.
3.3.3 Diffusion Characterizes Movement
The mean-squared displacements in the long-time limit are usually used to study the
diffusion of molecules [119]. Since in Papers I, II, and IV diffusion takes place in a
confined environment, this approach is not useful here.
It is assumed that on the surface of the lipoprotein droplet the diffusion takes
place on a two-dimensional surface, whereas in the core all the three dimensions are
available. Given this, we use a different approach.
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Calculating the displacements of the centers of mass of the molecules over a time
scale t gives a histogram, i.e. a jump length distribution. Assuming the movement of
the centers of mass to follow a random walk, the obtained jump length distributions
can be fitted to the theoretical curves based on two- and three-dimensional random
walkers, i.e. to the Gaussian distributions
P2d(d ; t) =
r
2Dt
e−
r2
4Dt (3.15)
and
P3d(d ; t) =
4pir 2
(4piDt)
3
2
e−
r2
4Dt . (3.16)
Different values for the time interval t were used to get the diffusion coefficient
D as a function of time. It is expected that the diffusion coefficient levels off at long
times, indicating the diffusive behavior to emerge in the hydrodynamic (long-time)
limit. At short time scales, the diffusion deviates from the long-time hydrodynamic
behavior due to dynamical correlations in the motion of the particles, while at very
long time scales the limited size of the confined environment may cause deviations.
3.3.4 Free Energy Calculations
In Paper IV free energy calculations were used to study the difference in free en-
ergy profiles between cholesteryl oleate and BODIPY-labeled cholesteryl oleate. The
method of choice was replica exchange umbrella sampling (REUS) [120]. In umbrella
sampling, a number of initial configurations for the umbrella windows are generated,
each having a different value for the chosen reaction coordinate [121, 122]. In this
case, the reaction coordinate r was chosen as the distance between the center of
mass of HDL and the center of mass of the cholesterol ring structure of the studied
molecule. Each umbrella window is then simulated for a sufficiently long time while
holding the reaction coordinate by an umbrella potential. The free energy profiles for
both molecules were computed using the weighted histogram analysis method [123].
The error was estimated by bootstrap analysis with autocorrelation estimation [124].
REUS combines replica exchange with traditional umbrella sampling. In REUS a
replica exchange event means exchanging the umbrella potentials of two neighboring
umbrella windows at specified time intervals. The REUS method has been shown
to provide a better quality of the resulting free energies than conventional umbrella
sampling [125, 126].

4 | Overview of the Simulation
Models Studied
Paper I
In Paper I, MD simulations of spheroidal HDL particles were performed using the
full lipid compositions of human plasma HDL [127]. The Martini model, described in
Section 3.2.3, was employed. Both the protein-free lipid droplet and the full apoA-I
containing HDL particles were considered. Cholesteryl oleate was used to model
cholesteryl ester, and trioleate to model triglycerides.
The construction of lipoprotein models was implemented in two stages. First, lipid
droplets without the apoA-I proteins were constructed. This was accomplished by
placing the lipid molecules randomly into a three-dimensional simulation box without
any solvent. The mixture of lipids was simulated under NpT conditions to reach the
correct density. After that, the lipid melt was solvated and equilibrated for 8 µs.
After equilibration, the lipid droplet was simulated for 4 µs.
Next, all-atom apoA-I molecules were generated and coarse-grained. The molec-
ular belt model of apoA-I for discoidal HDL was used as a reference for the confor-
mation of apoA-I [47, 62, 63, 128, 129]. Finally, two apoA-I molecules were added
around the equilibrated lipid droplet in a double-belt conformation at a distance of
4 nm from each other. The complete system was shortly equilibrated and simulated
over a total period of 19 µs.
The standard components of the Martini model were used for the phospholipids
(POPC and PPC), cholesterol, and water. The parameters for cholesteryl oleate and
trioleate were constructed using the Martini building blocks, carefully adjusting the
key particle types and angle potentials to match the bulk molecular properties found
through extensive atomic scale simulations [80, 82]. For the apoA-I molecules, a
pre-released version of the Martini model for proteins was used [108].
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Paper II
In Paper II, coarse-grained MD simulations of LDL particles were performed, one
system containing only the lipid droplet and four others considered with different
apoB-100 protein configurations. All the systems had the same lipid composition,
corresponding to an average LDL particle [41]. As in Paper I, the construction of
the models was implemented in two stages.
First, the lipid droplet was constructed in the manner as in Paper I by creating a
lipid melt which was solvated. The lipid melt was allowed to self-organize into a lipid
droplet containing phospholipids and some of the free cholesterol on the surface, and
cholesteryl oleate, trioleate, and the rest of free cholesterol in the core.
Because the exact structure for the apoB-100 protein is not known, two different
secondary structure configurations were constructed. Different sources and methods
were combined because none of the suggested models describe the full protein [78,
79, 130]. The first model was mainly based on the theoretical models [79], though
some parts of the model were constructed using secondary structure prediction [130].
The second model was similar to the first model, but the first 1000 residues were
based on a homology model [78] and the residues 1000-2000 were modeled as a
continuous amphipathic β-sheet. For both secondary structures, two different initial
placements were constructed.
The force field parameters used for the lipids were the same as in Paper I. The
apoB-100 protein was modeled using the Martini model for proteins [108]. For the
apoB-100 protein the elastic network model was employed. This approach has a
disadvantage in the sense that the secondary structures of proteins will remain fixed.
Because of this, it was not possible to study the apoB-100 protein itself in detail. Also
since the interaction between the protein and the lipids is defined by the structure of
the protein, the behavior of lipids close to apoB-100 was studied on a larger scale.
Paper III
In Paper III, cholesteryl ester transfer protein (CETP) was studied together with
HDL-like lipid droplets. Both atomistic and coarse-grained MD simulations were
performed.
The structure of CETP was acquired from the RCSB Protein Data Bank. Two
cholesteryl esters and two phospholipids were also included in the acquired struc-
ture. The lipid droplet consisted of 180 POPC molecules and 35 cholesteryl oleate
molecules. CETP was initially placed close to the lipid droplet. Simulations with
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different lipid compositions were performed, and the role of helix X was assessed in
additional simulations. To study the effect of curvature, a simulation with a planar
trilayer system including 512 POPC and 796 CE molecules was carried out.
In the atomistic simulations, Berger parameters [104] were used for the lipids,
and the GROMOS53A6 force field was employed for the protein [131]. The Martini
force field was applied in the coarse-grained simulations [12, 108]. For CETP, the
elastic network model was employed to keep the secondary structure stable.
Paper IV
In Paper IV, the function of BODIPY-labeled cholesteryl ester in HDL particles was
studied using atomistic MD simulations. The atomistic model of a pristine HDL
particle was taken from a previous study [65] containing 16 cholesteryl ester molecules
in the core, 56 POPC molecules, and two apoA-I chains on the surface of the particle.
In modified HDL, one or three of the cholesteryl ester molecules were replaced with
BODIPY-labeled cholesteryl esters. Free energy calculations were performed using a
series of replica exchange umbrella sampling simulations.
The Berger force field was used for the lipids [104], together with the OPLS-AA
force field for the apoA-I proteins [132]. The combination of the two force fields
has been validated, and the combination rules with the technique described by Neale
and Pomes were applied [133, 134]. The parameters for the BODIPY-probe were
adapted from an earlier study [135].

5 | Results and Discussion
The results discussed in this Chapter are based on data presented in Papers I - IV.
The publishers of these articles have granted permissions to show the articles in this
thesis, thus permissions to show the figures depicted in Chapter 5 are in order.
5.1 Role of Lipids in Spheroidal High-Density Lipoproteins
Cardiovascular diseases are the primary cause of death in western countries [8, 9].
Atherosclerosis, accumulation of lipids and plaque formation on arterial walls, is one
of the main causes. High levels of high-density lipoprotein (HDL) circulating in the
bloodstream is associated with a reduction of risk for atherosclerosis. However, the
function and also the structure of HDL are not well understood, partly due to ex-
perimental difficulties to deal with soft and nanosized HDL. Computational methods
can give insight that is not accessible through experiments. In Paper I, models mim-
icking high-density lipoprotein were constructed and simulated to study the role of
lipids in HDL structure and dynamics. Molecular dynamics (MD) using the coarse-
graining approach for both a lipid droplet without apoA-I and the full HDL particle
including two apoA-I molecules surrounding the lipid droplet were performed. These
simulations were the first computational studies where the size and lipid composition
of HDL were realistic, i.e., corresponding to human serum HDL. The main focus
was on the assembly of lipids and the influence of lipid-protein interactions on HDL
properties.
The simulations revealed the internal structure of the simulated HDL particles.
Here we summarise the main findings. The radial densities of different molecule
types are shown in Figure 5.1. The hydrophobic cholesteryl oleate and triglyceride
are located in the core, and the polar lipids are at the surface region facing the water.
Most of the cholesterol is located in the surface region, but a small but significant
amount is also found in the core. The apoA-I proteins are embedded on the surface,
and the presence of the proteins just slightly disturbs the lipid distribution when
compared with the result without the protein part. There is no relevant change in
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Figure 5.1: Radial densities showing the composition of the studied particles versus
distance from the center of mass (COM) of the particle. The solid lines are for the
full HDL particle, the dashed lines for the lipid droplet without apoA-I. Reproduced
from [10].
the distributions of hydrophobic lipids. The most significant change observed is the
shifting of the cholesterol distribution towards the water interface. Cholesterol seems
to prefer interactions with the apoA-I proteins.
The density distribution of cholesteryl oleate overlaps significantly with the dis-
tributions of the surface lipids, i.e., phospholipids and cholesterol. This finding is in
disagreement with the previously suggested two-layer model, i.e., a model consisting
of a hydrophobic core and a polar surface suggested for the structure of the lipid
droplet. Furthermore, the inspection of the ring structure orientation of cholesterol
and cholesteryl oleate reveals that in the center of the particle the orientation is
totally random, but as one approaches the surface region, ordering starts to appear,
see Figure 5.2. Close to the surface region the cholesteryl oleate ring structure
prefers to be aligned along the radial direction of HDL and interdigitating with the
phospholipid tails. Also, changes in the preferred conformations of cholesteryl oleate
and triglyceride are observed when the behavior in the core and close to the sur-
face is compared. The data show that the two-layer model is not sufficient and the
structure is better described by a model consisting of a surface, a core, and a more
ordered intermediate transition region between them. This transition region is rather
narrow, and rather difficult to define spatially, and it represents a crossover from the
hydrophobic to the hydrophilic environment rather than a true layer of its own.
In addition to structural properties, also the dynamics varies significantly in the
different regions. The diffusion is found to be about ten times faster on the surface
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Figure 5.2: Order parameter S for the ring structures of CHOL (left) and CE (right).
The black curves describe the lipid droplet and the red curves the full HDL. Repro-
duced from [10].
than in the core, and the diffusion coefficient in the intermediate region is between
the two extremities. Since theoretically the diffusion is inversely proportional to the
viscosity of the surrounding medium of the diffusing particle, this result suggests
that the viscosity increases as one moves towards the center of a lipoprotein particle.
The viscosity in turn could be increased by, e.g., entanglement between lipid chains.
However, how the intermolecular orientations affect the viscosity (or diffusion) of lipid
systems has not been discussed in the literature to the extent that a comparison would
here be possible. The apoA-I proteins may slow down the diffusion of lipids slightly,
especially close to the interfacial regions. It seems that the molecular transport
between the surface and the intermediate region is relatively fast, but the transport
between the surface and the core is relatively slow.
Studying protein-lipid interactions reveals that phospholipids and triglycerides pre-
fer to interact through the acyl chains, and phospholipids also through the glycerol
backbone. Cholesterol and cholesteryl oleate, on the other hand, interact mainly
through the sterol ring structure. About 80% of cholesterol is annular to apoA-I,
while only 10% of cholesteryl oleate is close to the protein part. Cholesterol molecules
spend half of their time in contact with apoA-I. The lifetime of cholesterol-protein
interaction is relatively long (175 ns) and longer than for cholesteryl oleate (15 ns).
The molecular scale insight of HDL structure and dynamics found and confirmed
here derives from the ordering and dynamical phenomena taking place close to the
HDL-water interface, in part driven by the interactions between cholesterol and apoA-
I. The results pave the way for future studies to gain a deeper understanding of HDL
properties and their relation to health.
CHAPTER 5. RESULTS AND DISCUSSION 42
Figure 5.3: Number density of particles vs. distance from the centre of the droplet
(r): all lipids (black), POPC (blue), PPC (cyan, scaled by 10), CHOL (green),
CO (orange), TO (yellow), water (dark blue, not in right panel), protein (brown,
only middle panel). The left panel shows the distribution in the lipid droplet (LD)
without apoB-100. The middle panel shows how the distribution changes under
apoB-100. The dotted lines are identical to those in the left panel; the solid lines
show the distribution in regions where there is protein on the surface. The right panel
compares the distribution between the regions covered and not covered by apoB-100
in S1r. S1r refers to system S1 where the structure of LDL was mainly based on
theoretical models, for more details, see [11]. The solid line is identical to the middle
panel. The dotted line shows the distribution in regions not covered by apoB-100.
Reproduced from [11].
5.2 Effects of ApoB-100 Binding on an LDL Lipid Droplet
Low-density lipoprotein (LDL) particles transport cholesterol and its esters in the
bloodstream. LDL has a central role in the development of cardiovascular diseases,
in particular, atherogenesis, as discussed in Section 2.4. Despite the importance of
LDL, its structure is not known in detail, which in turn is rather distressing since
the lack of LDL’s structural information makes it more difficult to understand its
function and develop treatments for cardiovascular diseases.
In Paper II, experimental and theoretical data were combined to construct low-
density lipoprotein models for near-atomistic MD simulations. Through multi-micro-
second molecular simulations using two different models for apoB-100, structural and
dynamical properties of LDL were unraveled with the primary focus on lipids and their
interactions with the apoB-100 protein. Doing this was exceptionally challenging due
to the size of LDL particle and the lacking knowledge about the precise structure of
apoB-100. Here we again summarise the main findings.
Figure 5.3 (left panel) illustrates the structure of the LDL lipid droplet by show-
ing particle densities as a function of distance from the center of the droplet. The
LDL particle is partitioned into a surface monolayer consisting mostly of phospho-
CHAPTER 5. RESULTS AND DISCUSSION 43
lipids (POPC and PPC) and cholesterol (CHOL), and a hydrophobic core containing
cholesteryl oleate (CO), triglycerides (TO), as well as about 13% of the cholesterol
molecules. It is noteworthy that the distribution of core lipids (CO and TO) extends
to the water phase. Given this, it is possible that the proteins on the surface can
interact with the neutral lipids in the core of the particle. This possibility is highly
relevant for lipid transfer proteins, for example, cholesterol ester transfer protein
(CETP), which is studied in Paper III [13]. Figure 5.3 (middle panel) shows the
changes on the surface close to apoB-100. It is observed that the densities of POPC
and lysoPC are reduced closer to apoB-100, suggesting that apoB-100 prefers to
interact directly with core lipids. ApoB-100 pushes POPC and lysoPC away, and this
increases the packing of surface lipids, which in turn affects the core lipids, as they
are not able to penetrate as often to the surface, as seen in Figure 5.3 (right panel).
The ordering of lipids was studied using the orientation of the ring structures of
cholesterol and cholesteryl oleate, see Figure 5.4 for the order parameters. In the core
the ordering is random, however within the surface monolayer the ring structures are
already mainly aligned along the normal, i.e. ring structures stand upright between
the phospholipid chains. Adding apoB-100 displaces the surface monolayer, and the
protein prefers to interact directly with the core of the particle. This results in a
significantly lower area per lipid in the surface monolayer, which in turn affects the
density distribution as the core lipids do not penetrate as often to the surface. The
ordering of the ring structures increases in regions not under apoB-100 and decreases
under the protein.
It is observed that the diffusion speeds up as one moves from the core towards
the surface, the diffusion coefficient increasing by a factor of 10. This observed
change in the diffusion rate might be related to changes in viscosity, local density,
and entanglement effects between lipid chains. The same behavior is observed in the
HDL lipid droplet in Paper I, as discussed in the previous chapter. ApoB-100 does
not affect the diffusion of the core lipids, but it slows down the diffusion of lipids on
the surface. The effect is more clearly seen close to apoB-100, but it is present also
in the other parts of the surface. The factors explaining the slowing down of diffusion
are in particular the decreasing area per lipid and possible specific interactions with
the protein residues.
Because of the limitations of the model used (uncertainty in the 3D structure of
apoB-100 and its fixed secondary structure), it is not possible to study the protein in
detail, or the specific interactions between the protein and the lipids that may depend
on the protein secondary structure, and are thus disregarded from this discussion.
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Figure 5.4: Order parameter of the angle between the CHOL plane and the local
normal for CHOL (green) and CO (orange) versus distance from the center of the
droplet. The left panel shows the situation in the absence of apoB-100. The middle
panel shows the effect of apoB-100 in S1r. The solid lines are identical to the left
panel, while the dashed and dotted lines show the situation in regions covered and
not covered by apoB-100, respectively. The right panel shows the effect of protein
secondary structure on the ordering in S2r. The dotted and dashed lines show the
order parameter in regions covered and not covered by apoB-100, respectively. The
solid line represents regions where apoB-100 has b-strands close to the lipid surface.
Reproduced from [11].
However, on a larger scale where the simulation used in the Ph.D. thesis work was
expected to be valid, the behavior of apoB-100 in the simulations is in agreement
with experimental findings [11].
In conclusion, this study provided the first molecular-scale model for LDL struc-
ture and dynamics based on near-atomistic simulations. The results show that LDL
structure cannot be described using a simple two- or three-layer model. According
to the results, the structure is better described with a hydrophobic core and a polar
surface, and a broad transition region between them. The results provide a solid basis
for future studies unraveling the role of LDL and its modifications in the development
of atherosclerosis.
5.3 Trying to Understand the Function of Cholesteryl Ester
Transfer Protein
Cholesteryl ester transfer protein (CETP) facilitates the transport of cholesteryl
esters, triglycerides, and phospholipids between different lipoprotein fractions. CETP
has a potentially important role in the development of cardiovascular diseases, since
lower CETP activity has been associated with a decreased risk for coronary heart
disease [136]. The inhibition of CETP has been shown to be a valid strategy to
prevent and treat the coronary heart disease [137, 138].
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In Paper III, MD simulations were performed to complement experiments and
to study mechanisms associated with the CETP-mediated lipid exchange. Both
atomistic and coarse-grained approaches were used. The results were consistent
with each other. Key findings are summarised here.
CETP anchors to the surface of high-density lipoprotein-like lipid droplets mainly
through its charged and tryptophan residues located mainly at the edge of the con-
cave surface. Figure 5.5 shows the locations of the amino acids playing a role in the
binding process, also showing the number of salt bridges formed. The structure of
CETP is found to be rather elastic, making it possible to adapt to different curvatures
of the lipoprotein lipid droplet.
Upon binding, CETP rapidly (in about 10 ns) induces the formation of a small
hydrophobic patch to the phospholipid surface of the droplet, opening a route from
the core of the droplet to the binding pocket of CETP. The timescale for the complete
formation of these hydrophobic patches might be of the order of microseconds. After
careful inspection of atomistic simulation data, the effect is also observed in these
cases, but the effect is not as profound as in coarse-grained simulations. By removing
phospholipids and thus lowering the surface pressure, the number of contacts between
cholesteryl oleate molecules and CETP increased. Figure 5.6 shows a snapshot of
the attachment and visualizes the formation of the hydrophobic patch, especially
in the case of a reduced number of phospholipids. Also, the number of contacts
between CETP and core lipids is shown.
Helix X and its hinge region are highly mobile, and it is observed that under
favorable conditions helix X becomes buried inside CETP, creating a hydrophobic
pathway from the droplet surface to the hydrophobic tunnel. The accessibility of
cholesteryl esters to the tunnel opening of CETP is observed to increase when helix
X is in an open state.
Removal of helix X leads to diffusion of cholesteryl oleate molecules into CETP.
The results hint that helix X might work as a lid, opening the hydrophobic tunnel when
bound to a lipoprotein and closing the tunnel when moving between lipoproteins.
This study provided a detailed atomistic picture regarding the first initial steps in
the process of the lipid exchange mechanism of CETP. This serves as a solid foun-
dation for further studies aiming for a more detailed understanding of the function
of CETP and also for discovering possibilities to design new drugs to be used in the
fight against atherosclerosis.
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Figure 5.5: Electrostatic interactions between CETP and lipid droplet. A) A number
of salt bridges formed between the charged residues of CETP and the head groups
of POPCs as a function of time. The upper profile shows the number of contacts
between the positively charged residues and P atoms of POPCs, and the lower pro-
file shows the number of contacts between the negatively charged amino acids and
N atoms of POPCs. B) Salt bridge-forming positively (red) and negatively (blue)
charged amino acids are marked to the structure of CETP. Trp residues are labeled
(green). Reproduced from [13].
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Figure 5.6: Interaction of CETP with core lipids. A) Snapshots from the coarse-
grained simulations. CG3 (left) corresponds to coarse-grained atomistic system A3
and CG3-90POPC (right) to the same system but half (90) of POPCs removed,
for more details of the systems, see [13]. The upper snapshots show side views
and the lower ones show top views of CETP bound to a lipid droplet. In the case of
CG3-POPC, the hydrophobic patch under CETP is clearly visible, mainly because the
removal of POPCs give CETP better access to core lipids. The structure of CETP
has been rendered using secondary structure information in upper snapshots (β-sheets
are yellow, α-helices violet, and random coils gray) or as dark transparent phantom
in lower snapshots. The green spheres are Trp residues. POPCs are transparent in
the upper snapshots, while those in the bottom snapshots are visible as grey (the
choline head groups are visible as blue). CEs are rendered with orange spheres.
Water molecules were omitted for clarity. B) Number of contacts between core CEs
and CETP with different surface-core lipid ratios as a function of time. The results
confirm what is visually observed in panel A. Reproduced from [13].
5.4 Is BODIPY a Feasible Molecular Probe in Lipoprotein
Environment?
Fluorescent probes are essential tools in experiments to visualize various cellular trans-
port processes and also to help in clarifying physiological and pathophysiological
changes in a body. However, labeling of molecules with fluorescent probes always
changes the nature of the host molecules. Sometimes the changes in behavior are
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so subtle that the properties of the labeled molecule closely match the properties
of the original molecule. Problems arise when the changes are substantial enough
to alter the behavior completely, thus making the probe unsuitable for a given task.
The probe might work in one environment but fail completely in a different situation.
It is thus vital to validate the used probes in the studied environment before using
them, or at least before interpreting the results.
In Paper IV, the behavior of BODIPY-labeled cholesteryl ester (BODIPY-CE) was
studied in a high-density lipoprotein environment and compared with the behavior of
unlabeled cholesteryl ester. Below we highlight the main results.
Figure 5.7: Radial distribution functions (RDF) from four independent unbiased
simulations of HDL. From a to d, the CE/BODIPY-CE counts are 13/3, 13/3,
15/1, and 16/0, in respective order. At small distances the RDF value of the CE
ring extends to 250, but for clarity’s sake we draw the plot only up to 140. In panel
b, one of the BODIPY-CE molecules is oriented tangentially with respect to HDL,
giving rise to a shoulder in the plot of the BODIPY-CE ring at r=2.3 nm. Reproduced
from [14].
The radial distribution functions are shown in Figure 5.7. In the unlabeled HDL
(Panel d), apoA-I proteins are located at the surface region comprised of POPC
molecules. The CE molecules are in the core, and based on their radial distribution
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they are randomly oriented as in a melt. Comparing the unlabeled HDL to the
systems with labeled BODIPY-CE (Panels a-c) reveals a major difference in the
core region. BODIPY-CE does not favor being in the center of the HDL particle,
as the oleate tail and the ring part avoid the particle center. This is due to the
BODIPY part favoring the region between the acyl chains and the headgroups of
the phospholipids. Studying the preferred orientation of both CE and BODIPY-CE
shows that the orientation of the ring structures of unlabeled CE is almost random,
whereas BODIPY-CE prefers orientations pointing outwards from the center of the
HDL particle.
The differences in localization were studied also using replica umbrella sampling.
The results show that both BODIPY-CE and unlabeled CE assemble similarly into
HDL upon contact. However, BODIPY-CE does not diffuse all the way to the core
but remains between the surface and the core, whereas unlabeled CE readily migrates
to the HDL core. Also, the diffusion of BODIPY-CE is slower than the diffusion of
its counterpart, which can be explained by the preference of keeping the BODIPY
probe in the surface region and the CE body away from it.
Figure 5.8: Free energy E as a function of distance r shown for CE and BODIPY-
CE. The distance r is from the center-of-mass (COM) of HDL to the COM of the
cholesterol ring in CE or BODIPY-CE. The free energy is set to zero at r = 5.5 nm.
The presented data also show the error bars depicted by varying thickness of the
curves. Reproduced from [14].
Based on the results, the labeling of CE with the BODIPY probe alters the
properties of BODIPY-CE to the extent that renders it unable to fully mimic the
behavior of cholesteryl ester in a lipoprotein environment. It seems that an essential
property for a valid probe in a lipoprotein environment is to have little or no affinity
for the hydrophilic surface region.

6 | Concluding Remarks
Studying the structure and function of lipoprotein particles using experimental meth-
ods is rather challenging due to the small size and dynamic nature of lipoproteins.
Often experiments are carried out in unphysiological conditions which might dramat-
ically alter the structure and function of lipoproteins. Through molecular dynamics
(MD) simulations, phenomena or properties unreachable by experimental methods
can be accessed. MD simulation methods can overcome limitations of experimental
methods related to the short time and length scales.
However, many biological processes take place in relatively long time and length
scales that for simulations in the atomistic regime are challenging due to the enor-
mous computational load. By removing some details through coarse-graining, one
can develop models that are feasible enough to consider sufficiently large system sizes
and time scales. In this thesis, MD simulations were employed to explore cholesterol
transport, high- and low-density lipoproteins in particular.
Through extensive coarse-grained simulations, the first detailed structural model
for both HDL and LDL was provided showing that the previously proposed 2- and
3-layer models are inadequate to describe the properties of the lipid droplets. It was
found that the structural and dynamic properties of lipids depend significantly on
their location and distance from the center of the particle. The protein components,
apoA-I in HDL and apoB-100 in LDL, are not just lying on top of the surface of the
lipid droplets but they, e.g., interact also with the hydrophobic lipids located beneath
the surface.
The detailed atomistic picture of the initial steps in the lipid exchange mechanism
of CETP was provided. The mechanism and the residues involved in the process of
anchoring CETP onto the surface of the droplet was revealed. Also, the critical role
of helix X as a door to the hydrophobic tunnel carrying the cargo lipids was stud-
ied. CETP anchors to the surface of HDL mainly through charged and tryptophan
residues. After attachment to HDL, a small hydrophobic patch forms rapidly, open-
ing a route from the binding pocket of CETP to the core of the lipid droplet. Helix
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X of CETP seems to work as a lid, opening the hydrophobic tunnel when bound to a
lipoprotein and closing it when moving between lipoproteins. These findings help us
to understand in a mechanistic way how CETP-mediated lipid exchange takes place
between different lipoproteins.
Studying the properties of BODIPY-labeled cholesteryl oleate in a lipoprotein-
like environment revealed that the influence of BODIPY is strong enough to render
the behavior of the BODIPY-labeled cholesteryl ester qualitatively different from its
unlabeled counterpart. Based on these differences BODIPY-labeled cholesteryl oleate
is not suitable to be used experimentally in a lipoprotein environment. It appears that
a successful probe in a lipoprotein environment should have no significant affinity for
a hydrophilic surface region.
Looking back and evaluating the work done, the choice of the Martini model and
the idea to apply it to lipoprotein systems is one of the strengths of this work. In
the beginning, it was not clear whether it could be applied successfully on lipoprotein
systems, as it was earlier mainly used for membrane studies [107]. The selected
method made it possible to simulate systems inaccessible at that time by conventional
atomic MD simulations. The results of these studies and later also the studies by
other groups have shown that this model can be applied to study many different
phenomena taking place in lipoproteins [110]. If the same studies were repeated
today, longer time scales would probably be used to improve the statistics, and more
realistic models for HDL in papers III and IV would be used. In the Martini model,
the secondary structure of proteins is fixed, and it limits the possibilities of studying
the dynamic nature of lipoprotein-associated proteins [108].
When the results of this thesis are considered overall, one can conclude that there
are three key take-home messages that have the most significant impact. First, the
research results discussed in this thesis provide compelling evidence that atomistic
and molecular-scale computer simulations are an exceptionally competent tool able
to complement experiments in the nanoscale. Consideration of the structure and
dynamics of soft nanoscale particles such as lipoproteins is an exceptionally tough
challenge, but through computer simulations, this insight can be revealed. Second,
these simulations provided pioneering atomistic insight into the structure and dy-
namics of lipoprotein particles and their interactions with carrier particles such as
CETP. Third, based on this knowledge, one can conclude that the simulation models
developed and the results found in this work provide a solid basis for further investi-
gations of cellular processes dealing with lipoproteins and lipid trafficking, examples
including the binding of lipoproteins with their receptors, the fusion of lipoproteins,
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and the development of new drugs for modulating the lipid trafficking processes. All
these processes contribute to our health in the context of cardiovascular diseases,
and thus further studies of these ideas using the models and tools developed in this
thesis work would be more than welcome.
Moving on in the same context, the findings pave the way for further studies of
HDL and LDL to better understand the key steps in the initial events of atheroscle-
rosis, and the molecular level events in the lipid exchange processes. One interesting
research topic would be to apply reverse coarse-graining on the CETP model to get
back to atomistic scale [139]. This would give a possibility to study the protein
behavior after the initial attachment and to get rid of the limitations of the Martini
model as to the protein secondary structure. Further, given that dietary and living
habits affect the lipid composition of lipoprotein particles [57, 140], methods used in
this work could be extended to study the coupling between the lipid composition of
LDL and its structure and function.
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Abstract
We study the structure and dynamics of spherical high density lipoprotein (HDL) particles through coarse-grained multi-
microsecond molecular dynamics simulations. We simulate both a lipid droplet without the apolipoprotein A-I (apoA-I) and
the full HDL particle including two apoA-I molecules surrounding the lipid compartment. The present models are the first
ones among computational studies where the size and lipid composition of HDL are realistic, corresponding to human
serum HDL. We focus on the role of lipids in HDL structure and dynamics. Particular attention is paid to the assembly of
lipids and the influence of lipid-protein interactions on HDL properties. We find that the properties of lipids depend
significantly on their location in the particle (core, intermediate region, surface). Unlike the hydrophobic core, the
intermediate and surface regions are characterized by prominent conformational lipid order. Yet, not only the
conformations but also the dynamics of lipids are found to be distinctly different in the different regions of HDL,
highlighting the importance of dynamics in considering the functionalization of HDL. The structure of the lipid droplet close
to the HDL-water interface is altered by the presence of apoA-Is, with most prominent changes being observed for
cholesterol and polar lipids. For cholesterol, slow trafficking between the surface layer and the regimes underneath is
observed. The lipid-protein interactions are strongest for cholesterol, in particular its interaction with hydrophobic residues
of apoA-I. Our results reveal that not only hydrophobicity but also conformational entropy of the molecules are the driving
forces in the formation of HDL structure. The results provide the first detailed structural model for HDL and its dynamics
with and without apoA-I, and indicate how the interplay and competition between entropy and detailed interactions may
be used in nanoparticle and drug design through self-assembly.
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Introduction
Cardiovascular diseases are the primary cause of death in
western countries [1]. One of the main causes is the lipid
accumulation and plaque formation on arterial walls, called
atherosclerosis. This eventually leads to the narrowing of arteries,
plaque rupture, clotting, and potential death. Generally speaking,
high levels of low density lipoprotein (LDL) in blood have been
found to increase the risk of atherosclerosis [2,3], whereas high
levels of high density lipoprotein (HDL) have been shown to
reduce the risk [4,5].
Despite more than a decade of extensive studies, LDL and HDL
structures are not well understood. This is largely due to their
small size which ranges from about 10 (HDL) to 25 nm (LDL)
rendering experimental studies of the detailed lipoprotein
structures extremely difficult. This challenge is further corrobo-
rated by the soft nature of lipoparticles whose structures are
transient due to thermal forces driving molecular assembly
processes in living matter. The challenge is to unravel the role
and mechanisms of lipoproteins in the trafficking of cholesterol
and in the cholesterol-based diseases. In this work, we focus on
HDL.
Let us briefly summarize the main insight one has about high
density lipopproteins. HDL particles are comprised of a lipid
droplet surrounded by proteins [6,7]. Apolipoprotein A-I (apoA-I)
is the main protein associated with HDL, which is the main carrier
of excess cholesterol from peripheral tissues to the liver, that is, for
reverse cholesterol transport [5,8]. After synthesization, the ATP-
binding cassette transporter A1 (ABCA1) assembles lipid-poor
apoA-I molecules and lipids into discoidal HDL particles [9], after
which the enzyme lecithin:cholesterolacyl transferase (LCAT)
esterifies cholesterol molecules, leading to the formation of
spheroidal HDL [10,11]. The spheroidal HDL is the main form
of HDL responsible for cholesterol transport to the liver.
Though a number of experimental studies have been carried
out to unravel the structure and dynamics of apoA-I molecules in
lipid-free form [12–15] and in discoidal HDL complexes [16,17],
the structure of the spheroidal HDL has remained unclear. As for
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the structure of apoA-I, a large amount of data is in favor of the so-
called double belt model (see Ref. [18] and references therein),
where the apoA-I proteins line along the lipid droplet. The
composition of the droplet has been resolved [19,20] (see Table 1),
indicating free cholesterol (CHOL), cholesteryl esters (CE),
triglycerides (TG), phospholipids, and lysolipids to be its main
constituents, distributed such that there is a hydrophobic interior
of triglycerides and cholesteryl esters and a surface covered by
polar head groups of phospholipids [21]. This is essentially the so-
called two-layer model for HDL [6,7,22]. Furthermore, parts of the
apoA-I proteins have been proposed to interact with the acyl
chains of the lipids [23–27].
Currently, the role of lipids for HDL functions are only vaguely
understood. This is partly due to the transient time scales
associated with and the nano-scale nature of HDL. Further issues
include the poor understanding of lipid organization and interplay
of lipids with apoA-I. Considering findings that lipids are an
integral component of protein structures, e.g., in membrane
proteins that are in constant interplay with lipids [28], it is obvious
that clarifying the role of lipids for HDL properties is extremely
important.
A number of computational studies have recently been
conducted to complement experiments. Previous computational
studies of HDL particles have focused on discoidal particles
consisting of phospholipids and two apoA-I molecules [29–32].
These studies have provided some insight into the mechanisms of
assembly and the dependence of the particle shape on the lipid/
protein molar fractions. In a different approach, bulk melts of
cholesteryl esters [33] and triglycerides [34], as well as combina-
tion of cholesteryl esters with POPCs [35] have recently been
simulated. Catte et al. [36] reported the first computational
approach towards understanding the structure of spheroidal HDL
particles. Their study clarified the conformation of apoA-I in
model spheroidal HDL particles using both all-atom (AA) and
coarse-grained (CG) molecular dynamics (MD) simulations. This
combination of AA and CG-MD simulations led to model
spheroidal HDL particles with prolate ellipsoidal shapes having
sizes consistent with experimental results and suggested that
cholesteryl esters stabilize the conformations of apoA-I [37]. In a
more recent work, Shih et al. also combined coarse-grained
simulations with atomistic ones in a series of simulations where
discoidal HDL was matured into spherical HDL upon incorpo-
ration of cholesteryl esters [38]. They found that maturation
results from the formation of a dynamic hydrophobic core
composed of cholesteryl esters, the core being surrounded by a
layer of phospholipids and apoA-I proteins. Interestingly, Shih et
al. also fine-grained the coarse-grained HDL particle to atomistic
description and then used atomistic simulations to consider the
structure of apolipoproteins around the lipid droplet, and in
particular the importance of salt bridges in apoA-I.
The main limitations of previous simulations of HDL particles
are two-fold. First, the lipid composition modeled in recent
simulations has been somewhat unrealistic: instead of a many-
component lipid mixture, the lipid droplet has been modeled as a
single-component POPC melt, or as a mixture of POPCs and
cholesteryl esters [36]. The role of the many different lipid species
in HDL has therefore remained unknown. Second, the time scales
of HDL simulations have been too short compared to the
characteristic time scales of lipid mixing and structural deforma-
tions associated with HDL. As even the time scale of lipid mixing is
of the order of 1 ms (derived through the diffusion of lipids inside
HDL), and the current state-of-the-art for atomistic simulations of
HDL extends over 10–100 ns, it seems obvious that currently
atomistic simulations are not the method of choice for dealing with
HDL over large enough time scales.
Our objective is to overcome the above limitations. We have
performed MD simulations of spheroidal HDL particles using the
full lipid composition of human plasma HDL [19]. Instead of
atom-scale simulations, we employ the coarse-grained MARTINI
model [39,40] that has performed exceptionally well in a number
of studies dealing with lipids and proteins [36,39–42]. We consider
both the protein-free lipid droplets and the full HDL particles
containing also two apoA-I molecules around the droplet, see
Figures 1 and 2. Composition of the HDL system is described in
Table 1 with abbreviations of all molecules included. By
comparing the protein-free and the full HDL models, we can
clarify the role of lipids and proteins in HDL. The principal
objective is to fill the gap of detailed structural and dynamic
Table 1. Molecular composition of HDL.
Component
N
(simulation)
mol %
(simulation)
mol %
(experiment)
POPC 260 53.9
56.1
PPC 10 2.1
CE 122 25.3 25.5
CHOL 49 10.2 10.2
TG 39 8.1 8.2
ApoA-I 2
The table shows the number of molecules (N) used in the simulations, together
with the experimentally measured molar percentages in human plasma HDL
[19]. While this choice reflects the relative amounts observed for the different
molecular components in HDL, there is reason to stress that HDL composition is
very heterogeneous and depends on, e.g., HDL size and diet [66,67]. The
present study essentially represents the largest HDLs, that is HDL2 ; the effect
of changes in lipid and protein concentrations are discussed below in this
article. The abbreviations: POPC (palmitoyl-oleoyl-phosphatidylcholine), PPC
(palmitoyl-PC), CE (cholesteryl ester, here cholesteryl oleate), CHOL (free
cholesterol), TG (triglyceride, here trioleate).
doi:10.1371/journal.pcbi.1000964.t001
Author Summary
Cardiovascular diseases are the primary cause of death in
western countries. One of the main causes is lipid
accumulation and plaque formation on arterial walls,
called atherosclerosis. The risk of being exposed to this
condition is reduced by high levels of high density
lipoprotein (HDL). The functionality of HDL has remained
elusive, and even its structure is not well understood.
Through extensive coarse-grained simulations, we have
clarified the structure of the lipid droplet in HDL and
elucidated its interactions with the apolipoprotein A-I
(apoA-I) that surrounds the droplet. We have found that
the structural and dynamic properties of lipids depend
significantly on their location in the particle (core,
intermediate region, surface). As for apoA-I, we have
observed it alter the overall structure of the lipid droplet
close to the HDL-water interface, with prominent changes
taking place for cholesterol and other polar lipids. The
nature of lipid-protein interactions is most favorable for
cholesterol. Our results reveal that not only hydrophobicity
but also conformational entropy are the driving forces in
the formation of HDL structure, suggesting how the
interplay and competition between entropy and detailed
interactions may be used in nanoparticle and drug design
through self-assembly.
}
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information of lipids in spheroidal HDL particles. We also address
questions related to the role of apoA-I proteins and their
interactions with lipids in HDL structures. The currently
incomplete understanding of the latter issue is largely due to the
size heterogeneity of HDLs (diameters range from 7.2 (HDL3) to
12 nm (HDL2)) and the large flexibility of apoA-I. The latter
renders the prediction of the positioning of different alpha helices
of apoA-I on a spherical surface very difficult. The distribution of
lipids inside HDL and their interplay with apoA-I are of profound
interest. From a more general perspective, knowledge of the
Figure 1. Descriptions of the molecules considered in the study. (Top) Atomistic (united atom) descriptions, and (bottom) the coarse-grained
representations.
doi:10.1371/journal.pcbi.1000964.g001
Figure 2. Example of a protein-free lipid droplet (left), its molecular distribution shown through a slice across the particle (middle),
and HDL including two apoA-I proteins (right). Dark gray stands for POPC headgroup and dark brown for PPC headgroups, light gray for POPC
hydrocarbon chains, light brown for PPC chains, light orange for CHOL OH-groups, bright yellow for cholesterol body, dark orange for CE ester bond,
orange for CE ester body and chain, dark green for TG ester bonds, and bright green for TG chain. In HDL, proline residues in apoA-I sequences are in
green.
doi:10.1371/journal.pcbi.1000964.g002
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structure of spheroidal HDL is crucial for understanding the
conformational changes when HDL makes the transition from
discoidal to spheroidal shape, and the trafficking of CHOL and
CE through the action of cholesteryl ester transfer protein [43].
Additionally, to design nanoparticles with desired surface and bulk
properties, e.g., for controlled transport and release of drugs and
contrast agents, it is vital to understand the conformational
changes as well as the underlying mechanisms in detail [44–51].
Results
Structure of Full HDL and the Lipid Droplet
The radial density distributions shown in Figure 3 reveal the
internal structure of the simulated lipoparticles. The hydrophobic
CE and TG molecules are located in the core of the particle and
have minimal overlap with water. The lipids with a polar head
group, POPC and PPC, are mostly located at the surface region
facing water, whereas most of CHOL is located just below these
two lipids. Note that a small but significant concentration of
CHOL is also found in the core of the particle.
Considering the size of HDL, the radii of gyration give an
average of Rg~4:079+0:001 nm for the droplet and
Rg~4:278+0:001 nm for the full HDL. Both particles are
effectively spherical, as indicated by the moments of inertia (data
not shown).
The apoA-I proteins are embedded onto the surface of the HDL
particle, their density peaking just slightly below the headgroup
region of POPC and PPC. The presence of the protein slightly
disturbs the distribution of these lipids as revealed by the
comparison of the lipid droplet with the full HDL particle. The
distribution of hydrophobic lipids remains undisturbed. Most
significant is the shifting of the distribution of CHOL, and partly
PPC, towards water phase when the protein is present, while the
distribution of POPC is shifted slightly towards membrane center,
making room for CHOL and PPC. In the full HDL particle, water
is found to distribute less to the particle compared to the droplet.
Our results clearly highlight the displacement of CHOL even
further towards the interface in the full HDL particle. The data
below shows that CHOL interacts prefentially with some of the
protein residues, strongly promoting the partitioning of CHOL to
the vicinity of apoA-I. CHOL further prefers to reside next to the
water region, facilitating (hydrogen) bonding via the polar OH
group. It has been proposed [52] that CHOL molecules can
mediate the relief of membrane stress arising from chain-chain
mismatches, since their dimerization is not favored in membranes
with high surface curvature. This view is supported by the
observations of Huang and Mason [53]. Their work suggests that
high surface curvature requires CHOL to be at the interfacial
region. Interestingly, Lemmich et al. have further found that very
small amounts of CHOL (less than about 3 mol-%) may soften the
interface and hence promote its fluidity [54]. In HDL, the average
concentration of CHOL is about 10 mol-%, but at the interface it
is about 5–10 mol-% depending on distance from the water phase
(see Figure 3).
The minor but significant concentration of CHOL in the core of
the particle calls for discussion. The usual assumption especially in
studies of lipid membranes is that CHOL resides at the water-lipid
interface due to its polar OH group. This is expected often to be
the case, though there are also reported exceptions such as CHOL
residing for short times in the middle of a polyunsaturated lipid
bilayer [55,56], and the suggestion of CHOL in the interior of
LDL [57].
To start with, one gets an impression that the density plot
adheres to the two-layer model [6,7,22] wherein one assumes
almost full separation of hydrophilic and hydrophobic molecules
into two separate regions. While the distribution of TG fits into
Figure 3. Radial densities showing the composition of the studied particles versus distance from the center of mass (COM) of the
particle. The solid lines are for the full HDL particle, the dashed lines for the lipid droplet without apoA-I.
doi:10.1371/journal.pcbi.1000964.g003
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this picture, the distribution of CE and CHOL does not. A rather
significant amount of CHOL is also in the core of the particle as
was discussed above. Detailed consideration further reveals that
there is a significant overlap of CE with CHOL, POPC, and PPC:
The radial density distributions shown in Figure 3 do not provide a
sufficiently unique description of only two different structural
regions inside HDL. Furthermore, by looking at the order
parameters of CHOL and CE presented in Figure 4 it becomes
evident that there are not only two regions but also the
intermediate one between the hydrophobic and hydrophilic ones.
The innermost core of the particle (rv3 nm) is clear, as there the
ring structures of both CHOL and CE are oriented in a
completely random fashion. The situation changes as one
approaches the lipid-water interface through the intermediate region
(3 nm vrv5 nm), which is characterized by significant ordering
of the ring structures, in a manner where the principal axis of CE’s
and CHOL’s ring moiety lies along the radial direction of HDL.
This intermediate region overlaps with the distribution of the acyl
chains of POPC and PPC, revealing that the sterol rings are also
aligned with the acyl chains. Finally, at the HDL-water interface,
one finds the region composed of hydrophilic headgroups of
POPC and PPC that constitute the surface part of the lipid droplet
interacting mostly with water.
The data clearly shows that instead of the two-layer model, the
distribution of lipids in HDL is more complex. The structural
nano-scale organization of CHOL and CE plays an important role
in constituting the intermediate layer. However, there is no
apparent reason to conclude that the lipid droplet in HDL would
be described by a ‘‘three-layer’’ model either, since the
intermediate region is narrow and represents a crossover from
the hydrophobic to the hydrophilic environment rather than a
clearly defined layer of its own. Our results for lipid dynamics are
in favor of this view and will be discussed below in the context of
diffusion. Meanwhile, while quantitative results have been missing,
a three-layer model has earlier been proposed for LDL particles
[3]. There the situation is different, though, since the diameter of
LDL is roughly three times larger compared to HDL and the
intermediate region can possibly be broader and more character-
istic compared to HDL.
There are significant differences when the order parameters of
CHOL and CE are compared (Figure 4). First, the height of the
main peak is considerably lower for CE than for CHOL,
indicating that the ring of CE has a lower tendency to orient
itself along the acyl chains than CHOL. Second, unlike for
CHOL, on the surface of the particle (rw5 nm) the order
parameter of CE obtains negative values. These indicate the ring
of CE to lie along the surface, perpendicular to the radial
direction. This obviously stems from entropic reasons, since while
CE strives in part to organize its structure like CHOL, also
directing its weakly polar ester bond region to the surface like
CHOL does for the OH group, CE also has a long oleate chain.
Previous atomistic simulations of CE in bulk conditions as well as
in a combined system with POPCs have shown that the oleate
chain of cholesteryl oleate has essentially three different confor-
mations with respect to the ring of CE [33,36]: one where the
angle of the oleate chain (describing it as a semi-stiff rod) with
respect to the principal axis of the ring is about 35 degrees, and
two other modes with an angle of 90 or 150 degrees. Compared to
CHOL with only one mode, CE inevitably aims to minimize free
energy by promoting entropic degrees of freedom.
Another interesting observation is that apoA-I suppresses the
main peak of both CHOL and CE molecules in Figure 4. The
effect is an indication that the protein disturbs the ordering within
the intermediate region (between the core and the surface), also
facilitating the displacement of CHOL towards the water phase.
This conclusion is supported by the broadening of the angle
distributions of POPC in the presence of the protein (see
Supporting Information (SI)).
An analysis of the internal conformations of CE molecules in
Figure 5 provides a more detailed view of the situation. In the core
of the particle, the most probable conformation of CE is the coil-
like conformation (maximizing entropy), where the angle between
the CE ring and the oleoyl chain is about 120 degrees. This is
largely consistent with recent atom-scale simulations of CE in bulk
conditions [33]. The behavior changes on the surface of the
particle. The two peaks of the distribution on the surface
correspond to two distinctly different conformations: one where
the ester group of CE (corresponding to the OH-group of CHOL)
Figure 4. Order parameter S for the ring structures of CHOL (left) and CE (right). The black curves describe the lipid droplet and the red
curves the full HDL.
doi:10.1371/journal.pcbi.1000964.g004
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points towards water and the oleate chain is extended towards the
solvent, and another where the ester region is pointing towards the
core of the particle, while the ring and the oleoyl chain form a
small angle with each other.
Also for TG, we find a change of conformation when it is shifted
from the core of the particle onto the surface. In the core, the three
chains of TG place themselves to a similar conformation as in a
bulk melt of TG [34]. When brought to the surface, the ester bond
regions seek contact with water, which brings the three chains of
TG closer to each other into a more tightly packed conformation
(see Figure S2). Additional data for molecular conformations are
presented in Figure S1, Figure S3, Figure S4, and Figure S5.
Dynamics of Lipids Characterized by Diffusion
The large-scale dynamics within HDL and the lipid droplet are
considered in terms of diffusion, characterized by the diffusion
coefficient D. The diffusion coefficients were determined by
considering lipid displacement distribution functions over a fixed
period of time (see SI). We found that the jump length distributions
for lipids in the core of the particle (TG and CE) fitted well with
the three-dimensional diffusion model, yielding D3d . Meanwhile,
the lipids on the surface (POPC, PPC, CHOL) fitted much better
with the two-dimensional description for diffusion, yielding D2d .
For details, see SI.
Table 2 shows the long-time diffusion coefficients of the lipid
components within the lipid droplet and the full HDL particle.
Figure 6 depicts how the diffusion rate varies significantly inside
the lipid droplet and/or full HDL. The diffusion is the slowest in
the middle of the particle, it speeds up as the molecules get closer
to the interface, and the fastest diffusion is found at the interface.
The influence of apoA-I on diffusion of lipids is modest. It turns
out that the lipid diffusion coefficients in the protein-free lipid
droplet and the full HDL particle are almost similar. The apoA-I
Figure 5. Distributions of CE conformations. The horizontal axis is the angle a between the CE ring and the effective normal of the lipid droplet.
The vertical axis is the angle b between the ring structure and the oleate chain. The left panels (A, C) describe the core of the droplet (rv2 nm) and
the right panels (B, D) the surface (rw3 nm). The pictures at the top (A, B) show the lipid droplet without apoA-I and those at the bottom (C, D) the
full HDL.
doi:10.1371/journal.pcbi.1000964.g005
Table 2. Diffusion coefficients in units of 10{7cm2=s.
Component Dimensionality D (droplet) D (HDL)
TG 3d 0:30+0:07 0:27+0:08
CE 3d 0:56+0:05 0:36+0:06
CHOL 2d 1:6+0:2 1:3+0:2
POPC 2d 1:5+0:3 1:5+0:1
PPC 2d 2:8+0:1 2:6+0:1
The dimensionality of 2d refers to diffusion along the lipid-water interface,
while 3d refers to diffusion in the core of the particle.
doi:10.1371/journal.pcbi.1000964.t002
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proteins may slow down the diffusion of lipids slightly especially
close to the interfacial regions. The effect is, however, weak (see
Table 2).
The diffusion coefficients of POPC, PPC and CHOL in the
surface region of the particles are about (1{3)|10{7cm2=s and
in good agreement with experimental estimates of D&1|
10{7cm2=s for two-dimensional lipid bilayers in fluid phase
[58]. On the other hand, the diffusion coefficients for CE and TG
are smaller by a factor of 10, about 0:3|10{7cm2=s. To our
knowledge, diffusion coefficients of lipids in HDL have not been
experimentally determined. However, for LDL and LDL-like lipid
droplets, Vauhkonen et al. used pyrene-linked PC lipids as probes
to find that D&(0:5{1:5)|10{7cm2=s at the surface of
lipoparticles [59], in good agreement with our findings. Massey
and Pownall have further used single-chain cationic amphiphiles
for considering lipid mobility at the surface regions of LDL and
HDL, and while quantitative estimates for D are missing, they
concluded that the diffusion at the surface is about 2–3 times
slower compared to cholesterol-free POPC vesicles [60]. Recent
MARTINI-model simulations for single-component PC bilayers
have yielded D&4|10{7cm2=s [61], which is about a factor of 2
larger than diffusion at the surface of HDL. While the comparison
of our simulation data and experiments is suggestive rather than
conclusive, the qualitative agreement is striking.
Our main result regarding diffusion is that diffusion at the
surface region of HDL is largely similar to diffusion of lipids in
cholesterol-containing lipid bilayers in the fluid-like phase, the
cholesterol concentration being roughly 10 mol%. Figure 6 also
shows convincingly that the effect of apoA-I on diffusion of lipids is
not significant.
Additionally, Figure 6 provides compelling evidence that the
dynamics of lipids in terms of their diffusion properties is not
consistent with the two-layer model. Instead of two clearly
different dynamic regions, we find the diffusion coefficients to
increase monotonously: diffusion rates are clearly different in the
core (rv3 nm), in the ordered intermediate region (r&4 nm), and
at the surface (r&5 nm).
Given the different proposed models for lipid distribution in
HDL, the striking difference of the present findings compared to
earlier studies is the role of dynamics: not only the structural and
ordering properties of molecules in HDL differ across HDL, but
also the dynamics in terms of molecular transport coefficients
varies significantly in the different compartments. The biological
relevance of this feature lies in the time scales of molecular
trafficking inside HDL: while molecular transport between the
surface and the intermediate region is relatively fast, the transport
between the surface and the core of HDL is slower by a factor of
*10.
Role of ApoA-I in HDL
The above results show that the apoA-I proteins do not induce
large changes to the lipids’ properties inside the droplet. Yet, while
the protein collapses onto the surface of the droplet, it does disturb
the packing, ordering and, although only slightly, also the
dynamics of the lipids at the surface region. What remains to be
explored is the nature of the lipid-protein interactions. In this work
our primary interest is the lipid component of HDL, thus we have
used the standard CG MARTINI model which does not enforce
the full secondary structures in apoA-I. This optimizes computa-
tional efficiency and allows us to focus on generic issues such as the
partitioning of lipids around apoA-I, and the influence of apoA-I
on the lipid droplet. Meanwhile, we cannot address questions
related to detailed atomistic phenomena at the lipid-apoA-I
interface.
Data for the surface accessible surface areas (SASAs) of apoA-I
hydrophilic and hydrophobic residues (data not shown) provide
evidence for the low contribution of protein hydrophobic residues
(11%) to the total SASA of the protein, the main contribution
coming from protein hydrophilic residues (89%). The average
value of SASA of protein hydrophobic residues (13:1+1:6nm2) is
in good agreement with that reported by Shih et al. [32] in a
recent study on the assembly of lipids and proteins into lipoprotein
particles.
The RMSFs of protein a carbons are shown in Figure 7 and
reveal the mobility of different protein domains. The a-helical
structure of the protein exhibits very little mobility for both chains.
This rigidity of the protein is also in agreement with the observed
slight disturbances produced on the lipid packing.
The number of annular lipids, as defined in the Method section,
is given in Figure 8 for each lipid component. It is interesting to
note that about 80% of CHOL molecules are annular (on average
40 out of 49) while only 10% of CE molecules (about 15 out of
122) are in close contact with the protein. An average of about 98
POPC molecules out of a total of 260 are annular. Overall, the
results indicate that there is a preferential interaction between
CHOL molecules and protein residues. This result is striking if one
considers that the number of POPC molecules is larger than that
of CHOL molecules.
It is known that the number of apolipoproteins in HDL depends
on particle size. We characterized its role for lipid distribution
through additional simulations with three apoA-Is. First, we
performed a 20 microsecond simulation of the same lipid droplet
with 3 apoA-I molecules placed 2 nm apart from each other. The
protein molecules were found to insert themselves in the lipid
droplet in the same way as was observed above, with hydrophobic
moieties pointing towards the droplet. The only interesting
difference was that in the structure with three apoA-Is, the C-
terminus and the helix 9 of one protein molecule were not inserted
in the lipid droplet. This situation is likely due to the crowded
Figure 6. Diffusion coefficients of the lipid components. Each
point in the plot describes the diffusion coefficient for one of the lipid
types. The distance r is the average distance of the given lipid from the
COM of the particle. To facilitate comparison between core (three-
dimensional diffusion) and surface lipids (two-dimensional diffusion),
the coefficients have been scaled with 2d , where d is the dimension of
the fit (either two or three).
doi:10.1371/journal.pcbi.1000964.g006
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arrangement of apolipoproteins, or due to the limited time scale of
the simulation. The addition of a third apoA-I molecule does also
affect the interaction of cholesterol with apoA-I: Almost 100% of
the cholesterol molecules (47+1 out of 49) are in contact with the
three proteins. That is, the addition of the third apoA-I molecule
enhances the average number of annular cholesterol molecules
from about 80% (observed with 2 apoA-I molecules) to about 96%
of the total unesterified cholesterol in the particle.
The lipid-protein interactions of different moieties of each lipid
component showed that POPC, PPC and TG molecules interact
with apoA-I residues preferentially through the acyl chains (POPC
and PPC glycerol backbone has also a high number of contacts
with apoA-I), while CHOL and CE molecules interact with the
protein mainly through the sterol ring (see Table S1). To better
understand the nature of the interaction between CHOL and
apoA-I we also measured the number of lipid-protein contacts per
residue (hydrophobic and hydrophilic), shown in Figure 9. It is
clear that there is a preferential interaction of CHOL molecules
with apoA-I hydrophobic residues, in particular tryptophane (Trp)
and phenylalanine (Phe) having aromatic side chains, but also
valine (Val) and leucine (Leu). Highly preferred interaction with
Trp and Phe is understandable through findings of aromatic ring
pairing in e.g. known protein structures [62]. We also observe a
relevant number of contacts with apoA-I hydrophilic residues with
aromatic side chains such as tyrosine (Tyr) and histidine (His). This
is not surprising, as Tyr has a hydrophobicity comparable to Phe
as has been shown experimentally by Wimley and White [63]
through the determination of a hydrophobicity scale for proteins at
membrane interfaces. There are less contacts of CHOL molecules
with the other apoA-I hydrophilic residues, namely serine (Ser),
threonine (Thr) and asparagine (Asp) being the most attractive
ones. These results are in good agreement with the observed large
number of contacts of the sterol ring of CHOL molecules with
protein residues.
The sterol ring of CHOL molecules can intercalate or interact
with the aromatic side chains of protein residues as observed for
CE in a recent study by Catte et al. [36]. This interaction between
CHOL molecules and apoA-I was also observed experimentally by
Dergunov et al. [64]. The authors estimated the degree of
exclusion of CHOL molecules from the boundary lipid region in
Figure 7. Root mean square fluctuation (RMSF) profiles for
apoA-I alpha carbons (black, chain A; red, chain B) measured
over the last 4 ms of the simulation of the full HDL particle.
Experiments suggest that the alpha-helical region is likely given by the
residues 44–241, and that the alpha-helical content overall is about 75–
80% [6,13,18,26].
doi:10.1371/journal.pcbi.1000964.g007
Figure 8. Number of annular lipid molecules over the last 4 ms of the simulation of the full HDL particle: POPC (blue), CHOL (red), CE
(orange), PPC (purple) and TG (green).
doi:10.1371/journal.pcbi.1000964.g008
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reconstituted discoidal HDL particles containing different apoli-
poproteins and observed an increase in the order A-I,E,A-II.
The partial exclusion of CHOL molecules operated by apoA-I and
the corresponding CHOL distribution among surface and bulk
lipids are in good agreement with our findings as depicted through
a series of snapshots in Figure 10 (see also SI).
The binding between CHOL molecules and apoA-I residues is
quite weak, which permits exchange among apoA-I -bound and
free CHOL molecules on the time scale of the simulation. We
characterized this trafficking process by computing the distribu-
tions of lifetimes between CHOL-protein and CE-protein
contacts. The average lifetime was found to be 146 ns for CHOL
Figure 9. Number of contacts of CHOL molecules with apoA-I residues normalized per residue. See text for details. Isoleucine and
cysteine are absent in the human apoA-I sequence considered here [13].
doi:10.1371/journal.pcbi.1000964.g009
Figure 10. Illustrative snapshots of HDL structure. (Top) Different snapshots of the full HDL simulation: (A) 0 ms, (B) 0.4 ms, (C) 1.4 ms, (D) 12.4 ms,
and (E) 19.04 ms. (Bottom) Snapshots displayed at the top of the figure showing here only the apoA-I molecules, and annular and bulk CHOL
molecules. The two apoA-I chains are in light red (chain A) and light blue (chain B) with proline residues in green. Annular CHOL molecules are shown
in purple with a dark red hydroxyl group. Bulk CHOL molecules are depicted in yellow with an orange hydroxyl group.
doi:10.1371/journal.pcbi.1000964.g010
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and 15 ns for CE. While the errors are of the same order as the
lifetime due to a limited number of samples, and the fact that the
distribution for CHOL is broad as there are cases where the
CHOL-protein contact is maintained throughout the simulation,
the results highlight the stability of CHOL-protein binding with
respect to that of CE. The relatively large lifetime of the CHOL-
protein binding also highlights that once CHOL has migrated to
the vicinity of apoA-I, it remains there for a long period of time.
For comparison, the average non-contact lifetime for CHOL-
protein pairs, describing the characteristic time for CHOL to not
be in contact with any parts of apoA-I was found to be about
175 ns. That is, CHOL molecules reside close to the water-HDL
interface and on average spend half of their time in contact with
apoA-I.
The above results are in good agreement with NMR
experiments performed on human HDL, which indicate that
CHOL molecules are present in two distinct environments [65].
More specifically, Lund-Katz et al. found that the cholesterol
molecules dissolved in the core of HDL are relatively disordered
and mobile, while the cholesterol molecules located among
phospholipid molecules in the surface of the particle undergo
relatively restricted, anisotropic motions. This view is in line with
our simulation results discussed earlier in this article. Lund-Katz et
al. thus proposed that cholesterol molecules are in two different
microenvironments, undergoing fast exchange between these two
regions, equilibrating between the surface and the core of HDL in
the time scale of milliseconds or more. While the time scales
proposed by Lund-Katz et al. are beyond those that are accessible
via simulations, we have found that there is local exchange taking
place at times up to microseconds. However, the time scales we
have found via simulations should be regarded as the lower limit,
since the diffusion coefficients we have found for the core of HDL
imply that the exchange of cholesterols between the core and
surface regions has to be larger than 1 ms.
Discussion
In this study, we elucidated the structure and dynamics of
spheroidal high density lipoparticles with a realistic lipid
composition corresponding to human serum HDL. We found
that the traditional two-region model for HDL is not accurate
enough. Instead, we found the distribution of the different lipid
types in HDL to be more complex.
The innermost core of HDL is mainly occupied by TG and CE,
which as hydrophobic lipids constitute a randomly oriented melt.
However, in contrast to the common view, the inner core was also
found to contain a rather significant fraction of free cholesterol
partitioned into the disordered melt. The outermost surface region
constitutes the interface with water, which is mostly occupied by
the polar headgroups of POPC and PPC. Between these two is the
intermediate region occupied by CHOL, partly also CE, and the
acyl chains of POPC and PPC. However, there is no apparent
reason to consider the intermediate region as a ‘‘third layer’’, since
it is narrow, unclear to define spatially, and represents a crossover
from the hydrophobic to the hydrophilic environment rather than
a true layer of its own. Yet it has properties that are distinct from
those in the core and at the surface.
This is most obvious in two aspects: ordering of steroid moieties
and molecular diffusion. Unlike in the core, in the intermediate
region the bulky rings of CHOL and CE are strongly ordered
along with the acyl chains. This ordering extends also to the
surface region of HDL, highlighting the difficulty to define the
intermediate region as a true layer of its own. This view is also
supported by the diffusion data, which illustrates that the diffusion
of molecules takes place at a clearly different pace in the different
regions. In the core and in the intermediate region of the particle,
diffusion was found to be three-dimensional, while the diffusion of
lipids at the HDL-water interface turned out to be two-
dimensional in nature. Quantitatively, diffusion in the core of
the particle was observed to be slow, as in a polymer melt, and to
speed up monotonously as one crosses the intermediate region and
ends up in the interfacial region.
The perspective arising from our results is novel, providing the
first molecular scale view to the nano-scale organization of lipids in
HDL. The present results indicate that the spatial distribution of
lipids within HDL provides only a narrow perspective to the
complexity of lipid organization. To understand this issue, one has
to pay considerable attention not only to density distributions but
also conformational and orientational degrees of freedom of the
lipids, and their dynamics within HDL.
Events where CE and TG penetrate to the surface were found
to be rare. In the few observed cases when it occurred, their
conformation was significantly changed. In the core of the particle,
both CE and TG were observed to be capable of obtaining more
coil-like conformations. This indicates that the formation of the
HDL core is not only driven by the hydrophobic effect, but that
conformational entropy has a significant effect.
When comparing the simulation of the full HDL (with apoA-I)
to the lipid droplet (without apoA-I), we found that the overall
structure of the lipid droplet was not significantly changed by the
presence of the protein. Rather, we found a disturbance in the
behavior of the surface lipids. In particular, the order of CHOL
and CE molecules decreased and the conformations of the acyl
chains of PC lipids got broader. Diffusion of the surface lipids was
slightly perturbed by the protein, but the effect was minor.
The low contribution of the SASA of apoA-I hydrophobic
residues to the total SASA of the protein and the large number of
contacts of hydrophobic moieties of each lipid component with
apoA-I evidence that the hydrophobic forces drive the insertion of
the protein and contribute to the stability of the full HDL.
Interestingly, we found that a large number of CHOL molecules
interact with apoA-I, mainly through their sterol ring and
especially with hydrophobic residues having an aromatic side
chain. We also observed fast exchange among protein-free and
protein-bound CHOL molecules. This result is in good agreement
with experimental findings for human HDL particles [65].
It is tempting to discuss the physiological relevance of the above-
discussed molecular level findings, especially the preferable
interaction of the sterol ring moiety with the aromatic amino
acids, and the observation that CHOL molecules spend about half
of their time in contact with apoA-I, trafficking relatively rapidly
back and forth in the vicinity of apoA-I. Such interaction is prone
to have impact on the availability of sterols and lipids for related
transfer proteins and enzymes, such as the cholesteryl ester transfer
protein (CETP) and cholesteryl esterases. This interaction may be
even more important in the process of cholesterol efflux, which is
the critical part of reverse cholesterol transport, where the
accumulated cholesterol is removed from macrophages.
For future purposes for characterizing the properties of HDL, as
well as HDL under enzymatic reactions, our results bring about a
useful view to consider. We have found that the interfacial region
of HDL close to the water phase is rather well defined in terms of
its molecular composition: it can be described as a model layer
composed of PCs, lyso-PCs, CHOLs, and the apolipoproteins A-I.
The diffusion results discussed in this study indicate that the lateral
diffusion along the interfacial layer is largely consistent with
diffusion taking place in model membranes, whose molecular
composition is of the same type. These features suggest that both
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the physical and chemical properties of HDL could be explored
with reasonable accuracy through studies of (planar) model
membranes, which are considerably easier to characterize
compared to nano-sized HDLs. Clearly, the insight gained in this
manner would be limited, since a number of inherent features
would be missing, such as the curved nature of the HDL-water
interface and its effect on apoA-I. Nonetheless, there is reason for
optimism, encouraging experiments and simulations to use model
membranes for better understanding of lipoprotein properties,
including both HDL and LDL.
The view presented in this article for HDL structure and
dynamics paves way to extend the scope of computational studies
for HDL, and to gain a much deeper understanding of HDL
properties in a number of conditions related to health. For
instance, there is reason to assume that the molecular composition
in HDL depends to some extent on factors such as diet and
lifestyle. In altered HDL the lipid composition can be abnormal
due to e.g. dyslipidemia [66]. Characterization of molecular
composition of HDL of subjects with varying degrees of health
would allow coarse-grained simulation studies of HDL in these
subject groups, using the present results as a reference. Preliminary
studies in this spirit have very recently been reported and discussed
by Yetukuri et al. [67], who found that an elevated triglyceride
concentration in low-HDL subjects also affected its distribution in
HDL, increasing the concentration of triglycerides markedly at the
lipid-water interface next to apolipoproteins. Such results based on
large-scale coarse-grained models can further be fine-grained to
atomistic description to study the atom-scale features that are
relevant e.g. in lipid-protein interactions, and the implications on
HDL stability due to reactions of enzymes such as phospholipases.
Work in this direction has already been initiated by Shih et al.,
who recently fine-grained coarse-grained models for matured
HDL particles comprised of apoA-Is, phopholipids, and choles-
teryl esters [38]. Similar work is in progress for the present HDL
models.
Altogether, considering the complexity of HDL, our study
highlights the importance of lipid-apoA-I interactions, and in
particular the specificity of apoA-I for free cholesterol and its
esters. The molecular-scale insight of HDL structure and dynamics
found and confirmed in our study largely stems from the ordering
and dynamical phenomena taking place close to the HDL-water
interface, being in part driven by the interactions between
cholesterol and apoA-I. Evidently, they have a prominent role to
play in a number of transport processes dealing with cholesterol.
Methods
Simulation Models
Construction of the models was implemented in two stages.
First, we constructed lipid droplets (without the apoA-I proteins)
using coarse-grained descriptions of lipids and water. Second, the
studies of pure lipid droplets were complemented by models where
the droplet was surrounded by two apoA-I proteins. Below, we
describe the main stages of the model construction.
The initial structure for the lipid droplet was obtained by
placing the set of lipid molecules (see Table 1) randomly into a
three-dimensional simulation box without water or any other
solvent. As CE, we used cholesterol oleate, while TG was chosen
as trioleate. The system was then simulated under NpT conditions
in order to reach proper density. The resulting molecular melt was
next hydrated with *100,000 water particles and the energy was
minimized, after which the system was equilibrated for 8 ms. After
equilibration, the system was simulated over a period of 4 ms that
was used for analysis. All time scales shown here represent the
realistic effective time (simulation time multiplied by the scaling
factor of four) [39].
For POPC, PPC, CHOL and water, we used standard
components of the coarse-grained MARTINI force field [39].
The parameters for CE and TG are those corresponding to
cholesteryl-oleate and trioleate respectively, and they come from a
combination of standard MARTINI-components and careful
adjustments of the key particle types and angle potentials (see
SI). The adjustments were justified by comparing structural
properties of the molecules in bulk with extensive atomic-scale
simulations [33,34], see SI for details. Sphingomyelin (SM) in ref.
[19] has been included in the POPC contribution, as SM’s
properties in the MARTINI description do not differ considerably
from those of POPC.
Next, all-atom apoA-I molecules were generated using as a
reference the molecular belt model of apoA-I for discoidal HDL
[68–72]. The hydrophobic faces of the amphipathic helices were
oriented toward the interior of the alpha helical ring but for the N-
terminal part of apoA-I; the first 32 residues of the N-terminus
were rotated, as in the lipid-mimetic solution NMR structure of
apoA-I [22,73], in order to have their hydrophobic face oriented
towards the lipid droplet surface. These all-atom models of apoA-I
were coarse grained using a pre-released version of the MARTINI
force field for proteins [40] for the assignment of beads to every
amino acid residue (see also ref. [36]). To obtain the initial
structure of the full HDL, two coarse grained apoA-I molecules
were added to the equilibrated lipid droplet (discussed above) in a
double-belt conformation at a distance of 4 nm from each other.
After energy minimization, the HDL particle was subjected to
very short equilibration runs using different time steps to get a
stable system for a simulation with a time step of 25 fs. Finally, the
particle was simulated for a total of 19 ms, of which the last 4 ms
was used for analysis.
To confirm the validity of the results, the simulations for HDL
discussed in this article were complemented by several additional
simulations that were started from different initial configurations.
Each simulation covered a multi-microsecond time scale, and the
results were found to be consistent with those discussed in this
article.
The molecular dynamics simulations were performed with the
GROMACS 3.3.1 package [74]. Time steps of 20 fs and 25 fs
were used for integrating the equations of motion of the lipid
droplet and of the full HDL, respectively. For production runs, the
Nose´-Hoover thermostat [75,76] and the Parrinello-Rahman
barostat [77] were used to ensure proper NpT conditions
(T~310 K, p~1 atm). Water and the lipids were coupled to
separate thermostats, and the whole system was coupled to the
barostat isotropically. Time constant of t~1:0 ps was used for all
couplings. For non-bonded interactions, we used the standard
distance of 1.2 nm [36]. The Lennard-Jones interaction was
shifted smoothly to zero after 0.9 nm.
Analysis Methods
The equilibration of the simulated lipoparticles was monitored
through the numbers of intermolecular contacts between different
lipid types and the radial density distributions as a function of time.
The intermolecular contacts between different molecular groups were
calculated using a 0.8 nm cutoff for all beads. The radial density
distributions describe the number densities of the coarse-grained
beads. The orientation order of CHOL and CE ring structures was
measured by the order parameter S~S3 cos2 w{1T=2, where w is
the angle between the molecular axis and the effective normal of the
lipoparticle at the location of the molecule in question. Being more
specific, the molecular axis in this definition for CHOL is drawn from
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the beginning of CHOL (carbon in the ring of CHOL attached to the
short chain) to the carbon connected to the hydroxyl group. The
effective normal is the vector from the center of mass (COM) of the
lipoparticle to the center of the molecular axis. For CE, an additional
measure is the angle between the molecular (ring, see above) axis and
the vector from the beginning to the end of the oleoyl chain.
Diffusion was analyzed by measuring the jump-length distribu-
tions of the COM positions of the lipids over a time scale t. Two
types of Gaussian functions were fitted to the distributions, the
two-dimensional (2d):
P2d(r,t)~
r
2D2d t
exp {
r2
4D2d t
 
,
and the three-dimensional (3d):
P3d(r,t)~
4pr2
(4pD3d t)
3=2
exp {
r2
4D3d t
 
:
The diffusion coefficient D from the best fitting function (P2d or
P3d) is reported, which in practice means that lipids at the water-
lipid interface were found to undergo 2d diffusion, while those
under the interface diffused in a 3d manner. Also, different time
scales were tested and the measured D was observed to level off at
long times, an indication of diffusive behavior in the hydrody-
namic (long-time) limit. ‘‘Long’’ times here refer to times of the
order of 100 ns, where D is found to level off to a well defined
constant value. Examples of data for P2d and P3d are shown in SI,
including also a more detailed description of how to choose the
diffusion time scale in the intermediate region under the lipid-
water surface (see Text S1, and Figure S6).
In many-component systems such as the present one, the
diffusion of different molecular components may take place at
different rates, and it is not obvious that CG models account for
this aspect correctly. For the MARTINI model used here, we have
previously confirmed that this is not an issue. For instance,
Niemela et al. [78] recently used atomistic and coarse-grained
models to show that the protein diffusion coefficient was about 10
times smaller compared to that of lipids, and the diffusion
mechanisms of lipids and proteins was similar in both models.
Ramadurai et al. [79] studied the influence of membrane thickness
(hydrophobic mismatch) with several peptides using both FCS
measurements and coarse-grained simulations and found essen-
tially quantitative agreement for the peptide diffusion coefficients
after the MARTINI results had been scaled by a factor of 4. The
simulations were also in agreement with experiments for the trend
predicted with increasing hydrophobic mismatch. Further,
Apajalahti et al. [61] considered the lateral diffusion of lipids in
many-component protein-free membranes and found the diffusion
of lipids in raft-like membrane domains (in the liquid-ordered
phase) to be about 10 times slower compared to diffusion in
domains that were in the liquid-disordered phase. Therefore,
diffusion has been studied in several multi-component lipid
systems, and the MARTINI models have been found to be
consistent with experiments.
The solvent accessible surface area (SASA) of hydrophobic,
hydrophilic and all-protein residues were measured using a radius
of the solvent probe of 0.56 nm (the all-atom 0.14 nm radius of the
solvent probe is converted to the coarse-grained one because one
water bead corresponds to four water molecules) inside the
GROMACS program g{sas. The SASA values were averaged
over the entire trajectory used for analysis. The root mean square
fluctuations (RMSFs) of protein alpha carbons were measured for
both apoA-I chains to monitor protein flexibility.
Lipid-protein interactions were monitored through the number
of intermolecular contacts and their lifetimes for every lipid
component with the protein. Annular lipid molecules, defined as
those with any bead within 8 A˚ of any protein bead, were
monitored over the analyzed trajectory. The average percentage of
the number of contacts of each lipid component with the protein
residues were estimated separately for each of the following
moieties of every lipid component: POPC (polar head group,
glycerol backbone, oleoyl and palmitoyl chains), PPC (polar head
group, glycerol backbone and palmitoyl chain), CHOL (short acyl
chain, sterol ring), CE (short acyl chain, sterol ring, and oleate
chain) and TG (glycerol backbone, sn–1, sn–2, and sn–3 chains).
Cholesterol-protein interactions were also tested by measuring the
average number of contacts per protein residue of the cholesterol
molecule with hydrophilic and hydrophobic protein residues.
Additionally, for evaluation of CHOL-protein and CE-protein
lifetimes, we accounted for cases where the distance between the
molecules fluctuated around 8 A˚: for an annular lipid, if its
distance from apoA-I exceeded 8 A˚ temporarily for less than 10
frames (0.1 ns), the coupling was considered unbroken.
Here our primary interest is the lipid part of HDL, for which
reason we have used the standard CG MARTINI model which
does not enforce the full secondary structures in apoA-I. This
computational efficient approach allows us to focus on generic
issues such as the partitioning of lipids around apoA-I, as well as
the influence of apoA-I on the disttributions of lipids in a droplet.
By fine graining our equilibrated structures back to atomistic level,
one could employ atom-scale simulations to elucidate the more
detailed aspects of the system.
Supporting Information
Figure S1 POPC angle distributions showing the orientation of
the P-N vector and hydrocarbon chains with respect to the
effective normal.
Found at: doi:10.1371/journal.pcbi.1000964.s001 (0.18 MB PDF)
Figure S2 Distributions of TG conformations in different
regions of HDL. Distributions are given in terms of the angle
between the hydrocarbon sn-1 and sn-3 chains, and the angle
between the sn-1 and sn-2 chains.
Found at: doi:10.1371/journal.pcbi.1000964.s002 (0.63 MB PDF)
Figure S3 Conformations of cholesteryl ester and triglyceride in
different parts of the droplet.
Found at: doi:10.1371/journal.pcbi.1000964.s003 (0.24 MB PDF)
Figure S4 Angle distributions describing cholesteryl ester
conformations.
Found at: doi:10.1371/journal.pcbi.1000964.s004 (0.11 MB PDF)
Figure S5 Angle distributions characterizing conformations of
triglyceride molecules.
Found at: doi:10.1371/journal.pcbi.1000964.s005 (0.14 MB PDF)
Figure S6 Displacement distributions for CE (Panel A) and
POPC (Panel B) together with the fits of P2d and P3d.
Found at: doi:10.1371/journal.pcbi.1000964.s006 (0.19 MB PDF)
Table S1 Average percentages of different moieties of each lipid
component interacting with apoA-I.
Found at: doi:10.1371/journal.pcbi.1000964.s007 (0.01 MB PDF)
Text S1 Description of additional data (for Figures S1, S2, S3,
S4, S5, S6 and Table S1), details of coarse-grained model
construction, and description of diffusion analysis.
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Low-density lipoprotein (LDL) transports cholesterol in the bloodstream and plays an important role
in the development of cardiovascular diseases, in particular atherosclerosis. Despite its importance to
health, the structure of LDL is not known in detail. This is worrying since the lack of LDL’s structural
information makes it more difficult to understand its function. In this work, we have combined
experimental and theoretical data to construct LDL models comprised of the apoB-100 protein
wrapped around a lipid droplet of about 20 nm in size. The models are considered by near-atomistic
multi-microsecond simulations to unravel structural as well as dynamical properties of LDL, with
particular attention paid to lipids and their interactions with the protein. We find that the distribution
and the ordering of the lipids in the LDL particle are rather complex. The previously proposed 2- and 3-
layer models turn out to be inadequate to describe the properties of the lipid droplet. At the surface of
LDL, apoB-100 is found to interact favorably with cholesterol and its esters. The interactions of apoB-
100 with core molecules, in particular cholesteryl esters, are rather frequent and arise from hydrophobic
amino acids interacting with the ring of cholesteryl esters, and also in part from the rather loose packing
of lipids at the surface of the lipoparticle. The loose packing may foster the function of transfer
proteins, which transport lipids between lipoproteins. Finally, the comparison of the several apoB-100
models in our study suggests that the properties of lipids in LDL are rather insensitive to the
conformation of apoB-100. Altogether, the findings pave the way for further studies of LDL to better
understand the central steps in the emergence of atherosclerosis.
Introduction
Low-density lipoprotein (LDL) particles transport cholesterol
and its esters in the human bloodstream. Clinically, LDL plays
a central role in the development of cardiovascular diseases, in
particular atherosclerosis. In the initial stages of atherogenesis,
LDL-derived lipids accumulate in the arterial intima, and high
LDL levels have been shown to increase the risk of
atherosclerosis.1,2 This together with formation of plaque on
arterial walls leads to the narrowing of arteries, rupture, clotting,
and potential death.
On average, LDL particles (see Fig. 1) have a diameter of 22
nm and contain3000 lipids. Their density ranges between 1.019
and 1.063 g ml1 (ref. 3), highlighting that quite a heterogeneous
group of particles can be called LDL. Most abundant lipid
species in LDL are triglycerides and cholesteryl esters assumed to
reside in the core of the particle, while different phospholipids are
expected to be located on the surface,3 the location of unesterified
cholesterol being less well understood. Further, there is also
a single copy of apolipoprotein B-100 (apoB-100) which, with
4536 residues, is one of the largest monomeric proteins known.
While the general features of the structures of LDL and apoB-
100 have been determined experimentally,4,5 detailed under-
standing of their structures, dynamics, and hence also function is
lacking. Molecular simulations could be expected to shed some
light on these issues since they have recently been shown to
provide detailed insight into many lipid-based biological
systems.6Yet, as far as LDL is concerned, there is reason to stress
that this quest is exceptionally challenging. First, given that the
diffusion of lipids at the LDL surface is of the order of 107 cm2
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s1 (ref. 7), the diffusion time across LDL is of the order of
microseconds. Any simulation should hence cover at least several
microseconds to equilibrate the lipid distribution. Second, as the
precise structure of apoB-100 is not known, one should simulate
more than one protein structure and compare their differences.
Further, due to the major size of the system, atom-scale simu-
lations of LDL are not currently feasible.
Due to these reasons, we have chosen to use the MARTINI
approach8,9 to describe LDL on a coarse-grained (CG) level (see
Fig. 1 and Materials and Methods section). A similar approach
has earlier been used in studies of high density lipoproteins
(HDL, diameter of 7–8 nm),10–15 which have also been simulated
in atomic detail.11,16–18 Related work on simulations of lipid
droplet biogenesis,19 and properties of triglyceride20 and choles-
teryl ester melts21 in the hydrophobic core of lipoproteins has
also been recently discussed. Nonetheless, so far LDL has not
been studied at all through molecular simulations.
Our objective in this work is to fill this gap, thereby providing
insight into the structural as well as dynamical properties of LDL
in semi-atomistic detail. We focus on lipids and their interactions
with apoB-100. We find that the distribution and ordering of the
lipids in the LDL particle are rather complex, and the previously
proposed 2- and 3-layer models (see, e.g. ref. 3) are inadequate to
describe the properties of the lipid droplet in LDL. The dynamics
of lipids is also untrivial and depends on the location of lipids in
the particle. At the surface of LDL, apoB-100 is found to interact
favorably with cholesterol and its esters. The interactions of
apoB-100 with core molecules, in particular cholesteryl esters,
are rather frequent and arise from hydrophobic amino acids
interacting with the ring of cholesteryl esters, and also in part
from the rather loose packing of lipids at the surface of the lip-
oparticle. The loose packing is expected to foster the function of
transfer proteins, which transport lipids between lipoproteins.
Finally, the distribution of lipids is found to be rather insensitive
to the conformation of apoB-100.
The models we have developed for LDL and the results dis-
cussed in this article provide a solid basis for further simulations
of LDL functions, such as the effect of enzymatic modifications
and oxidation due to free radicals that promote the development
of atherosclerosis.
Materials and methods
We have run five MD simulations with GROMACS22 starting
from different initial structures (Table 1), each simulation
spanning several microseconds. All the systems have the same
lipid composition, corresponding to an average LDL particle:3
1600 cholesteryl oleates (CO), 180 trioleates (TO), 600 unesteri-
fied cholesterols (CHOL), 630 double-tailed phospholipids (PC),
and 80 lysolipids (lysoPC). The force field used in this work is
based on the MARTINI approach.8,9
In the MARTINI description for proteins, the secondary
structures have to be constructed separately, and here we realized
this with the elastic network model.23 The downside of this
Fig. 1 LDL particle structure. (A) Lipids. Red beads show the location
of glycerol (PC, lysoPC), hydroxyl (CHOL), and ester (CO, TO) groups.
(B) Full LDL from the final structure of S1r. Lipids shown in similar
colours as in (A), without red highlights, and PC and lysoPC coloured
blue. ApoB-100 shown in tan, with the lipovitellin domain (first 1000
residues) pointing up. (C) Same as (B), except that lipids are shown as
transparent spheres. (D) LDL simulated without the protein, cut through
the middle. Note how the core penetrates to the surface. (E) Same as (B),
except that the lipid part has been cut through the middle. The core
penetrates to the lipid surface under the protein. (F) Close-up image of
the surface from (B). Table 1 Description of LDL simulations performed
System Length Lipids apoB-100 structure
LD 18 ms Random
droplet
No apoB-100
S1 10 ms LD at 8 ms From ref. 22, missing residues manually
from PSIPRED
S1r 10 ms LD at 8 ms Same as S1 but different placement at
surface
S2 6 ms LD at 8 ms Residues 1–1000 from ref. 21, 1000–2000 an
amphiphilic b-sheet, otherwise as S1
S2r 10 ms LD at 8 ms Same as S2 but different placement at
surface
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approach is the fact that the secondary structures will remain
fixed. However, in this work where we focus on lipids and their
interactions with apoB-100, this is not a major limitation.
We first simulated only the lipid droplet (LD) in water, i.e.,
without apoB-100. The structure of the LD in this simulation
after 8 ms was used as the initial lipid droplet for the other four
simulations that contain apoB-100 (Fig. 1). Here, two different
secondary structures were constructed for the protein, referred to
as S1 and S2. S1 was mainly based on the theoretical models by
Krisko and Etchebest.24 The domains (10% of all residues) were
constructed using secondary structure prediction from
PSIPRED.25 The second model (S2) used the homology model of
Richardson et al.26 for the first 1000 residues, and a continuous
amphipathic b-sheet for residues 1000–2000. The remaining part
was modelled as in S1. For both secondary structures, two
different initial placements of the protein were constructed,
referred to as S1 and S1r (and S2 and S2r, respectively). Fig. 1B
showing the structure for the protein that lays on the particle
surface is in line with the low-resolution model, which is based on
neutron scattering studies of desolubilized apoB.27 Analysis
focuses on systems S1r and S2r, as S1 and S2 were found to
behave very similarly.
All further details are given in the ESI†.
Results and discussion
Molecular distribution and order within LDL
As for the reference system (without apoB-100), Fig. 2 (left
panel) shows the average radial distribution of the different
molecules in LD. The curves show the number density of beads
as a function of the distance from the centre of the droplet for
each molecule type separately. Also shown is the total lipid bead
density. The figure clearly depicts how the particle is partitioned
into a surface monolayer consisting mostly of PC, lysoPC and
CHOL lipids, and a hydrophobic core that contains CO and TO,
as well as around 13% of the CHOL lipids. Note, however, that
the core lipids (CO and TO) penetrate the surface monolayer,
having non-negligible densities up to the water phase. This is to
be expected, because there are about 1300 PC, lysoPC, and
CHOL lipids in total, while the total surface area is 1000 nm2
(for a radius of 9 nm). Therefore, the area per lipid in the surface
monolayer is well above the equilibrium area for these lipids in
a lipid bilayer. In fact, the area per lipid is similar in magnitude to
a value that has been observed to lead to formation of small,
transient pores in monolayers,28 but different compositions of the
layers prevent any quantitative comparison. Nevertheless, we
observe small transient pores to form, exposing some of the core
lipids on the surface, see snapshots in Fig. 1D and E.
The results for the surface area of lipids suggest some ideas
that would be worth testing later, using either other simulations
or experiments. First, would it be possible that the surface of
LDL is like a lipid layer under low surface pressure. If this was
the case, then some aspects of lipoproteins could be characterized
using, e.g., lens lipid membrane29 like layers instead. Second,
given the looser packing at the surface, is it possible that the
protein can to a significant extent interact with the neutral
molecules (TO, CO) in the core of the particle. This possibility
would be highly relevant for lipid transfer, since transfer proteins
such as the cholesteryl ester transfer protein (CETP)30 first bind
to the lipoprotein surface and then allow lipids to migrate to their
binding pocket/tunnel. The looser is the lipoprotein surface, the
more efficient can the transfer process be expected to be.
Notably, lysoPCs reside further out from the centre as
compared to PCs. This conclusion holds even after accounting
for the fact that the headgroup is a larger part of lysoPC than PC.
Similar observations have also been made for CG vesicles.31
Fig. 3 (left panel) depicts the average orientation of the ring
structures of CO and CHOL vs. distance from the centre of the
droplet. The orientation is measured as S ¼ (1/2) h3 cos2q  1i,
where q is the angle between the radial unit vector and a vector
from the head/ester group to the first bead in the tail. The
distance and the radial unit vector are measured using the centre
of the mentioned vector. A value of zero indicates a completely
random distribution, while one signifies perfect radial alignment,
and 0.5 stands for alignment parallel to the surface. The blue
dashed lines show the region where the surface monolayer
resides. The core is largely unordered with all orientations
equally likely. Within the monolayer, the molecules are mainly
aligned along the normal, i.e., they sit upright between the lipids.
Close to the outer boundary, there are a few molecules, thus the
large peaks are mainly due to poor statistics. The alignment of
Fig. 2 Number density of particles vs. distance from the centre of the droplet (r): all lipids (black), POPC (blue), PPC (cyan, scaled by 10), CHOL
(green), CO (orange), TO (yellow), water (dark blue, not in right panel), protein (brown, only middle panel). The left panel shows the distribution in LD
without apoB-100. The middle panel shows how the distribution changes under apoB-100. The dotted lines are identical to those in the left panel; the
solid lines show the distribution in regions where there is protein on the surface. The right panel compares the distribution between the regions
covered and not covered by apoB-100 in S1r. The solid line is identical to the middle panel. The dotted line shows the distribution in regions not covered
by apoB-100.
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CO along the normal is weaker than for CHOL. This comes from
the fact that the hydrophilic part of CO is in the middle of the
molecule, thus rendering it difficult to place the molecule in the
surface monolayer such that the ring structure would be upright
and the hydrophilic part on the surface. The hydroxyl group in
CHOL is also more hydrophilic than the ester linkage in CO. The
four protein simulations all behave quite similarly, thus we focus
on the system S1r to identify the main effects of the protein on
the lipids. We note that the lipid droplet remains spherical, as
measured by the radii of gyrations calculated along the principal
axes of the droplet (results not shown).
Fig. 2 (middle panel) shows how the surface composition
changes close to apoB-100: the figure compares the radial
densities in LD (left panel) to those in S1r. The latter are
calculated only for sections under apoB-100, defined as the parts
of the particle that are within 2 of any protein atom when seen
from the centre of the LD. A complementary comparison is
shown in the right panel: it shows the radial densities for S1r,
calculated for sections under and not under apoB-100.
The total lipid density shows that the radius of the droplet is
slightly smaller below the protein. This comes from reduction of
the PC and lysoPC densities, while the core lipids (CO and TO)
as well as CHOL actually move closer to apoB-100. These
observations suggest that the protein prefers to interact directly
with the core of the particle, displacing the surface monolayer,
see below. This also means that in the systems that contain the
protein, the surface monolayer has a significantly lower area per
lipid. This has an effect on its composition: in these systems, the
core lipids do not penetrate as often to the surface (Fig. 1D).
Fig. 3 (middle panel) shows how the protein affects CO and
CHOL orientation under it. The order parameter in regions
without apoB-100 is higher than in LD, in line with the common
notion that smaller area per lipid on the surface increases order.
Under the protein, order parameter is lower, and in particular the
CO molecules prefer orientations parallel to the surface (S < 0).
Dynamics and lipid–protein interactions
For dynamics, we estimated the diffusion coefficients for the
different molecules in different parts of the lipid droplet, see
Table 2. By considering particle displacement distributions over
fixed time intervals, we readily identified core lipids to undergo
3D diffusion, while lipids at the surface diffused in a 2D manner
(see ESI†). Table 2 shows clearly that the diffusion speeds up
monotonically as one leaves the core and approaches the surface,
the diffusion coefficient increasing by a factor of 10. At the
surface, the diffusion coefficient is in line with the experiments by
Vauhkonen et al.,7 who used pyrene-linked PCs as probes to find
D ¼ (0.5–1.5)  107 cm2 s1 at the surface of lipoparticles.
The addition of the protein does not significantly affect the
diffusion in the core of the droplet, but considerably slows down
the motion on the surface. This effect is most pronounced close
to the protein, but can also be seen for other parts of the surface
as well as in the core lipids close to the surface. The overall
slowing down can be explained by noting that the area per lipid
in the surface monolayer reduces considerably upon addition of
the protein. Close to the protein, there may be specific interac-
tions, e.g., between hydrophilic beads in the protein and in the
lipids. The slowing down is stronger for CHOL than for CO,
which also supports the picture that CHOL interacts strongly
with some parts of the protein. Here, we refer to Fig. 4 which
shows the number of contacts between CHOL/CO and different
Fig. 3 Order parameter of the angle between the CHOL plane and the local normal for CHOL (green) and CO (orange) vs. distance from the center of
the droplet. The left panel shows the situation in the absence of apoB-100. The middle panel shows the effect of apoB-100 in S1r. The solid lines are
identical to the left panel, while the dashed and dotted lines show the situation in regions covered and not covered by apoB-100, respectively. The right
panel shows the effect of protein secondary structure on the ordering in S2r. The dotted and dashed lines show the order parameter in regions covered
and not covered by apoB-100, respectively. The solid line represents regions where apoB-100 has b-strands close to the lipid surface.
Table 2 Diffusion coefficients are in units of 108 cm2 s1. The distance r
from the center of the lipid droplet/LDL is given in units of nm. Error
estimates are of the order of 5%. Values for CHOL have been computed
over all molecules, although 13% of them lay in the core. In the last
column are given diffusion coefficients separately for molecules that are
either near or far from apoB-100 (in the system LD, there is no protein,
thus only one value is given)
Molecule System r < 2 2 < r < 4 4 < r < 6
r > 6
Near/far apoB
CO LD 1.8 2.0 3.0 4.2
S1r 1.9 2.0 2.5 2.5/3.4
S2r 1.9 1.9 2.3 2.4/3.0
TO LD 1.1 1.4 2.1 3.3
S1r 1.2 1.4 1.7 1.9/2.4
S2r 1.1 1.2 1.5 1.7/1.9
CHOL LD 8.8
S1r 3.7/6.4
S2r 3.5/5.8
PC LD 8.0
S1r 3.5/5.6
S2r 3.0/5.0
Lyso-PC LD 14.0
S1r 5.7/10.0
S2r 5.3/9.0
8138 | Soft Matter, 2011, 7, 8135–8141 This journal is ª The Royal Society of Chemistry 2011
Pu
bl
ish
ed
 o
n 
20
 Ju
ly
 2
01
1.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f H
el
sin
ki
 o
n 
18
/1
0/
20
17
 2
3:
37
:3
0.
 
View Article Online
ORIGINAL PAPERS 91
amino acids in apoB. The figure demonstrates that the majority
of the contacts between CHOL/CO and the protein occur at
hydrophobic amino acids. Note that the figure carries a certain
bias towards larger amino acids (Trp, Phe, Tyr, His) since they
contain more beads, but even if these are ignored, the general
conclusions still hold. We also separated contributions from the
sterol rings and the rest of the molecule. For CO, there is no clear
preference for either, but for CHOL the rings form much more
contacts with the protein than the CHOL tails, even when we
account for the tails having fewer beads than the rings. The CO
bars in Fig. 4 can also be used to assess which amino acids
interact preferentially with the core (with similar conclusions as
above); this is because TO forms only few contacts with the
protein (Fig. 2, middle panel), and these do not influence the
image significantly. A similar figure with secondary structure
classes on the x-axis (not shown) indicates that some helices, and
in the case of S2 also some b-sheets, are the main secondary
structure elements interacting with the core. These regions are
easily identified as the C-terminal extended helical region, where
most of the helices lay on the interface as single helices, and the
extended b-sheet (residues 1000–2000) in S2, which by
construction lays flat on the surface.
Influence of protein conformation on lipids
As the three-dimensional structure of apoB-100 is not well
known, we considered two different models for the protein. The
comparison of our results for the different models indicates that
all the protein systems behave qualitatively in a similar manner.
There are only minor differences between S1 and S1r (S2 and
S2r): it takes some time for the protein to bind to the surface in
S1/S2, and how these systems equilibrate slower than S1r/S2r.
The main difference between the two secondary structure models
(S1r and S2r) is in the area covered by the protein: S1r covers, on
average, 35% of the surface, while S2r covers 40%. This
difference comes mainly from the extended b-sheet in model S2
that is much thinner than the same region in S1, so it spans
a larger surface area: in S2r, the residues 1000 to 2000 cover 13%
of the particle surface, while this figure is 8% for S1r. The effect of
the protein structure on the radial densities is also minor.
However, there are larger differences in the CHOL orientations
(Fig. 3, right). Again, the difference comes from the presence of
the large b-sheet in S2, which orders the cholesterols a bit deeper
in the core. This extended ordering is not present for CO.
We conclude that the three-dimensional conformation of
apoB-100 does not play a significant role for lipid distribution
and orientation in LDL. Further results for lipid diffusion (data
not shown) result in the same conclusion. This largely implies
that we cannot conclude one of the protein models to be better
than the other, as the observed differences in lipid properties are
not significant to the extent that we could say one of the models
to be physically unreasonable.
Are there ‘‘core ridges’’ under the b-sheets?
Segrest et al. proposed in 2001 an appealing idea of ‘‘core ridges’’
under the b-sheets of apoB-100.4 This model depicts cholesteryl
esters to distribute not only in the core of LDL but also under the
b-sheets of apoB-100. Further, CO molecules under the b-sheets
would be aligned along the surface plane, and organize to form
strong smectic-like liquid crystal phases.
When we compare our simulation data to the ideas underlying
the core ridge model, we first find that the core molecules (CO,
TO) extend further outwards from the center of the LDL particle
when they are close to the protein. Also, the order parameters for
the COs and CHOLs under the b-sheets are lower than elsewhere
under the protein, meaning that the rings of COs and CHOLs
prefer to orient parallel to the b-sheets and therefore also
the LDL surface. Further, the diffusion of lipids that are under
the protein is slower compared to lipids that are elsewhere in the
surface region. These findings are in general agreement with the
idea of core ridges proposed by Segrest et al.4
Meanwhile, the simulation data indicate that the effect of
the b-sheets spans the surface monolayer, but does not affect the
structure significantly deeper in the core. The ordering of the
lipids and the extent of the ordered layers of molecules are not as
pronounced as the core ridge model suggests. The effect that we
observe is quite weak, while Segrest et al. proposed strong,
smectic-like organization of COs.
What can we say about the protein itself?
Because of the limitations of our model (uncertainty in the apoB
structure and its fixed secondary structure), it is not possible to
study the protein itself in detail. Yet, let us discuss how the
protein evolves during the simulations. First, on a global scale,
the protein conformation remains unmodified. The RMSD
values between the initial and final protein structures are
1.5 nm. The protein also expands to cover 2–3% more of the
total particle surface. The observed RMSD is not large consid-
ering the protein’s size and flexibility: the protein consists of
several domains that can move more or less freely relative to each
other, and the domains also form a chain with a total contour
length of about 70 nm instead of a compact globule. Experi-
mentally it is also known that apoB-100 can adapt to large
changes in the particle diameter (from 70 nm in VLDL down to
20 nm in LDL), also supporting the view that the protein is quite
flexible. Finally, the two large b-sheets in the lipovitellin domain
(the first 1000 residues in S2) spread out to follow the lipid
surface, in agreement with the proposition of Richardson et al.26
Fig. 4 Average number of contacts between different amino acids of
apoB-100 and CHOL or COmolecules for systems S1r (left bars) and S2r.
Each pair of beads within 0.8 nm of each other constitutes one contact.
This journal is ª The Royal Society of Chemistry 2011 Soft Matter, 2011, 7, 8135–8141 | 8139
Pu
bl
ish
ed
 o
n 
20
 Ju
ly
 2
01
1.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f H
el
sin
ki
 o
n 
18
/1
0/
20
17
 2
3:
37
:3
0.
 
View Article Online
ORIGINAL PAPERS 92
Transition from core to surface: can LDL be characterized by
a two- or three-layer model?
Given that we now have a complete view of the results for lipids’
structure as well as dynamics in LDL, and we also have some
understanding of the role of apoB-100 in LDL, let us comprise
this information to consider the model that best matches our
findings. In this respect it is widely accepted that apoB-100
resides on the surface of LDL, but there are several conflicting
propositions of how the protein interacts with the lipids.3,4 There
has also been discussion on whether a two-layer (core + surface
monolayer) or a three-layer picture is more correct.3
We find that the protein resides on the surface and displaces
the surface monolayer, but does not penetrate into the core. Also,
the core near the surface is more ordered than deep inside the
particle, in particular close to large b-sheet structures. The
protein thus displaces the surface layer nearly completely from
under it, and also influences the lipids under the protein by
decreasing the tail density and partially orienting the CHOL
rings along the surface.
Further, as for lipids, our simulations show that CO and TO
mainly reside in the core, though small amounts of these lipids
are also found close to the surface. CO molecules are randomly
oriented in the core, but under the surface and at the surface they
are rather strongly oriented to stand upright along the radial
normal direction of the particle. The orientation of cholesterol is
largely similar to that of CO, though cholesterol is almost
entirely in the surface region and only occasionally in the inside
of the particle. Polar phospholipids occupy the surface of LDL,
where they are abundant and highly ordered as the acyl chains
have to pack themselves tightly. Finally, when one considers the
diffusion of the lipids, it is slow in the core and speeds up the
more the closer one is to the surface.
Altogether, the data support a picture for the lipids where
there is (1) a hydrophobic core composed of randomly oriented
CO, TO, and some CHOL, (2) an ordered intermediate hydro-
phobic layer composed of PC tails, CHOL, and some CO, and (3)
a surface layer composed mostly of the PC headgroups.
However, assigning a fixed number of layers is quite arbitrary,
since there is no unique way to define the boundaries between
them. Instead of being in favor of either the two- or three-layer
model, we consider it more appropriate to conclude that there is
a broad transition from the core to the polar surface region.
Concluding remarks
In conclusion, our study provides the first molecular-scale model
for LDL structure and dynamics based on extensive near-
atomistic simulations, with emphasis on lipids’ distribution and
interactions with apoB-100. The results highlight the importance
of lipids in understanding LDL function. Not only the surface
lipids but also the core lipids play an important role in LDL, as
interactions between lipids and apoB-100 drive core lipids to the
surface. This may have biological significance for trafficking as
carriers such as cholesteryl ester transfer proteins embrace cho-
lesteryl esters and triglycerides from LDL and HDL to their
binding pocket for transport. The rather loose packing at the
surface and the observed fast diffusion at the LDL surface
compared to the core would promote this for lipids close to the
surface layer.
The detailed structural and dynamical simulation data show
that there is no simple model in terms of two or three well-defined
layers in the lipid droplet of LDL to describe the distribution and
structural as well as dynamical properties of the lipids. Instead an
appropriate paradigm is more complex, describing LDL with
a hydrophobic core and polar surface regions, and a broad
transition between them. At the surface, the simulations are in
partial agreement with the idea of core ridges proposed by
Segrest et al.,4 suggesting that cholesteryl esters are attracted by
apoB-100 to come close to it and align themselves along the
surface plane. However, we did not observe significant layers of
ordered cholesteryl ester molecules under apoB-100.
The results provide a solid basis for further simulations of
LDL functions, such as the effect of enzymatic modifications and
oxidation due to free radicals that promote the development of
atherosclerosis. Of major biological importance is to understand
the coupling between lipid composition of LDL and its structure
and function, as the lipid composition depends on the subject’s
diet and living habits.14,32
As for applications, the view presented here promotes the
development of LDL-based molecular transporters and athero-
sclerosis blockers. In all these aspects, the LDL model found in
this work can be employed as a basis for full atomistic and even
ab initio simulations through systematic fine-graining of the
coarse-grained model to an atomistic representation.
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Abstract
Cholesteryl ester transfer protein (CETP) transports cholesteryl esters, triglycerides, and phospholipids between different
lipoprotein fractions in blood plasma. The inhibition of CETP has been shown to be a sound strategy to prevent and treat
the development of coronary heart disease. We employed molecular dynamics simulations to unravel the mechanisms
associated with the CETP-mediated lipid exchange. To this end we used both atomistic and coarse-grained models whose
results were consistent with each other. We found CETP to bind to the surface of high density lipoprotein (HDL) -like lipid
droplets through its charged and tryptophan residues. Upon binding, CETP rapidly (in about 10 ns) induced the formation
of a small hydrophobic patch to the phospholipid surface of the droplet, opening a route from the core of the lipid droplet
to the binding pocket of CETP. This was followed by a conformational change of helix X of CETP to an open state, in which
we found the accessibility of cholesteryl esters to the C-terminal tunnel opening of CETP to increase. Furthermore, in the
absence of helix X, cholesteryl esters rapidly diffused into CETP through the C-terminal opening. The results provide
compelling evidence that helix X acts as a lid which conducts lipid exchange by alternating the open and closed states. The
findings have potential for the design of novel molecular agents to inhibit the activity of CETP.
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Introduction
Cholesteryl ester transfer protein (CETP) is a 476-residue-long
glycoprotein which promotes the transfer of cholesteryl esters
(CEs), triacylglycerols (TGs) and phospholipids (PLs) between the
different lipoprotein fractions (high density lipoprotein (HDL), low
density lipoprotein (LDL), and very low density lipoprotein
(VLDL)) in human blood plasma. CETP is believed to mediate
the transfer by a hetero-exchange mechanism in which CEs are
carried from HDL to VLDL and LDL particles, and TGs are
carried in the opposite direction from VLDL and LDL to HDL
particles, resulting in CE depletion and TG enrichment of HDL
[1]. Interestingly, CETP is structurally homologous to the
phospholipid transfer protein (PLTP), the lipopolysaccharide
binding protein (LBP), and the bactericidal/permeability-increas-
ing protein (BPI) [1]. As all these proteins are able to bind
phospholipids, similarity in their transportation mechanisms has
been suggested. Importantly, however, CETP is the only protein
able to transfer neutral lipids (cholesteryl esters and triglycerides)
in human plasma [2].
The broad interest to understand CETP and its lipid trafficking
properties stems from the fact that it has a potentially protective
role in the development of cardiovascular diseases, in particular
atherosclerosis, which are currently the main cause of death in
Western countries, claiming ,17 million lives a year. The role of
CETP in the development of atherosclerosis became evident when
it was found that CETP deficiency and the inhibition of CETP
lower LDL and increase HDL levels in human plasma [3]. High
HDL levels have been clinically found to be inversely correlated
with the development of atherosclerosis, since HDL particles are
considered crucial components in the transport of cholesterol from
atherosclerotic plaques back into the systemic circulation.
Unfortunately, the clinical trial with the first oral anti-atherogenic
drug candidate with a CETP-inhibitory activity, torcetrapib, was
unsuccessful because of its potentially lethal side effects [4].
Treatment with torcetrapib increased blood pressure and
circulating aldosterone levels and also altered serum electrolyte
levels. However, subsequent studies indicated that these adverse
effects of torcetrapib were unrelated to the inhibition of CETP and
are not necessarily shared by the other members of the class of
CETP inhibitors. Indeed, a recent clinical trial showed that
another CETP inhibitor, anacetrapib, effectively raises HDL and
has an acceptable side-effect profile in patients with coronary heart
disease or risk factors for coronary heart disease [5]. Importantly, a
recent meta-analysis of 92 studies involving 113,833 participants
concluded that the CETP genotypes that have lower CETP
activity are associated with a decreased coronary risk [6].
Considering the central role of CETP in the development of
coronary atherosclerosis and its complications, we face an
outstanding challenge to better understand the mechanisms
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associated with CETP functions. Recently, Qiu et al. resolved the
X-ray structure of CETP showing that it carries CE molecules
inside a long hydrophobic tunnel, whose ends are plugged by
phospholipids (Figure 1) [7]. This kind of hydrophobic tunnel is
unique among proteins, and it was speculated that CEs diffuse into
and out from the tunnel through the two tunnel openings, which
are closed by PLs during the transportation in aqueous
surroundings. In addition, based on the X-ray structure it has
been speculated that CETP is attached to lipoproteins via its
concave surface where also the two hydrophobic tunnel openings
reside [7]. Further, it has been proposed that the formation of
CETP-lipoprotein complexes is modulated by pH, surface
pressure, and the ionic interactions between CETP and phospho-
lipids [8,9]. Fluorescence quenching has been used to demonstrate
that the interaction between tryptophan residues of CETP and
PLs could be important in the attachment [10]. Regarding the
lipid exchange mechanism of CETP, helix X has been suggested
to play a role in lipid loading and unloading by acting as a lid at
the C-terminal tunnel opening, being in the open state when the
exchange of lipids takes place, and in the closed state when CETP
detaches from the lipoprotein surface to become surrounded by
aqueous medium [5]. Various mutational studies further suggest
that helix X is possibly crucial in the transfer of CEs and TGs but
not in the transfer of PLs [11,12].
The above findings and suggestions are appealing and
insightful, but call for better understanding of the structure-
function relationship and of the dynamics that drive CE, TG and
PL transfer. In essence, atomic and molecular scale insight into the
lipid exchange between CETP and lipoproteins is limited, which
largely stems from exceptional difficulties to experimentally probe
the related transient processes in the nanometer scale. In the
current study, our objective is to complement experiments through
atomistic and coarse-grained molecular dynamics simulations to
investigate the binding of CETP to a small lipid droplet and a
planar lipid trilayer, and to determine the initial stages of the lipid
exchange mechanism. By doing so, we can follow the lipid
exchange in atomic detail, shed light on its mechanism, consider
the effect of lipoprotein curvature, and unravel the dynamics of the
related processes. These mechanisms and phenomena are
considered over a multitude of time scales by bridging atomistic
and coarse-grained simulations, which are shown to provide
consistent results. The present study paves the way for future
simulations to elucidate interactions of anacetrapib with CETP
and CETP-lipoprotein complexes, with an objective to unlock its
inhibitory mechanism. Given the significant role of CETP in
Author Summary
Coronary heart disease is a major cause of death in the
Western societies. One of the most promising interven-
tions to prevent and slow down the progress of coronary
heart disease is the elevation of high density lipoprotein
(HDL) levels in circulation. Animal models together with
early clinical studies have shown that the inhibition of
cholesteryl ester transfer protein (CETP) is a promising
strategy to achieve higher HDL levels. However, drugs with
acceptable side-effects for CETP-inhibition do not yet exist,
although the next generation CETP inhibitor (anacetrapib)
has great potential in this regard. In this study, our
objective is to gain more detailed information regarding
the interactions of CETP with lipoprotein particles. We
show how the CETP-lipoprotein complex is formed and
how lipid exchange between CETP and lipoprotein
particles takes place. Our findings help to understand in
a mechanistic way how CETP-mediated lipid exchange
occurs and how it could be exploited in the design of new
and more efficient molecular agents against coronary
heart disease.
Figure 1. Structure of CETP and starting configurations for simulations. A) X-ray structure of CETP from the side (left) and bottom (right).
Two DOPCs (grey and blue spheres) plug the tunnel openings that lead to the hydrophobic tunnel where two CETP-bound CEs (orange spheres) are
located. Helix X is labelled and marked with a red sphere. B) The starting configuration for droplet simulations. C) The starting configuration for lipid
trilayer simulation. POPCs and DOPCs are coloured as grey, CEs are orange, head group nitrogens are blue, and Trp residues green. Water molecules
were removed from the snapshots for clarity.
doi:10.1371/journal.pcbi.1002299.g001
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cardiovascular diseases, the broad interest of the topic is hoped to
attract substantial interest to extend the present work.
Results
Flexible structure of CETP helps it to bind to curved
lipoproteins
We carried out three 100 ns atomistic simulations for fully
hydrated systems containing CETP with different interior lipid
compositions and a small pre-equilibrated HDL-sized lipid droplet
composed of POPCs and CEs (A1, A2, A3; Figure 1; see Materials
and Methods). In addition to these spherical droplets, CETP was
simulated with a pre-equilibrated planar POPC-CE trilayer system
(A4; Figure 1C) to study the effect of less curved lipoprotein
particles, like VLDL and LDL, on the conformation of CETP.
Root mean square deviation (RMSD) profiles indicate that the
structures do not deviate considerably from the X-ray structure
(Figure 2B). The radius of gyration fluctuated between 3.2 and
3.5 nm, and its profiles together with snapshots from simulation
trajectories show that the conformation of CETP is able to bend to
bind to surfaces with different curvatures (Figure 2A). In the case
of spherical A3 the curvature of CETP is clearly higher than in the
planar A4 system, and it became apparent that the conformation
of CETP is not able to rearrange sufficiently to fully match the
planar surface. Nonetheless, our results imply that the structure of
CETP is elastic and facilitates the binding of CETP to different
lipoprotein surfaces with varying curvatures. Yet, due to its
inherent curvature that closely matches the curvature of HDL,
CETP prefers to bind to HDL-sized particles compared to larger
VLDL-sized particles. Consequently, we propose that the free
energy change associated with the binding of CETP to HDL is
more favorable compared to the formation of a CETP-VLDL
complex.
Radial distribution functions and density profiles indicate that
CETP does not penetrate deeper than to the level of POPC
phosphate groups (Figure 2C). Therefore, in all atomistic
simulations the core CEs were observed not to interact directly
with CETP, as instead they were found to reside only in the core.
This suggests that the surface-core lipid ratio is important for the
exchange of neutral lipids by CETP.
During the simulation A2, CETP-bound DOPCs did not diffuse
into the lipid droplet. However, we found that during the
simulation S1 the hydrophobic tunnel of CETP collapsed, which
strongly suggests that the structure of CETP is not stable without
interior lipids (See Figure S2 and Text S2). This finding is
important regarding the lipid exchange process of CETP as it
suggests that during the neutral lipid exchange, the hydrophobic
cavity is not empty at any point. We return to this matter later.
Salt bridges and tryptophans stabilize CETP-lipoprotein
complexes
In atomistic lipid droplet simulations, we calculated the number
of salt bridges that formed between CETP and POPCs as a
function of time, in order to characterize the key charged residues
involved in the attachment of CETP. The number of salt bridges
that formed between the positively charged lysine residues of
CETP and the negatively charged phosphate (P) groups of POPCs
stabilized to a level of 12–20 (Figure 3A). Salt bridging of lysines is
much more efficient in A2 and A3 than in A1 (19–20 compared to
12, see Figure 3A). The number of salt-bridges between arginines
and P groups was on average two or three. Additionally, we
calculated the number of salt bridges formed by the negatively
charged Asp and Glu residues and found that Asp residues were
able to form 6–8 and Glu residues 2–4 salt bridges with the
positively charged choline groups. Amino acids that form most of
the salt bridges are shown in Figure 3, revealing that they are
mainly located at the edge of the concave surface of CETP.
In the spirit of the earlier Trp quenching study [10], we
inspected more carefully the behavior of Trps during binding. In
all droplet simulations, Trp299 formed hydrogen bonds with
POPCs (Figure 3B). Trp264 stayed buried inside the structure of
the protein and Trp162 was able to interact with the water
molecules. In A1 and A2, Trp105 and Trp106 were located facing
the water phase, while in A3 the flap V5 interacted with POPCs by
anchoring Trps 105 and 106 to the carbonyl region of POPC
surface, highlighted in Figure 2. In the trilayer simulation only two
Trp residues (105 and 299) were able to interact with the POPC
surface.
Our results highlight the importance of electrostatic interactions
between CETP and phospholipids in the formation of CETP-
droplet complexes. The results provide compelling evidence that
three Trp residues anchor CETP to lipid droplets, introducing
additional stability to CETP-lipoprotein complexes where the
curvature of CETP and a lipoprotein matches.
Coarse-grained simulations reveal that the ratio of
surface and core lipids in lipid droplets is an important
modulator of CETP activity
Interpretation of atomistic simulations requires care due to the
limited time and length scales that are feasible through atomistic
studies. For example, the diffusion of lipids in HDLs is slow
compared to the time scales we have simulated and, thus, claims
regarding the principal binding site and penetration depth of
CETP must be carefully considered. In order to add liability to our
atomistic simulations, we also carried out coarse-grained simula-
tions, covering time scales beyond 2 ms.
Figure 2. The binding of CETP to lipid surfaces with different
curvatures. A) Snapshots from the end of atomistic simulations A3
and A4. POPCs are transparent and grey, and COs are orange. Water
molecules were omitted for clarity. CETP is rendered using secondary
structures and Trp residues are marked with green color. Dashed and
yellow lines present the curvature of CETP. B) RMSD and radii of
gyration profiles for CETP in droplet and trilayer simulations. C) Radial
distribution functions and density profiles for the droplet and trilayer
systems, respectively.
doi:10.1371/journal.pcbi.1002299.g002
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CG simulations support and validate atomistic simulations by
showing that the concave surface is the principal lipoprotein
binding site of CETP. We did not observe any deviations from this
conclusion during the three independent 2-microsecond simula-
tions. Radial distribution functions shown in Figure 2 depict a
similar distribution of molecules as in atomistic simulations.
However, intriguingly we found that POPCs which were in
contact with the concave surface of CETP migrated away from the
tunnel openings, forming a small hydrophobic patch under the
concave surface (Figure 4A). In essence, CETP drives phospho-
lipids to diffuse away from the slightly hydrophobic tunnel
openings to its edges where most of the salt bridge-forming amino
acids reside. We analyzed the spatial densities of the polar beads
(GL1, GL2, and NC3, PO4, using the descriptions of the Martini
model) of POPCs to clarify the patch formation more clearly. The
spatial density map revealed the formation of a hydrophobic patch
under the concave surface, and specifically in the region where the
N- and C-terminal tunnel openings reside (see Figure S1 and Text
S1 in Supporting Information (SI)).
The time associated with the formation of the hydrophobic
patch is difficult to estimate accurately, since the process fluctuates
depending on the dynamics of the CETP-droplet complex. In
practice we found the patch to emerge in roughly 10–40 ns, and it
increased to a size of about 1 nm63 nm in 100–500 nanoseconds,
depending on the system studied (see Figure S1). At longer times
the patch fluctuated quite a lot but there was a trend showing a
slow increase in size, suggesting that the total formation time may
be of the order of microseconds.
To gain further support for patch formation, as predicted by
CG simulations, we repeated the analysis with two additional CG
Figure 3. Electrostatic interactions between CETP and lipid
droplet. A) Number of salt bridges formed between the charged
residues of CETP and the head groups of POPCs as a function of time.
The upper profile shows the number of contacts between the positively
charged residues and P atoms of POPCs, and the lower profile shows
the number of contacts between the negatively charged amino acids
and N atoms of POPCs. B) Salt bridge-forming positively (red) and
negatively (blue) charged amino acids marked to the structure of CETP.
Trp residues are labeled and green.
doi:10.1371/journal.pcbi.1002299.g003
Figure 4. Interaction of CETP with core lipids. A) Snapshots from
the coarse-grained simulations CG3 (left) and CG3-90POPC (right). The
upper snapshots show side views and the lower ones top views of CETP
bound to a lipid droplet. In the latter, the hydrophobic patch under
CETP is clearly visible. The structure of CETP has been rendered using
secondary structure information in upper snapshots (b-sheets are
yellow, a-helixes violet and random coils gray) or as dark transparent
phantom in lower snapshots. The green spheres are Trp residues.
POPCs are transparent in the upper snapshots, while those in the
bottom snapshots are visible as grey (the choline head groups are
visible as blue). CEs are rendered with orange spheres. Water molecules
were omitted for clarity. B) Number of contacts between core CEs and
CETP with different surface-core lipid ratios as a function of time.
doi:10.1371/journal.pcbi.1002299.g004
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simulations where we used PME for electrostatics with the non-
polarizable Martini water model, and PME with the polarizable
Martini water model [13]. With the polarizable water model the
solubility of charged species to apolar media should be better
described compared to the standard Martini model. In both
additional CG simulations, hydrophobic patch formation was
observed too (Figure S1).
Given that the patch emerged in CG simulations in tens of
nanoseconds, and the atomistic simulations lasted for 100 ns, we
returned to our atomistic simulation data to consider this aspect in
atomic detail. We analyzed the spatial density profile of POPC
head groups and observed similar hydrophobic patch formation.
For example, in A3 we noticed that a small hydrophobic patch was
formed under CETP already in,20 ns, and the patch slowly grew
in size and number as in,80–100 ns there were two patches close
to one another (data not shown). The fact that also 100 ns
atomistic simulations show the hydrophobic patch formation
confirms that the CETP-lipoprotein interaction is strong specifi-
cally under the concave surface and promotes the formation of a
path between the droplet core and CETP.
The hydrophobic patch formation exposes the hydrophobic
parts of the lipids to the concave surface where the hydrophobic
tunnel openings are located. However, hardly any of the CEs were
in contact with CETP, as can be seen from Figure 4. Thus, we
reduced the number of POPCs from 180 to 90 (CG3-90POPC)
and simulated the system again for 2 ms in order to see if the lower
surface pressure of a lipid droplet would promote the solubility of
CEs to the surface lipid monolayer and the interaction between
CETP and CEs. Indeed, the contacts between core CEs and
CETP increased. Clearly, the concave surface of CETP has some
affinity for CEs, over random thermal fluctuations, as the
hydrophobic patch under CETP guides core CEs to the concave
surface. However, the surface pressure must be low enough for
CEs to localize to the surface monolayer and CETP to bind to the
surface. This implies that the ratio of surface and core lipids
(surface pressure) and the formation of the small hydrophobic
patch under CETP are important factors modulating the core lipid
transfer activity of CETP.
Structure fluctuations show that the hinge region of helix
X is highly mobile
Root mean square fluctuations (RMSFs) of the protein
backbone were analyzed after 40 ns of atomistic lipid droplet
simulations to find the regions, which wobble the most after CETP
attached to the surface of the lipid droplet (Figure 5). This was
done as follows. First, the RMSF of backbone atoms was
computed by fitting the atomic positions to the reference structure
(average structure of CETP after its binding to the lipid droplet
surface) and then calculating the average distance deviation from
the reference structure. The RMSFs of individual backbone atoms
were then averaged per residue to determine the residual RMSF
profile. Similar results were observed in all droplet simulations.
The N- and C-terminal ends and loop regions (marked by omegas)
of CETP showed high fluctuations, as expected. We also found
that in the helix X region (residues 460–476) the conformational
fluctuations peaked near the residue 462. This region has
previously been proposed to be a potential hinge region of helix
X with elevated B-factors [7]. In addition, it was found that the
flaps V1 and V2 resulted in high fluctuations to the RMSF profile
as was also proposed based on the B-factors of the X-ray structure
of CETP [7]. In addition to the suggested high fluctuations, we
found that another five regions of CETP were also highly
fluctuating in each simulation. These regions were V3 (residues
380–400), V4 (residues 40–50), V5 (residues 90–110), V6 (residues
150–170), and V7 (residues 230–260). All regions are found in the
loops, and hence high fluctuations can be expected. Previously it
has been speculated that the hinge region could promote the
needed flexibility to helix X that is important in the lipid exchange
process [5]. To study further the role of helix X in lipid exchange,
we did two additional atomistic simulations to probe its role in the
lipid exchange process, see below.
Helix X regulates the accessibility of cholesteryl esters
inside CETP
Earlier point and deletion mutations suggest that helix X is
important in the transfer of core lipids, while it is not needed in
phospholipid transfer [12]. Since we found that the hydrophobic
patch was formed under the concave surface of CETP in both CG
and atomistic simulations, we asked if the fully formed hydropho-
bic patch could induce changes to the conformation of helix X. To
test this hypothesis, we did one additional atomistic simulation
with 90 POPCs (that is, starting from the system A3-90POPC)
where we expanded the hydrophobic patch under the concave
structure by removing POPCs near the two tunnel openings of
CETP, so that helix X was only able to interact with the
hydrophobic parts of POPCs and CEs. Here, it is worth to
mention that atomistic simulations are the only method of choice
for this purpose, since this kind of conformational change can not
take place in our CG simulations, where we used the elastic
network model to keep the secondary structure of CETP stable
[14]. We found that the conformation of helix X rearranged and
became buried inside the hydrophobic cavity of CETP, where it
interacted with CETP-bound CE (Figure 6). This conformational
change generated a hydrophobic pathway from the droplet surface
Figure 5. Dynamical properties of CETP. A) Root mean square
fluctuations for atomistic droplet simulations. Loop regions are marked
with omegas and the hinge region of helix X has been slightly
darkened. B) Residual B-factors mapped to the backbone structure of
CETP. Red color indicates the most rigid structures, whereas white and
blue indicate the most flexible structural regions. The hinge region of
helix X is marked with a transparent blue sphere.
doi:10.1371/journal.pcbi.1002299.g005
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to the tunnel, increasing the accessibility of core CEs to the
hydrophobic tunnel of CETP.
To further assess the regulatory role of helix X, we created a
deletion mutant of CETP, in which the residues 462–476 (helix X)
were removed from the structure, and we simulated this structure
for 80 ns. Deletion mutation simulation revealed that three CEs
readily diffused into CETP when helix X was completely removed
from the structure (see the spatial density maps and the number of
contacts plot in Figures 6B and 6C). This provides further support
for the view that helix X acts as a lid at the C-terminal tunnel
opening, and that its conformation regulates the accessibility of
CEs to the hydrophobic tunnel.
Discussion
Previously, the role of electrostatic interactions in the formation
of isolable CETP-lipoprotein complexes was demonstrated by
Pattnaik et al., who showed that (in addition to CETP-HDL
complexes) CETP was able to form isolable complexes with LDL
and VLDL particles when negative surface charge was increased
by phospholipase A2 digestion or by acylation of phospholipid
amino groups. They reached the conclusion that the phospholipid
phosphate groups are the primary sites for the interaction of
lipoproteins with CETP [8]. They also found that the formation of
isolated CETP-HDL complexes was hindered by decreasing the
pH, introducing positive divalent ions into the solution, or by
digesting lipoproteins by phospholipase C. Moreover, Nishida et
al. reported that the affinity of CETP for various lipoproteins is
governed by a delicate balance of electrostatics and hydrophobic
interactions [15]. The importance of electrostatic interaction in
CETP binding has been shown also by several point mutation
studies applied to the positively charged lysine residues of CETP
[16]. Our results are in agreement with experiments, as in the
present simulations most of the salt-bridges with the negatively
charged phosphate groups of POPCs were formed by the Lys
residues at the concave surface, when CETP fastened to the lipid
surface. However, also Glu and Asp residues formed salt-bridges
with the positively charged choline groups of POPCs, although the
ratio of salt-bridges formed by the positively and negatively
charged amino acids is approximately 1.8, indicating that mostly
the positively charged amino acids contribute to the formation of
CETP-lipoprotein complexes. Another important factor playing a
role in the binding of CETP is Trp residues located in the flaps V5
and V1 that were found to become buried into the lipid matrix.
Most likely Trp residues add more stability to the CETP-
lipoprotein complexes by anchoring CETP to a lipoprotein
surface. Interestingly, Desmuraux et al. made mutations to the
structurally similar flap V5 region (Trp-91, Phe-92 and Phe-93) of
PLTP and showed that the phospholipid transfer activity of PLTP
from liposomes to HDL particles decreased up to 60% [17]. This
finding together with our results suggests that the flexible flap V5
region of CETP and Trp residues therein are crucial in the
binding of CETP to HDL particles, playing an important role in
the CETP-mediated lipid transfer.
Penetration depth of CETP is an important factor in CETP-
mediated lipid exchange, as it determines how efficiently the
neutral core lipids are able to interact with CETP. Previous studies
have shown that the exclusion pressure of CETP is lower than the
exclusion pressure of other apolipoproteins, like apoA-I [9,10].
Moreover, it has been argued that the weaker penetration of
CETP to the emulsion particles compared to apoA-I makes the
activation energy of the attachment and detachment of CETP
lower, rendering the transportation process more efficient [9,10].
Our atomistic and CG simulation results showed that CETP is not
able to bury its amino acid residues deeper than to the level of the
phosphate groups of POPCs. The above findings therefore imply
that core lipids have to diffuse to or reside at the surface to enter
CETP. Therefore, the amount of core lipids at the lipoprotein
surface is an important factor modulating the activity of CETP, as
has been suggested previously based on liposome studies [18], and
it can be promoted by defects as is outlined below. The number of
surface-located neutral lipids can be regulated by the lipid and
apolipoprotein composition of lipoprotein particles.
Figure 6. Hypothesis for the initial event of helix X assisted
core lipid exchange. A) Two RMSD-fitted snapshots from the
simulation A3-90POPC showing the rearrangement of helix X (darkened
colour). The green conformation is for the open state and the blue one
for the closed state. A more detailed structure of helix X and the role of
the hinge region during the conformational change (red and
transparent region) are shown in the lower snapshots. CEs are shown
as orange sticks. The residues 462–476 and 193–202 of CETP have been
rendered using sticks, and coloring is based on the polarity of residues.
B) Spatial number density of POPCs (grey and transparent) and CEs
(orange) during the simulation A3-90POPC. Core CEs diffuse into the
hydrophobic tunnel of CETP (green spheres) without helix X. C) Number
of contacts between core CEs and interior CE-473 when helix X is in the
open state (black) or completely removed (red).
doi:10.1371/journal.pcbi.1002299.g006
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Interestingly, we found that when CETP attaches to the surface
by the aid of electrostatic interactions, the head groups of POPCs
moved aside, providing access to the hydrophobic lipid region. In
this manner, the two tunnel openings of the concave surface are
exposed to the hydrophobic lipid matrix of the lipoprotein. The
hydrophobic patch formation facilitates, by generating a defect to
the surface monolayer, the diffusion of core lipids to the surface
monolayer region located under CETP (Figure 6B). Thus, the
localization of neutral lipids at the surface monolayer itself is not
crucial to allow CETP to exchange neutral lipids between
lipoproteins but the neutral lipids can enter CETP through the
formation of the hydrophobic patch. Consequently, we envision
that the activity of CETP could be inhibited by nonpolar drugs
that are transferred into the hydrophobic tunnel of CETP through
the hydrophobic core of lipoproteins. Further, we observed that
the concave surface interacted directly with CEs that diffused
more readily to the hydrophobic tunnel openings when the
surface-core lipid ratio was decreased.
Finally, we found CEs to diffuse into the hydrophobic tunnel of
CETP and interact with CETP-bound CE when the conformation
of helix X was in the open state or completely removed. A previous
mutational study argued that CETP is not able to transfer neutral
lipids when helix X is removed from the structure [11,12].
However, CETP is able to transfer phospholipids without helix X.
Our results showed that the conformation of helix X rearranges,
and helix X moves inside the hydrophobic tunnel of CETP where
it can interact with CETP-bound CE. Given this, we suggest that
there are two important functional properties of helix X that make
the neutral lipid exchange possible. First, helix X is able to
facilitate the neutral lipid exchange by opening the hydrophobic
pathway from a lipoprotein surface to the hydrophobic tunnel of
CETP. Second, helix X promotes the diffusion of neutral lipids
from the hydrophobic tunnel to lipoproteins by filling the volume
of CETP-bound neutral lipid when it diffuses out from CETP.
Afterwards, another neutral lipid from the lipoprotein core or
inside CETP could take the place of helix X after which the C-
terminal tunnel opening closes again. We propose that helix X is
needed to prevent the structure of CETP from collapsing as was
registered in the simulation A1 without the CETP-bound lipids.
The above reasons would explain why helix X is important in the
neutral lipid exchange, but not in the exchange of phospholipids.
It is tempting to contemplate the possible roles of helix X in the
inhibition of CETP. It has been reported that dalcetrapib, a novel
CETP inhibitor, binds covalently to CETP by forming a
disulphide bond with Cys-13, which is located inside the
hydrophobic tunnel of CETP [19]. In addition, it has been
suggested that the disulphide bond formation is a necessary
requirement for the dalcetrapib-mediated CETP inhibition.
However, that is not the case with torcetrapib or anacetrapib
(another novel CETP inhibitors), both of which bind reversibly to
CETP [19]. Yet, all inhibitors stabilize HDL-CETP complexes,
which has been found to be the second major inhibitory
mechanism of the neutral lipid transfer exerted by the synthetic
CETP inhibitors [19]. Based on our simulations, we can
hypothesize that helix X is locked to the open state when
inhibitors are bound to CETP. The driving force for this could be
the small size of an inhibitor that enforces helix X to be located
inside the hydrophobic tunnel and, thus, prevents collapse of the
lipid pocket. Another reason could be the more favorable
interaction between helix X and the inhibitor inside the tunnel,
which could conceivably force the conformation of helix X to the
open state, or change the conformation distribution to favor the
open state. Consequently, the detachment of CETP from the
surface of HDL would be hindered since the helix X is not able to
shield the hydrophobic tunnel opening of the lipid pocket when
CETP is completely in the aqueous phase. In addition, the open
state could prevent the binding of phospholipids to the C-terminal
tunnel opening, which, based on the X-ray structure of CETP, is
known to be occupied by phospholipids when CETP is not
attached to a lipoprotein surface. A reduced ability of CETP to
bind and transport phospholipids could further stabilize the HDL-
CETP complex.
In summary, we have provided a detailed atomistic picture
regarding the initial steps in the lipid exchange mechanism of
CETP and, furthermore, we have offered a plausible mechanism
for the exchange of neutral lipids mediated by CETP. Overall, our
work paves the way for additional future studies to elucidate
interactions of the available promising CETP inhibiting drugs,
such as anacetrapib and dalcetrapib, with CETP and CETP-
lipoprotein complexes. Our findings for the factors that affect the
lipid exchange process can also be exploited in the design of novel
molecular agents capable of inhibiting the activity of CETP, one
possible strategy being the design of nonpolar drugs which can be
transferred into the hydrophobic tunnel of CETP. Together with
recent simulation models for both HDL and LDL [20], these ideas
are a reasonable goal already at present.
Materials and Methods
System setup
The coordinate file of CETP in the PDB format with an
accession code 2OBD was acquired from the RCSB Protein Data
Bank. In addition to the protein, the structure provides
information of the lipids carried by CETP: there are two CEs
located inside the long hydrophobic tunnel of CETP, and two
dioleoylphosphatidylcholine (DOPC) lipids that cover the two
endings of the hydrophobic tunnel. The charge state of CETP was
chosen to represent the physiological pH that is 7.4. A detailed
explanation of the protein structure is given elsewhere [7].
For atomic-scale simulations, three different setups were
constructed by combining pre-equilibrated lipid droplets consisting
of 180 palmitoyloleoyl-PC (POPC) and 35 CE molecules [21]. In
each system, CETP was placed approximately at a distance of
1 nm from the surface of the lipid droplet (Figure 2). In the first
simulated system (A1), the two DOPCs and CEs were removed
from CETP. In the second simulation (A2), both DOPCs and CEs
were included, while in the third simulation (A3) only CEs were
kept inside CETP. We also simulated CETP with a planar trilayer
system composed of 512 POPCs and 796 CEs (A4). The droplet
systems were solvated with ,180,000 water molecules at a salt
concentration of 0.2 M including counter ions, while the trilayer
system included ,50,000 water molecules. Altogether, the systems
included ,500,000 atoms. Finally, three additional atomistic
systems were constructed to characterize the role of helix X in lipid
exchange in more detail (see text). First, we studied the effect of the
hydrophobic patch on the structure of helix X by removing half of
the POPCs from A3 at 100 ns (A3-90POPC). Second, we also
considered CETP through its helix X deletion mutant to probe the
regulatory role of the helix. Third, we used A3-90POPC as a basis
and removed some of the surface lipids to model the complete
formation of a hydrophobic patch under the concave surface of
CETP. The context of these simulations to the studied processes
will become clear in the discussion below.
In addition to atomistic simulations, we carried out four coarse-
grained (CG) simulations. First, the system A3 was directly coarse
grained (in the text, we refer to this simulation as CG3) by using a
script that is available at the homepage of the Martini force field.
Second, 90 POPCs were removed from CG3, ending up in the
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system denoted as CG3-90POPC. The systems CG3 and CG3-
90POPC were simulated under standard Martini model (see
below) conditions with regard to electrostatics (using truncation of
electrostatic interactions) and the water model that is non-
polarizable. To clarify the influence of long-range interactions
and the water model, we simulated two additional systems. That is,
in the third case we focused on the system CG3 which was
simulated with full electrostatics using the particle mesh Ewald
(PME) method [22]. Finally, in the fourth coarse-grained model,
we simulated the system CG3 using both PME and the polarizable
Martini water model [13].
Simulation parameters and force field
The GROMACS simulation package with version 4.0 was used
in the simulations [23]. In atomistic studies, we used the Nose-
Hoover thermostat [24,25] with a coupling constant of 1.0 ps to
set the temperature to 330 K in which the particle core is certainly
in liquid state. The pressure was set to 1 bar using the Parrinello-
Rahman barostat [26] with isotropic pressure coupling and a
coupling constant of 0.1 ps. The van der Waals interactions were
chosen to have a cutoff at 1.0 nm. Electrostatic interactions were
evaluated by the particle mesh Ewald technique with a real space
cut-off of 1.0 nm [22]. Water molecules were described using the
SPC water model. All non-water bonds were constrained using the
LINCS algorithm [27] and the SETTLE algorithm [28] was used
to constrain water molecules, allowing the use of a time step of 2 fs
in the integration of equations of motion. Berger parameters [29]
were used for lipids, while the GROMOS53A6 force-field [30]
was employed for the protein. Combination rules were introduced
for the interactions between lipids and the protein. The four
leading atomistic systems (A1–A4) were simulated for 100 ns, and
the last two ones that focused on helix X for 80 ns. The total
simulation time of atomistic simulations was 0.56 ms.
CG simulations were also carried out with GROMACS, using
the Martini force field with an extension to proteins [31,32]. The
ElNeDyn elastic network model was used to keep the structure of
CETP stable [14]. The Berendsen thermostat and barostat were
used with time constants of 1.0 ps. Temperature was set to 320 K
and isotropic pressure coupling was used with pressure set to 1 bar.
Cut-off distance for electrostatic interactions was set to 1.2 nm.
For Lennard-Jones interactions we used a cut-off of 1.2 nm, and
Lennard-Jones interactions were shifted to zero from 0.9 nm.
Time step was 25 fs. The simulation time of each CG system was
beyond 2 ms, and the times reported here are given in units of the
effective Martini time. All rendered figures were done by VMD
[33].
Supporting Information
Figure S1 Spatial density maps for one of the atomistic systems
and for two additional coarse-grained models.
(TIF)
Figure S2 Number of intrinsic contacts of CETP as a function of
time.
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ABSTRACT: We compare the behavior of unlabeled and BODIPY-labeled cholesteryl ester
(CE) in high density lipoprotein by atomistic molecular dynamics simulations. We ﬁnd
through replica exchange umbrella sampling and unbiased molecular dynamics simulations
that BODIPY labeling has no signiﬁcant eﬀect on the partitioning of CE between HDL and
the water phase. However, BODIPY-CE was observed to diﬀuse more slowly and locate
itself closer to the HDL-water interface than CE due to the BODIPY probe that is
constrained to the surface region, and because the CE body in BODIPY-CE prefers to align
itself away from the HDL surface. The implications as to the suitability of BODIPY to
explore lipoprotein properties are discussed.
1. INTRODUCTION
Bioimaging has become one of the versatile techniques in
considerations of cellular systems.1−3 “Seeing is believing”, as
many say; thus, there is considerable interest to develop and
use techniques that render visualization of the various transport
processes in cells possible, thereby also helping in the
clariﬁcation of physiological and pathophysiological changes
in the body.
Fluorescent probes are one of the means used for this
purpose.4−6 When bound to their host molecules such as lipids
or proteins, they allow one to follow the motion of the host
molecule in question, which in turn can reveal a wealth of
information on cellular processes. The probes have a number of
advantages as they enable highly sensitive studies of local and
time-dependent phenomena with limited invasion, and the
ﬂuorescence signal of the probe can be modulated to yield
information on phenomena based on activation, too. Especially
the emergence and establishment of super-resolution micros-
copy have generated a lot of momentum for the development
and use of novel ﬂuorescent probes that have consequently
become indispensable tools in modern cell biology to
investigate nanoscale dynamical processes.
Unfortunately, the advantages of ﬂuorescent probes also have
a price. Perhaps the greatest concern is the inevitable fact that
labeling changes the nature of the host molecules attached to
probes. Therefore, the labeled molecule may not interact with
its surroundings in a similar manner as the unlabeled (pristine)
counterpart, and the information given by the probe may not
reﬂect the environment that it is designed to gauge. Obviously,
the probe would be the better the less it perturbs the host
molecule and its vicinity.
Given that the size of ﬂuorescent probes is typically of the
order of nanometers, the atomistic molecular dynamics (MD)
simulation7,8 is deﬁnitely the method of choice to investigate
how signiﬁcantly probes alter the properties of the system they
gauge. Until now this approach has been used mainly in the
context of lipids, where previous studies have largely focused on
probes embedded in lipid membranes. Studies of, e.g., pyrene,
diphenylhexatriene, BODIPY, and Texas Red, have shown9−14
that probe-induced perturbations are local and extend typically
only a few nanometers away from the probe. Yet, as the
perturbations can be locally signiﬁcant, the data measured
based on probes has to be interpreted with great care.15
Here we consider this issue in the context of the high density
lipoprotein (HDL). The role of HDL is important in
preventing cardiovascular disease, since it carries cholesterol
and cholesteryl esters (CEs) from cells to the liver in
circulation,16 and by doing so it also works against the
formation of atherosclerotic plaques by removing excess
cholesterol and its esters.17 Meanwhile, low density lipoprotein
(LDL) acts as the reverse of HDL, carrying cholesterol and CE
molecules in the blood to be taken up by cells. Cholesteryl ester
is transferred between HDL and LDL in a process mediated by
the cholesteryl ester transfer protein. Besides being a key
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molecule in cholesterol transport, CE is a major component of
atherosclerotic plaques.18,19
Mature HDL particles that transport cholesteryl ester are
spherical and have a size range from 7.5 to 11 nm in
diameter.20,21 The amphipathic surface of a HDL particle
consists of apolipoprotein molecules and a monolayer of
phospholipids and cholesterol. Under its surface, there is a
hydrophobic core of cholesteryl esters and triglycerides as a
disordered melt. The numbers of apolipoprotein molecules and
lipids vary with the size of the HDL particle.21−23 Although it is
diﬃcult to directly study HDL due to its small size and
heterogeneity, recent experimental and computational studies
have provided insight into its structure and dynamics.24−29
The molecular-level understanding of the mechanisms
related to HDL and cholesterol transport is essential for
designing eﬀective treatments for diseases caused by high levels
of cholesterol. As discussed above, ﬂuorescent probes are a very
useful tool for revealing these mechanisms. During the past
decade, dipyrromethene diﬂuoride (BODIPY) probes have
been found to be useful in the study of cholesterol-related
systems.4,30 Speciﬁcally, a compound where the BODIPY
moiety is linked to the carbon-24 in cholesterol has been shown
to reproduce some key features of cholesterol including
membrane partitioning and traﬃcking.4,31−34
In order to study cholesterol transport in a lipoprotein
environment, it is important to label also the esteriﬁed form of
cholesterol. Recently, this has been done with a cholesteryl 1-
pyrenedecanoate probe in reconstituted discoidal HDL
particles.35 To our knowledge, the behavior of esteriﬁed
BOPIPY-labeled cholesterol in lipoproteins has not yet been
characterized. However, access to an eﬀective and well-
characterized ﬂuorescent CE analogue would be paramount
for eﬀorts to study cholesterol transport.
In this study, we unravel how the structural and dynamical
properties of BODIPY-labeled CE diﬀerentiate from those of
unlabeled CE inside spherical HDL particles. To this end, we
consider atomistic simulation models studied through the
replica exchange umbrella sampling (REUS) technique as well
as conventional (unbiased) molecular dynamics simulations.
REUS calculations have been shown to increase the accuracy of
free energy results compared to regular umbrella sampling,36,37
thus it is an ideal technique to elucidate how BODIPY
inﬂuences the partitioning of CE to HDL. Meanwhile, unbiased
atomistic MD simulations are used in this work to get a detailed
picture about BODIPY-induced changes in the structural
organization and the diﬀusive dynamics inside HDL. We
show that BODIPY labeling has no signiﬁcant eﬀect on the
partitioning of CE between HDL and the water phase.
However, due to the hydrophilic nature of the BODIPY
moiety, BODIPY-CE was observed to diﬀuse more slowly and
locate itself closer to the HDL-water interface than CE due to
the double constraint of keeping the BODIPY probe in the
surface region and the CE body away from it. We close the
article by brieﬂy discussing the implications of the observed
ﬁndings.
2. METHODS AND ANALYSIS
2.1. Model Systems. We modeled HDL particles with
diﬀerent lipid compositions through a series of replica exchange
umbrella sampling (REUS) simulations and unbiased molecular
dynamics (MD) simulations. In each simulation, there was a
single HDL particle solvated in water. Our atomistic model of
the HDL particle was taken from a previous study28 and
contained a hydrophobic core (see below) surrounded by 56 1-
palmitoyl-2-oleoylphosphatidylcholine (POPC) molecules, and
two apolipoprotein A-I chains on the surface of the particle.
The apoA-I proteins were placed in a hairpin arrangement. The
HDL particle was solvated by 48 000 water molecules.
In pristine HDL, the hydrophobic core was comprised of 16
cholesteryl ester (CE) molecules that in our simulations were
chosen to be cholesteryl oleate. In modiﬁed HDL, one or three
of the CE molecules were replaced with BODIPY-cholesteryl
ester (BODIPY-CE). In this paper, we use the notation 13/3,
15/1, and 16/0 to describe the numbers of CE and BODIPY-
CE molecules, respectively, in each system. Notably, in two
model systems an additional CE or BODIPY-CE molecule was
pulled into the HDL particle, making the total number of CE
and BODIPY-CE molecules 17. The chemical structures of CE
and BODIPY-CE are shown in Figure 1. All performed REUS
and unbiased simulations are summarized in Table 1. The
details of system preparation and simulations are given in
sections 2.3 and 2.4.
2.2. Force Field and Simulation Parameters. We used
the Berger force ﬁeld for the lipids38 together with the OPLS-
AA force ﬁeld for the proteins.39 Combining the two force
ﬁelds has been validated in an earlier study.40 We applied the
combination rules with the technique described by Neale and
Pomes41 to combine the two force ﬁelds. The force ﬁeld
parameters for the BODIPY probe were adapted from an earlier
study.31 For water, we used the SPC model.42 We applied the
Nose−́Hoover thermostat43,44 and the Parrinello−Rahman
barostat45 to maintain a temperature of 310 K and a pressure
of 1 bar. We used a time constant of 5 ps for temperature and
pressure coupling, and a compressibility of 4.5 × 10−5 bar−1 for
the coupling of pressure in the barostat.
Figure 1. Chemical structures of unlabeled and BODIPY-labeled
cholesteryl oleate. The positions of carbon atoms C3 and C17, which
deﬁne the director of the molecule, are also shown.
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We used a cubic simulation box with sides of 11.8 nm in
length and applied periodic boundary conditions in all
directions. The linear constraint solver (LINCS) algorithm46
was used to constrain all bond lengths. The Lennard-Jones
interaction cutoﬀ was 1.4 nm. Electrostatic interactions were
calculated by the particle mesh Ewald method47 with a grid
spacing of 0.12 nm and a Coulomb cutoﬀ of 1.0 nm. A time
step of 2 fs was used in the simulations.
2.3. Replica Exchange Umbrella Sampling. We
calculated all free energy results with the REUS technique,48
which has been shown to improve the quality of the resulting
free energies compared to regular umbrella sampling.36,37 We
used the REUS simulations to calculate the free energy change
of detaching CE and BODIPY-CE molecules from HDL. The
REUS method combines umbrella sampling49,50 with replica
exchange of the umbrella potentials. In conventional replica
exchange, exchanges take place between systems at diﬀerent
temperatures. In REUS the exchange is done between
neighboring umbrella windows, which are all considered at
the same temperature, and a replica exchange event then means
exchanging the umbrella potentials of two neighboring
umbrella windows. To carry out REUS simulations, we used
a customized version of the GROMACS 4.6.5 molecular
dynamics software package.51 We used a force constant of 1000
kJ mol−1 nm−2 for the umbrella potentials and an exchange
attempt interval of 2 ps for replica exchange. The free energy
proﬁles were computed with the weighted histogram analysis
method and the error estimation was done with bootstrap
analysis with autocorrelation estimation.52,53
For the REUS simulations, we started with an initial
conﬁguration for HDL from a well-equilibrated system
(simulated for ∼650 ns without any umbrella potential). To
generate the initial conﬁgurations for the umbrella windows,
four diﬀerent methods were used. For the two 13/3 CE/
BODIPY-CE systems with the pull direction outward from
HDL, we pulled a single CE or BODIPY-CE molecule out of
the HDL particle into the water phase (for the simulated
systems, see Table 1). For the two 13/3 systems with the pull
direction inward, the system was ﬁrst let to evolve for 100 ns
with the pulled CE or BODIPY-CE molecule kept at a distance
of 5.5 nm from HDL center, followed by pulling the molecule
back to the inside of the HDL particle. For the 13/4 and 14/3
systems, a BODIPY-CE or CE molecule was added to the water
phase and pulled into the HDL particle. Finally, for the 15/1
system, a single CE molecule was removed from the HDL
particle and a BODIPY-CE molecule was added to the water
phase, followed by pulling the BODIPY-CE molecule inside the
HDL particle. Using the above procedures, we generated 54
umbrella windows for each system with a spacing of 0.1 nm
between the windows. To get the free energy proﬁles, we ran
the umbrella simulations for 200 ns per window for a total
simulation time of 10.8 μs per system. The ﬁrst 50 ns of each
umbrella window were discarded as equilibration.
The reaction coordinate r was chosen as the distance
between the center of mass (COM) of HDL and the COM of
the cholesterol ring in the target CE or BODIPY-CE molecule,
except in one test case where the COM of the whole pulled
molecule was used instead of the COM of the cholesterol ring.
In the free energy proﬁles, we deﬁne ΔEmin as the minimum
free energy with respect to the free energy in the water phase,
r(ΔEmin) as the corresponding value for the distance r, and
ΔEcore as the free energy diﬀerence between the minimum free
energy and the free energy at r = 0.2 nm.
The free energies discussed in the results section correspond
to the two systems with CE/BODIPY-CE counts of 13/3 and
15/1. In the 13/3 system, we calculated the free energy proﬁles
for both CE and BODIPY-CE. In the 15/1 system, we made
the proﬁle for BODIPY-CE only. To make sure that our main
ﬁndings were not compromised by any of the practical choices
made for the calculations in the studied systems, we performed
additional REUS simulations where we varied the lipid counts,
the pulling of the center of mass, and the pull direction. Full
description of the additional simulations is given in the
Supporting Information (SI).
2.4. Unbiased Simulations. To study the behavior of CE
and BODIPY-CE molecules in HDL without any biasing
potential, we made four separate simulations with no umbrella
sampling (Table 1). The length of each of these unbiased
simulations was 1 μs, and the CE/BODIPY-CE counts were
13/3, 13/3, 15/1, and 16/0. An energy minimization followed
by a 100 ns equilibration run was done for each model system
before starting production simulations. The unbiased simu-
lations were made with the GROMACS 4.6.5 software.51
2.5. Radial Distribution Functions and Orientation
Angles. We calculated the radial distribution function (RDF)
from the four independent unbiased simulations listed in Table
1. The RDFs were computed atom-wise using volume and
density normalization and using the COM of HDL as the
reference point (r = 0).
To study the orientations of CE and BODIPY-CE in the
umbrella sampling simulations, we deﬁned the molecular
director as the vector from the carbon atom C17 to C3 in
the steroid moiety of the molecule (see Figure 1). Further, for
this calculation the eﬀective local normal of HDL was taken as
the vector from the COM of HDL to the midpoint of the
director. The orientation angle θ was then deﬁned as the angle
Table 1. Summary of the simulations made in this studya
simulation
CE/
BODIPY-
CE counts
simulation
type
pulled
molecule
pull
direction
reaction
coordinate
1 15/1 REUS BODIPY-
CE
in HDL COM −
ring COM
2 13/3 REUS BODIPY-
CE
in HDL COM −
BODIPY-CE
COM
3 13/4 REUS BODIPY-
CE
in HDL COM −
ring COM
4 13/3 REUS BODIPY-
CE
out HDL COM −
ring COM
5 13/3 REUS CE in HDL COM −
ring COM
6 14/3 REUS CE in HDL COM −
ring COM
7 13/3 REUS CE out HDL COM −
ring COM
8 13/3 unbiased none n/a n/a
9 13/3 unbiased none n/a n/a
10 15/1 unbiased none n/a n/a
11 16/0 unbiased none n/a n/a
aThe details on preparing and running the simulations are described in
sections 2.3 and 2.4. In the reaction coordinate, “ring COM” refers to
the center of mass (COM) of the cholesterol rings in the pulled
molecule, and “BODIPY-CE COM” refers to the center of mass of the
whole pulled molecule. “REUS” stands for Replica Exchange Umbrella
Sampling, “unbiased” stands for MD simulations without any biasing
potential, and “n/a” stands for not available. The pull directions “in”
and “out” correspond to motion that is directed towards the HDL
center, and away fror it, in respective order.
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between the director and the eﬀective normal. To plot the
density map of orientations, we divided the distance r into 0.1
nm bins and calculated the angle distribution in each bin.
2.6. Diﬀusion. We used the method described by Vuorela25
to compute the diﬀusion coeﬃcients of CE and BODIPY-CE.
In this approach, we calculated over a time interval Δt the
displacement of the molecule whose motion was being
followed. During the time interval Δt the molecule moved a
relatively short distance inside the HDL particle. Then one
ﬁnds the probability distribution function to ﬁnd the molecule
at a distance r from the origin after time Δt has elapsed:
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Δ
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Δ
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in three dimensions (3D). The displacement distribution
function is then the probability distribution for the distance
that the COM of the particle has traveled during the given time
interval Δt. Importantly, as the above equations highlight, the
distribution is diﬀerent in 2D and 3D motion, which provides a
means to clarify whether the molecule in question moves along
the particle surface (approximately in a 2D manner) or
uniformly in the hydrophobic core region (as in 3D motion).
To ﬁx the value of Δt, we used the value of D = 0.36 × 10−7
cm2 s−1 reported earlier for CE diﬀusion in HDL.25 Then based
on the expected 3D diﬀusion of CE, the average length
migrated by the diﬀusing particle during a period Δt is lD =
(6DΔt)1/2. To consider particle displacements smaller than the
molecular size, we used an educated guess of about 1 nm for lD,
which is satisﬁed if Δt is 50 ns. During the analysis (see section
3.3), this choice turned out to be appropriate.
The displacements were calculated for the center of mass of
the sterol rings in CE and BODIPY-CE. The data for the
displacements were taken from the same 1 μs unbiased
simulations that we used to calculate the radial distribution
functions. For each molecule type in each of the four simulated
systems, we calculated an averaged diﬀusion coeﬃcient using
the displacement data of all the identical molecules.
3. RESULTS AND DISCUSSION
3.1. Labeled Cholesteryl Ester Orients So that the
BODIPY Moiety Touches the Headgroup Region at the
Surface of HDL. The radial distribution functions are shown
in Figure 2. One ﬁnds that in the unlabeled (pristine) HDL
(without BODIPY-CE; Figure 2d) there are apoA-I proteins
located at the surface region surrounding the lipid particle,
which in turn has a surface region comprised of POPCs. The
CE molecules are in the core, and based on their radial
distribution they are randomly oriented as in a melt.
Comparison of the unlabeled HDL (Figure 2d) to the HDL
systems with BODIPY-CE (Figures 2a−c) reveals that there is
one major diﬀerence: the structure in the core of HDL where
cholesteryl esters and BODIPY-CE molecules reside. The
surface region comprised of apoA-I and POPC is largely similar,
however, with minimal changes induced by the probe.
BODIPY-CE does not favor being in the center of the HDL
particle. This is highlighted by the data in Figures 2a−c, which
show that both the oleate tail and the ring part of BODIPY-CE
avoid the particle center. This is due to the BODIPY moiety,
which instead of the hydrophobic core of HDL favors being in
the region between the acyl chains and the headgroups of the
Figure 2. Radial distribution functions from four independent unbiased simulations of HDL. From a to d, the CE/BODIPY-CE counts are 13/3, 13/
3, 15/1, and 16/0, in respective order. At small distances the RDF value of the CE ring extends to ∼250, but for clarity’s sake we draw the plot only
up to 140. In panel b, one of the BODIPY-CE molecules is oriented tangentially with respect to HDL, giving rise to a shoulder in the plot of the
BODIPY-CE ring at r = 2.3 nm.
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phospholipids. As the BODIPY unit is tightly bound to this
region, it also aﬀects the radial distribution of the probe overall,
which is quite evident when the radial distribution functions of
CE and BODIPY-CE are compared in Figures 2a−c: the large-
distance tails of the distributions of the ring and the oleate
chains of BODIPY-CE are ∼0.5 nm closer to the HDL surface
than in the corresponding distributions of CE.
The orientation angles of CE and BODIPY-CE are shown in
Figure 3. The most important diﬀerence between CE and
BODIPY-CE is found at the respective r(ΔEmin) of each
system, where the free energy is minimized (see Figure 4,
section 3.2): at about 0.8 nm for 13/3 CE, and at ∼1.6 nm for
13/3 and 15/1 BODIPY-CE. For CE, the orientation of the
cholesterol ring at r = 0.8 nm covers all possible values from 0
to 180° with a slight preference for angles between 50 and
140°. In contrast, in the 13/3 and 15/1 systems close to 1.6
nm, BODIPY-CE strongly favors angles from 110 to 150°,
while the angles below 60° are completely absent. Thus,
BODIPY-CE aims to orient itself in a manner where the
ﬂuorescent probe is pointing outward from the center of HDL.
The same conclusion holds over the entire range of r for which
the free energy is less than ΔEmin + 3 kcal mol−1 (c.f. section
3.2), regarding both CE and BODIPY-CE.
The two BODIPY-CE simulations (Figures 3b,c) diﬀer from
each other in their angle distributions at 2 nm < r < 5 nm. This
is due to the fact that in these two sets of umbrella sampling
simulations, the BODIPY-CE molecule took diﬀerent paths
from the water phase into its minimum free energy position
inside the HDL particle. For example, at r = 4 nm, the angle
distributions show a “probe up” orientation for the 13/3
simulation and a sideways orientation for the 15/1 simulation.
Despite these diﬀerent ways to enter HDL, the free energy
results are very similar in the two simulations, as discussed in
the following section.
3.2. Free Energy Calculations Show Diﬀerent Local-
ization of Unlabeled and BODIPY-Labeled Cholesteryl
Ester. The free energy proﬁles of CE and BODIPY-CE are
shown in Figure 4. The values of free energy minimum
positions as well as the corresponding free energies are listed in
Table 2. For BODIPY-CE, there are results shown from two
diﬀerent simulations to illustrate the fact that independent
simulations with slight diﬀerences in system preparation result
in similar conclusions. This conclusion holds for all the seven
diﬀerent REUS simulations, but for the sake of conciseness, we
focus here on the three simulations shown in Figure 4. For a
full description of all the free energy proﬁles based on the
REUS simulations, see SI.
Based on the values for ΔEmin, it is very favorable for both
labeled and unlabeled CE to enter the HDL particle from the
water phase. The free energy minima of CE and BODIPY-CE
are essentially identical with respect to the free energy in the
water phase. The main diﬀerence is the position of the free
energy minimum, r(ΔEmin), which for BODIPY-CE is about
0.7−0.8 nm closer to the HDL surface than in the case of CE.
In the minimum free energy position, the BODIPY probe is in
contact with the HDL-water interface region composed of the
apoA-I proteins and the phospholipid headgroups. This places
the ring and the oleate tail of BODIPY-CE into the core of
HDL, in contact with cholesteryl esters and POPC hydro-
carbon tails. CE also has more freedom than BODIPY-CE to
move in the HDL core. To express this quantitatively, the range
of distance r for which the free energy is less than ΔEmin + 3
kcal mol−1 is 2.1 nm (between 0.04 and 2.12 nm) for CE
Figure 3. Orientation of the cholesterol ring during umbrella sampling for (a) 13/3 CE, (b) 13/3 BODIPY-CE, and (c) 15/1 BODIPY-CE. White
regions correspond to no observations. Angles between 90 and 180° correspond to the BODIPY probe pointing “outward” away from the center of
HDL and the oleate tail pointing “inward” toward the HDL center. At r < 1.5 nm, the density of angles in (a) is almost uniform. In contrast, there is
a high density of angles between 110 and 160° in (b) and (c) at this distance.
Figure 4. Free energy E as a function of distance r shown for CE and
BODIPY-CE. The distance r is from the COM of HDL to the COM of
the cholesterol ring in CE or BODIPY-CE. The free energy is set to
zero at r = 5.5 nm. The presented data also show the error bars
depicted by varying thickness of the curves.
Table 2. Free Energy Diﬀerences and the Positions of the
Minima for the Systems Shown in Figure 4a
system
ΔEmin
(kcal mol−1)
ΔEcore
(kcal mol−1)
r(ΔEmin)
(nm)
13/3 CE −32.6 ± 0.2 −1.6 ± 0.4 0.8
13/3 BODIPY-CE −32.7 ± 0.2 −5.9 ± 0.4 1.7
15/1 BODIPY-CE −33.0 ± 0.5 −5.7 ± 0.9 1.4
aΔEmin is the minimum energy, r(ΔEmin) is the corresponding value of
distance r, and ΔEcore is the free energy diﬀerence between the
minimum free energy and the free energy at r = 0.2 nm. The value of
0.2 nm is used here instead of r = 0, since the number of samples in
the HDL center is very low, and the value of 0.2 nm was the limit very
close to the origin where sampling was still considerable. The values of
r(ΔEmin) listed here are consistent with the RDF data from our
unbiased simulations in Figure 2.
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compared to 1.6 nm (between 0.86 and 2.41 nm in 13/3 and
0.75−2.25 nm in 15/1) for BODIPY-CE, see Figure 4.
The diﬀerent values of ΔEcore for BODIPY-CE and CE bring
out another important diﬀerence between the labeled and
unlabeled molecules. For BODIPY-CE, the high free energy
cost to approach the HDL center implies that the labeled
molecule does not diﬀuse all the way to the core but remains in
the region between the core and the hydrophilic surface of
HDL. For CE, the free energy barrier is much smaller and of
the order of thermal energy, thus in this case the unlabeled CE
does readily migrate in the HDL center region, too. These
results are consistent with the data in Figure 2.
Consideration of the contacts of each molecule in their
respective free energy minimum energy positions (see SI)
reveals that the ring of CE is surrounded mostly by other CE
molecules as well as some POPC tails, while the ring of
BODIPY-CE is mostly in contact with POPC tails rather than
CE molecules. Therefore, CE and BODIPY-CE are in quite
diﬀerent local environments. The free energy minimum of
BODIPY-CE correlates with the smallest value of r where the
BODIPY moiety makes contact with the POPC headgroup and
the protein regions. This indicates that BODIPY-CE is
balancing between the tendency of the CE body to reside in
the core and the anchoring of the ﬂuorescent label to the
headgroup region. This has implications for the ability of
BODIPY-CE to diﬀuse and rotate, which is discussed in section
3.3.
Figure 5 depicts snapshots of HDL based on the REUS
simulations, where the umbrella sampled molecules CE and
BODIPY-CE are shown in their respective equilibrium
positions at r(ΔEmin). It is clearly visible that the ﬂuorescent
BODIPY moiety in BODIPY-CE associates with the headgroup
region of HDL, while unlabeled CE resides in the HDL core.
The snapshots are also consistent with the angle distributions
shown in Figure 3 and the results for contacts discussed in SI.
It is worth pointing out that ΔEcore is negative also for
unlabeled CE, while one could assume ΔEcore to be zero if the
core were homogeneous. However, as Figures 2 and 5 show, it
is not. Based on Figure 2 the size (diameter) of the core under
the phospholipid tail region is about 2 nm, which implies that
there is no space in the HDL core for the formation of a true
bulk region. If the size of the lipoprotein were increased, such
as to consider the low-density lipoprotein (LDL) instead of
HDL, then the situation would likely change. Here, however,
molecular features give rise to the minor free energy barrier
close to the HDL center.
CE and BODIPY-CE have similar values for ΔEmin, which
suggests that the two molecules will in a similar manner readily
assemble into HDL upon contact. In the same spirit, the
partitioning of CE and BODIPY-CE between HDL and the
water phase is expected to be similar.
Figure 5. Cross sections of HDL taken from REUS simulations of (a) unlabeled CE and (b) BODIPY-CE. In (a), the CE molecule (shown in blue)
is the subject of the umbrella potential and shown in its minimum free energy position r(ΔEmin) = 0.8 nm. Likewise, in panel (b), the BODIPY-CE
molecule (shown in green and gray) is the subject of the umbrella potential and shown here at r(ΔEmin) = 1.4 nm. The CE snapshot is taken from
the 13/3 simulation and the BODIPY-CE snapshot is based on the 15/1 simulation. Color code is as follows: umbrella sampled CE (blue); BODIPY
probe attached to CE (green); CE attached to the BODIPY probe (gray); CE (orange); phospholipid tails (cyan); phospholipid headgroups (red);
apolipoprotein A-I (purple).
Figure 6. Particle displacement distributions (shown in blue) of (a) CE and (b) BODIPY-CE in HDL. The distributions are based on displacements
over a period of 50 ns. Also shown are ﬁts based on diﬀusion in 2D (red line), which was found to describe the data better than a ﬁt in 3D (black
line).
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Comparison of the two BODIPY-CE proﬁles (15/1, 13/3)
shows that both simulations yield essentially the same values of
ΔEmin and ΔEcore. The location and the width of the free energy
minima are almost the same as well. These results suggest that
in the considered dilute limit the interactions between
BODIPY-CE probes do not aﬀect the results to a signiﬁcant
extent. Therefore, if in experiments several probes ended up in
the same lipoprotein, the results would still correspond to those
of the dilute limit in BODIPY concentration.
3.3. BODIPY Probe Slows Down the Diﬀusion of
Cholesteryl Ester. We next studied the inﬂuence of the
BODIPY probe on the rate and type of diﬀusion of CE within
HDL. Figure 6 shows the distributions of particle displacements
for CE and BODIPY-CE, together with a ﬁt to the 2-
dimensional (2D) diﬀusion model (both CE and BODIPY-CE
undergo diﬀusion in 2D instead of 3D, see the discussion
below). The diﬀusion coeﬃcient D2D resulting from the ﬁt is
(0.29 ± 0.02) × 10−7 cm2 s−1 for CE and (0.07 ± 0.02) × 10−7
cm2 s−1 for BODIPY-CE. In an earlier computational study
using a coarse-grained model, a diﬀusion coeﬃcient of 0.36 ×
10−7 cm2 s−1 was reported for CE in HDL,25 in good agreement
with the present result.
Because the CE and BODIPY-CE molecules occupy diﬀerent
radial positions in HDL, diﬀerences in their respective diﬀusion
rates can be due to diﬀerences in the viscosities of local
environments. In order to diﬀerentiate between the intrinsic
properties of CE and BODIPY-CE and the eﬀect of the local
environment, we separately analyzed the diﬀusion coeﬃcient of
those CE molecules, which are located at the same distance
from the HDL core as the BODIPY-CE molecules, allowing us
to compare the diﬀusion of BODIPY-CE and CE on equal
footing. The analysis showed that CE molecules in the
BODIPY-CE region have a diﬀusion coeﬃcient of (0.14 ±
0.04) × 10−7 cm2 s−1. Comparing this value to the diﬀusion
coeﬃcient of all CE molecules in the system ((0.29 ± 0.02) ×
10−7 cm2 s−1) suggests that the viscosity in the core is higher
than in the BODIPY-CE region that is close to the surface of
HDL, and the diﬀerence between the calculated BODIPY-CE
and CE diﬀusion coeﬃcients is partly due to this diﬀerence in
the local viscosities. Nevertheless, when the diﬀusion of CE and
BODIPY-CE is compared in the same local environment, CE
still diﬀuses twice as fast as BODIPY-CE.
Recently, Dergunov et al. reported experimentally measured
values of 0.17−0.33 × 10−7 cm2 s−1 for the lateral diﬀusion
coeﬃcient for a cholesteryl 1-pyrenedecanoate (CPD) probe in
reconstituted HDL particles.35 This value is in agreement with
our result for unlabeled CE. Also, there are some important
similarities between our unlabeled CE and the CPD probe. In
CPD, the pyrene moiety is located in the end of the decanoate
tail and the short lipid tail in the cholesterol moiety is
unchanged from regular cholesterol BODIPY. Furthermore, the
pyrene moiety is hydrophobic, which makes the 1-pyrenede-
canoate tail chemically similar to the unlabeled oleate tail, only
somewhat bulkier. Although caution is advised when comparing
our CE and BODIPY-CE calculations to the measurements
done with CPD, the aforementioned similarities between CPD
and unlabeled cholesteryl oleate may explain why the CPD
probe would diﬀuse at the same rate as unlabeled CE, while
BODIPY-labeled CE diﬀuses more slowly.
Several factors may contribute to the result that normal CE
diﬀuses faster than BODIPY-CE. First, the BODIPY probe is
much bulkier than the isobutyl group it replaces in the
cholesterol tail of CE, which slows down the movement of
BODIPY-CE. Second, our free energy calculations show that
BODIPY-CE stays within a narrow distance range from the
center of HDL, approximately between 1 and 2 nm in terms of
distance between the COM of HDL and the COM of the
cholesterol ring, while the equivalent range for CE is 0 to 2 nm.
This limits the distance that BODIPY-CE can diﬀuse along the
direction of the HDL normal. Third, the apoA-I protein chains
hinder the tangential diﬀusion of BODIPY-CE close to the
surface region, especially because BODIPY-CE cannot easily
pivot under the protein because the ﬂuorophore moiety resists
entering the hydrophobic part of the HDL particle.
Interestingly, both types of molecules carry out diﬀusion in
2D rather than 3D (Figure 6). For normal CE, this suggests
that movement along the inner boundary of the amphipathic
surface region of HDL is the dominant type of diﬀusion.
Despite this, we expect that the movement of CE within the
hydrophobic core of HDL would follow diﬀusion in 3D over
some time scale larger than the considered Δt = 50 ns.
However, one has to keep in mind that the diﬀusion of CE
takes place in a conﬁned environment, thus consideration of
diﬀusion over length scales larger than 6 nm (see Figure 2), and
thus over time scales larger than ∼3 μs is not relevant. In a LDL
particle with a larger core, one could try to ﬁt the overall
diﬀusion of CE to a linear combination of the 2D and 3D
models, where the contributions from 2D and 3D would reﬂect
the numbers of CE molecules at the boundary of the
hydrophilic−hydrophobic region and in the hydrophobic
core. As for the diﬀusion of BODIPY-CE, we concluded from
our free energy calculations that BODIPY-CE tends to stay at
the boundary between the surface and the core regions, thus
our ﬁnding that BODIPY-CE undergoes diﬀusion in 2D is
consistent with this.
4. CONCLUSIONS
In summary, we have considered how well BODIPY-CE mimics
the distribution of CE inside a HDL particle, and how its
partitioning and dynamics deviate from the behavior of
unlabeled CE molecules. The atomistic simulation results
from our replica exchange umbrella sampling studies as well as
our unbiased MD simulations showed that BODIPY-labeled
cholesteryl ester localizes just below the phospholipid head-
group and the apolipoprotein regions in HDL particles, while
unlabeled CE resides in the HDL core. Despite this, the free
energy barriers for CE and BODIPY-CE desorption from HDL
to the water phase were found to be essentially identical.
Furthermore, BODIPY-CE was observed to diﬀuse more slowly
than CE due to the double constraint of keeping the BODIPY
probe in the surface region and the CE body away from it. We
conclude that while BODIPY-CE is a useful marker to mimic
CE behavior, the inﬂuence of BODIPY is strong enough to
render the behavior of the BODIPY-labeled cholesteryl ester
qualitatively diﬀerently from its unlabeled counterpart in a
lipoprotein environment. Our results suggest that in order to
ﬂuorescently label cholesteryl ester molecules in spherical HDL
without aﬀecting the behavior of the molecules, one requires a
probe with no aﬃnity for the hydrophilic surface region.
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